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Abstract 
Identification of Novel Lysophospholipid Acyltransferases in Yeast (LPT1) and Humans 
(LPCAT3) and Regulation of Triglyceride Synthesis in Yeast 
Shilpa Jain, MS 
Peter Oelkers, Ph.D. 
 
 
Cells require membranes for survival and need energy to meet the costs of living. 
Phospholipids and triglyceride together fulfill both the requirements. Phospholipids are 
predominant membrane lipids and triglycerides allow for storage of surplus energy therby 
enhancing survival in energy poor conditions. Therefore, an understanding of how cell 
regulates triglyceride synthesis and maintains membrane composition by acyl chain 
remodeling of phospholipids is important.  
Saccharomyces cerevisiae was used as a model system to study the intracellular 
regulation of triglyceride synthesis at the step of diglyceride esterification. Using 
metabolic labeling with [3H] oleate, we found that the inability to hydrolyze fatty acids, 
significantly (p<0.05) increased triglyceride synthesis by 75%. Disabling glycogen 
synthesis (alternative energy reserve) did not alter triglyceride synthesis. Additionally, 
inability to store energy as triglyceride did not result in a compensatory increase in 
glycogen synthesis. To address the possibility of regulation at the level of enzyme 
activity, microsomal diacylglycerol acyltransferase assays were performed in the 
presence of a variety of metabolites (AMP, ADP, ATP, NAD+, NADH, acetyl-CoA and 
malonyl-CoA). DGAT activity was not regulated at physiological concentrations of these 
metabolites. 
Acyl chains in the sn-2 position of phospholipids are introduced by de novo 
synthetic pathway involving 1-acylglycerol-3-phosphate acyltransferase (AGPAT) or by 
acyl chain remodeling that requires lysophospholipid acyltransferases (LPLAT). LPT1 
 xii
 
(YOR175c) an acyltransferase with unknown function was identified by its synthetic 
lethal interaction with Slc1, the known AGPAT in yeast. LPT1 was shown to encode for 
a novel AGPAT/ LPLAT in yeast with high apparent affinity for saturated acyl-CoAs but 
higher apparent Vmax for monounsaturated acyl-CoAs. Lpt1 does not share sequence 
similarity with known LPLAT/AGPAT family members and belongs to membrane-
bound-O-acyltransferase (MBOAT) super family. Homology search with Lpt1 identified 
the human MBOAT5, a protein with unknown function. Cell lysates from insect cells 
expressing human MBOAT5 (renamed as LPCAT3) showed a 10 fold increase in 
LPCAT activity over control. In summary, the identification of a novel LPLAT in yeast 
has proved to be the founding member of LPLAT family in humans. Future 
characterization of this family is likely to shed light on how membrane composition is 
adjusted and controlled in humans.   
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CHAPTER 1: INTRODUCTION 
 
 
1.1 Triglyceride synthetic pathway  
 Triglyceride, also known as triacylglycerol, is composed of a glycerol molecule 
joined to three acyl chains by ester bonds. This is an energy-rich molecule that allows for 
compact energy storage and yields twice the amount of energy in comparison to a 
polysaccharide such as glycogen or starch. All eukaryotes and a subclass of prokaryotes 
(Actinomycetes), have intracellular triglyceride stores in structures known as lipid 
droplets, lipid particles and oil bodies. Probably, the ability to store surplus energy in 
form of triglyceride offers a metabolic advantage during the periods of nutritional surplus 
and nutritional stress (Alvarez 2002). Triglyceride also sequesters fatty acids and 
diacylglycerol, precursors for phospholipid biosynthesis. 
The Kennedy pathway or glycerol -3- phosphate pathway is the de novo route for 
intracellular triglyceride synthesis (Kennedy 1961). Initial steps of this pathway are 
common for triglyceride and glycerophospholipid biosynthesis. The Kennedy pathway 
requires glycerol 3-phosphate and fatty acyl-CoA as substrates (Appendix 1). Glycerol 3-
phosphate can be generated either by reduction of dihydroxyacetone phosphate, an 
intermediate of glycolysis, or from the phosphorylation of glycerol.  Acyl-CoAs, the other 
substrates, come from activation of fatty acids by coenzyme A.  Glycerol 3-phosphate 
undergoes sequential acylation by two fatty acyl CoA molecules to form phosphatidic 
acid (PA) (Figure 1.1). 
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Figure 1.1: Triglyceride synthetic pathway 
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Acyl-CoA: glycerol-sn-3-phosphate acyltransferase (GPAT) catalyzes the first step in the 
Kennedy Pathway to form 1-acylglycerol-sn-3-phosphate (lysophosphatidic acid) (Figure 
1.1). The subsequent acylation of 1-acylglycerol-3-phosphate to phosphatidic acid is 
catalyzed by acylglycerol-3-phosphate acyltransferase (AGPAT) also called 
lysophosphatidate acyltransferase (LPAAT). Phosphatidic acid is then converted to 
diacylglycerol in a reaction catalyzed by phosphatidic acid phosphatase (PAP). 
Phosphatidic acid and diacylglycerol generated in this pathway can be converted into 
triglyceride or phospholipid. In the pathway to generate triglyceride, diacylglycerol 
acyltransferase (DGAT) catalyzes diacylglycerol esterification with a third acyl-CoA to 
generate triglyceride. This is the terminal and unique step in the de novo triglyceride 
synthesis. 
 
Triglyceride Synthesis in Yeast 
The triglyceride synthesis occurs in yeast by Kennedy pathway reactions, as 
discussed above, with a few differences. The first step of acylation reaction starts with 
either glycerol 3-phosphate or dihydroxyacetone phosphate (DHAP) and acyl-CoA 
(Figure 1.3). If dihydroxyacetone phosphate is the substrate, it is acylated, and the product 
1-acyl DHAP is reduced to form lysophosphatidic acid. Unlike mammals, DHAP in yeast 
is not   utilized to synthesize ether lipids but contributes to the formation of glycerolipids 
(Coleman 2004). However, the relative contributions of the glycerol 3-phosphate and 
DHAP to triglyceride and phospholipid synthesis are not known (Racenis 1992). 
Lysophosphatidic acid is further acylated to form phosphatidic acid.   
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Figure 1.2: Triglyceride synthetic pathway in mammals 
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Figure 1.3 Triglyceride synthetic pathway in Saccharomyces cerevisiae 
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Diacylglycerol formed from phosphatidic acid is acylated to triglyceride by two reactions, 
acyl-CoA dependent and acyl-CoA independent. The acyl-CoA dependent reaction is 
similar in mammals and yeast. In the acyl CoA independent reaction the diacylglycerol 
esterification occurs by using the sn-2 acyl group of glycerophospholipids preferentially 
phosphatidylcholine and phosphatidylethanolamine (Oelkers 2000). This reaction has not 
been characterized in humans. 
 
1.1.1 Steps and enzymes of triglyceride synthetic pathway 
Step 1: Synthesis of 1-acylglycerol 3-phosphate (Lysophosphatidic acid)  
This is the first step of glycerolipid synthesis. Glycerol-3-phosphate is acylated to 1-acyl-
glycerol-3-phosphate (also known as lysophosphatidic acid) and is catalyzed by acyl-
CoA: glycerol -3-phosphate acyltransferase (GPAT) (Figure 1.1, Appendix 1). 
In mammals 
In mammals, four GPAT isoforms, GPAT1-4 have been cloned. GPAT1 and 
GPAT2 encoded activity is associated with mitochondrial fraction while GPAT3 and 
GPAT4 encoded enzymes are microsomal (Coleman 2004; Cao 2006; Wang 2007; Chen 
2008; Nagle 2008) (Figure 1.2). The microsomal GPAT contributes to about 90% of total 
cellular activity in most tissues. This activity has only been recently characterized hence 
not much is known about its regulation. Regulation of the mitochondrial GPAT has been 
intensively studied and found to occur by the transcriptional activation during adipocyte 
differentiation and by sterol regulatory element binding protein-1c (SREBP-1c) (Ericsson 
1997).  
 7
 
 
The mitochondrial activity is also subject to nutritional and hormonal regulation. 
In rats, 48 hours of fasting has been shown to reduce hepatic mitochondrial GPAT1 
protein expression and activity by 30% while refeeding for 24 hours, a high carbohydrate 
or high sucrose diet increases mRNA abundance and activity by 60% (Lewin 2001). 
Fasting and refeeding result in an increase in insulin secretion hence the mitochondrial 
GPAT mRNA level and activity was examined in streptozotocin induced diabetic mice. In 
the diabetic mice the mRNA levels of the mitochondrial GPAT could not be detected and 
upon insulin injection the mRNA levels increased about 20 fold after 6 hours (Shin 1991).  
In energy rich conditions, there is up regulation of triglyceride synthesis while 
fatty acid utilization by beta-oxidation is reduced. Over expression of mitochondrial 
GPAT in primary cultures of rat hepatocytes resulted in 81% reduction in fatty acid 
oxidation and a significant increase in hepatic diacylglycerol and phospholipid 
biosynthesis. Interestingly, the increase in triglyceride synthesis was seen only in cells 
provided with additional fatty acids in media, akin to energy replete condition favoring 
triglyceride synthesis (Linden 2004). The mitochondrial GPAT activity is affected by 
energy rich and poor conditions in a cell. Low ATP levels result in activation of AMP 
kinase that inhibits mouse mitochondrial GPAT activity in liver and adipose tissue 
(Coleman 2004). Besides these studies, on regulation of mitochondrial GPAT isoform the 
regulation of microsomal isoforms and their contribution to triglyceride synthesis still 
requires future studies.   
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In Yeast 
In yeast, Gat1 and Gat2 are responsible for the GPAT activity in endoplasmic 
reticulum (ER) and lipid particles (Athenstaedt 1997; Zheng 2001) (Figure 1.3). Both 
Gat1 and Gat2 are able to utilize glycerol-3-phosphate and dihydroxyacetone phosphate 
as substrates (Zheng 2001). Both yeast enzymes share sequence similarity (12%) with the 
mammalian mitochondrial GPATs. A gat1Δgat2Δ double mutation is lethal for yeast cells 
indicating that these two genes encode for the principal GPATs in yeast. GAT1 deletion 
results in about 80% decrease in GPAT activity while GAT2 deletion results in 30% 
decrease in GPAT activity. The gat1Δ and gat2Δ single deletion yeast cells when grown 
to mid log phase and pulse labeled with [14C] acetate show 50% decrease in labeling of 
triglyceride in gat2Δ and 50% increase in gat1Δ yeast cells. This results suggests that  
acylation through Gat2 plays a larger role in triglyceride synthesis (Zaremberg 2002). The 
GPAT activity increases by 3-fold in yeast grown in media containing non-fermentable 
carbon sources glycerol and ethanol versus fermentable carbon source glucose (Minskoff 
1994).  Apart from this observation, nothing is known about the regulation of GPAT 
activity in yeast.  
 
Step 2: Synthesis of phosphatidic acid 
Lysophosphatidic acid is acylated by acyl-CoA:1-acylglycerol-3-phosphate 
acyltransferase (AGPAT) also known as lysophosphatidic acid acyltransferase (LPAAT). 
Phosphatidic acid formed by AGPAT is an important intermediate in the Kennedy 
pathway because it can serve as precursor for phospholipids as well as triglyceride 
(Figure 1.1; Figure 1.4; Appendix 1). 
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Table 1.1: Amino acid alignment score of human AGPAT family members 
 
 
 
 
 
 
 
 
 
 
Figure 1.4: Phylogenetic tree based on amino acid sequence similarity of AGPAT 
family members  
 
 
 
Gene Identity (%) 
 AGPAT1 AGPAT2 AGPAT3 AGPAT4 AGPAT5 AGPAT6 AGPAT7 AGPAT8
AGPAT1 - 47 7 13 11 16 16 16 
AGPAT2 47 - 4 10 9 8 16 6 
AGPAT3 7 4 - 61 18 2 6 25 
AGPAT4 13 10 61 - 18 2 4 22 
AGPAT5 11 9 18 18 - 3 8 18 
AGPAT6 16 8 2 2 3 - 12 8 
AGPAT7 16 16 6 4 8 12 - 8 
AGPAT8 16 6 25 22 18 8 8 - 
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In mammals 
The human AGPAT1 and AGPAT2 were identified based on sequence homology 
to the bacterial (plsC) and yeast AGPAT (SLC1) genes (Eberhardt 1997; Stamps 1997; 
West 1997; Aguado 1998) (Figure 1.2). Seven other putative members of AGPAT family 
AGPAT3-9 have been identified. By analyzing the conserved sequences of all the 
AGPAT family members AGPAT1 and AGPAT2 belong to the same sub group and have 
been confirmed as AGPATs. AGPAT3, AGPAT4 and AGPAT5 belong to the same 
subgroup and have very weak AGPAT activities (Figure 1.4, Table1.1) (Agarwal 2007). 
AGPAT1 and AGPAT2 have been shown to convert lysophosphatidic acid to 
phosphatidic acid; the same cannot be said about the biochemical properties of other 
member AGPATs (Leung 2001; Lu 2005) 
Cell lysates from insect cells expressing AGPAT1 showed 3-fold incorporation of 
[14C] oleoyl CoA in lysophosphatidic acid over background (Aguado 1998). The transient 
expression of AGPAT2 in COS 7 cells showed 6 to 17-fold increase in AGPAT activity 
compared to mock transfected cells. The AGPAT1 and AGPAT2 encoded activity was 
specific for lysophosphatidic acid and did not utilize other acyl acceptors, glycerol 3-
phosphate, lysophosphatidylcholine, lysophosphatidylethanolamine (Eberhardt 1997). 
      Murine AGPAT3, AGPAT4 and AGPAT5 expressed in COS-1 cells showed only 1.4 
fold AGPAT activity over the background. The acyltransferase activity in cell lysate was 
measured by incorporation of radioactive [14C]oleoyl-CoA in oleoyl-lysophosphatidic 
acid (Lu 2005). The substrate specificity of AGPAT3, AGPAT4 and AGPAT5 for other 
acyl acceptors has not been determined.  
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Recently AGPAT8 and AGPAT6 were characterized as microsomal GPAT3 and GPAT4 
(Cao 2006; Chen 2008; Nagle 2008). Human AGPAT7 upon ectopic expression in E.coli 
shows weak acyltransferase activity with lysophosphatidylethanolamine (lysoPE) and 1-
alkeny lysoPE (Cao 2008) while mouse AGPAT9 displays lysophosphatidylcholine 
acyltransferase activity (LPCAT1) (Chen 2006; Nakanishi 2006).  
AGPAT1 mRNA is detectable in all human tissues with highest expression in 
skeletal muscle (Agarwal 2002). Overexpression of AGPAT-1 in C2C12 myotubes and 
3T3-L1 adipocytes resulted in 25% increase in AGPAT activity. In AGPAT1 over 
expressing 3T3-L1 adipocytes, the uptake of [3H] oleate and its incorporation in 
triglyceride increased by two fold compared to the mock transfected cells. AGPAT1 over 
expressing C2C12 myotubes upon stimulation by insulin showed 30% decrease in 
incorporation of [14C] glucose in glycogen concomitant with 33% increased incorporation 
in total lipids. In the same study, the immunofluorescence microscopy of 3T3L1 
adipocytes and myotubes showed that the overexpressed AGPAT1 protein was localized 
to cytosol (Ruan 2001). 
 However,  AGPAT1 when expressed in  mammalian Chinese hamster ovary cell 
line, shows endoplasmic reticulum staining and lack of plasma membrane localization 
(Aguado 1998). Thus, the physiological role of AGPAT1 cannot be predicted based on 
the results of this study. AGPAT2 is expressed in most of the human tissues with high 
expression levels in heart and liver. AGPAT2 mRNA levels in adipose are two fold 
higher than AGPAT1 while other AGPATs 3, 4, 5  are not expressed at detectable levels 
in adipose tissue (Agarwal 2002).  
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AGPAT2 gene expression is induced during adipocytes differentiation and is 
required for the early induction of transcription factors (c/EBP and PPARγ) required for 
adipocyte differentiation (Gale 2006). Murine AGPAT3 mRNA shows equal expression 
in all the tissues while AGPAT4 and AGPAT5 are highly expressed in brain and 
epidermis respectively (Lu 2005). 
The biological significance of having multiple (at least 2) isoforms of AGPATs 
has not been determined. One obvious explanation might be the redundancy in AGPAT 
family. This possibility is ruled out because AGPAT2 gene mutation in individuals results 
in congenital generalized lipodystrophy type 1, a disorder characterized by lack of body 
fat, insulin resistance and hypertriglyceridemia (Agarwal 2002). In this condition, other 
members of the AGPAT family cannot compensate for the critical role of AGPAT2 in 
triglyceride synthesis and its role in adipocyte differentiation and maturation. Another 
possibility is that AGPAT isoforms perform different biological functions in different 
tissues. Due to the lack of data about the physiological role of AGPAT isoforms, nothing 
is known about the regulation of multiple AGPAT isoforms. Further studies are required 
to know whether there is coordinated or independent regulation of isoforms and what is 
their contribution in triglyceride synthesis and regulation. 
In Yeast  
In yeast, Slc1 mediates all of the AGPAT activity in the lipid particles and 54% of 
the total enzyme activity in microsomes (Athenstaedt 1997). SLC1 (sphingolipid 
compensation-1) was identified by a screen to search for suppressors of a genetic defect 
in sphingolipid synthesis and was found to be homologous to bacterial AGPAT 
(plsC)(Coleman 1990).  
 13
 
A mutation in the plsC gene causes the strain to grow slowly at 37ºC and not at all 
at 42ºC. The ectopic expression of SLC1 in a bacterial strain mutated for plsC gene 
enabled the strains to grow normally at 37ºC and promoted growth at 42ºC. This 
suggested that SLC1 encodes for AGPAT activity in yeast (Coleman 1990; Nagiec 1993). 
Further studies showed that slc1Δ mutants showed no AGPAT activity in lipid particles 
but microsomes prepared from slc1∆ strain retained 46% of the total AGPAT activity. 
This indicates that alternative pathway or another enzyme involved in glycerolipid 
biosynthesis must exist in yeast, which contributes to the formation of phosphatidic acid 
in the absence of Slc1(Athenstaedt 1997). The enzyme, which mediated phosphatidic acid 
synthesis in yeast in the absence of Slc1 was not known before the current study was 
undertaken (Jain 2007). Triglyceride levels in slc1∆ mutants grown to log phase are 3-4 
times higher than normal (Athenstaedt 1997). This unidentified enzyme with AGPAT 
activity might be primarily involved in triglyceride synthesis. This uncharacterized 
AGPAT activity might have higher expression and activity in specific  growth phase, 
such as log phase or stationary phase, a characteristic shared with diacylglycerol 
esterifying enzymes in yeast (Oelkers 2002). Identification of the enzyme or enzymes 
responsible for the Slc1 independent AGPAT activity will complete the characterization 
of almost all of the enzymes involved in triglyceride synthesis in yeast. The only enzyme 
which has not been characterized yet is the residual magnesium dependent phosphatidic 
acid phosphatase (PAP) activity in cells lacking the known PAPs DPP1, LPP1 and PAH1.  
Acetate labeling of cells lacking PAH1, DPP1, and LPP1 show a minor contribution (~ 
10%) of this unknown enzyme to triglyceride synthesis.  
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Thus the characterization of novel AGPAT in yeast will help to understand 
intracellular regulation of triglyceride synthesis in total.  
 
Step 3: Synthesis of diacylglycerol  
Phosphatidic acid phosphatase (PAP) dephosphorylates phosphatidic acid to form 
diacylglycerol (Figure 1.1). Two kind of PAP activity exist in yeast and mammalian 
tissues. PAP1 is magnesium dependent and is sensitive to N-ethylmaleimide (NEM), a 
cysteine modifying reagent, while PAP2 is neither dependent on magnesium nor is NEM 
sensitive. (Carman 2006).  
 
In mammals 
The PAP1 activity is thought to be involved in the synthesis of triglyceride, 
phosphatidylethanolamine and phosphatidylcholine (Cascales 1984). Studies with rat lung 
microsomes have shown that the magnesium dependent PAP1, was removed from 
microsomes when washed with (0.5M) of sodium chloride while magnesium independent 
PAP-2 remained associated with microsomes. The washed microsomes lost their ability to 
incorporate [14C] glycerol-3-phosphate through phosphatidic acid into triglyceride and 
phosphatidylcholine. There was also a concomitant increase in labeling of phosphatidic 
acid in washed microsomes. Addition of magnesium dependent PAP1 isolated by gel 
filtration from wash supernatant restored the labeling of triglyceride and 
phosphatidylcholine. Magnesium independent PAP2 isolated from cytosol when added to 
the washed microsomes was incapable of restoring glycerolipid synthesis (Walton 1984).  
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PAP1 activity is cytosolic and upon stimulation by fatty acids or acyl-CoAs the 
enzyme has been shown to translocate from cytosol to the endoplasmic reticulum, where 
it is active (Reue 2008).  The molecular identity of PAP1 was unknown until recently. In 
yeast PAP1, activity was purified and the amino acid sequencing identified it as Pah1, the 
yeast ortholog of mammalian lipin protein (Han 2006). LPIN-1 a member of the LPIN 
gene family was initially identified by positional cloning as the gene responsible for fatty 
liver dystrophy (fld), diabetes and diminished adipose tissue in mice (Péterfy 2001). The 
mechanism by which this gene would cause lipodystrophy was not clear.  
Subsequent biochemical characterization of human LPIN 1-3 encoded lipin 
proteins (lipin-1A, lipin-1B, lipin-2 and lipin-3) confirmed their role as PAP activity 
specific for phosphatidic acid. It was an exquisite example of the power of using model 
organisms as tools to establish identity of mammalian lipid metabolizing enzymes.  
Recombinant lipin proteins, when expressed in 293T cells, show that lipin-2 and lipin-3 
exhibit 4- fold less PAP activity than lipin-1. In the fld mice, PAP1 activity encoded by 
LPIN-1 was completely absent in white and brown adipose tissue and skeletal muscle. 
Thus Lipin-1 accounts for all PAP activity in these metabolic tissues (Han 2006; Donkor 
2007). Human LPIN-1 mRNA levels are abundant in liver and brain while LPIN2-3 are 
significantly expressed in stomach, pancreas and intestine (Reue 2008). The lipin-1 
activity is regulated transcriptionally. In primary culture of mouse hepatocytes the mRNA 
level of LPIN-1 increased upon 4 hour incubation in media containing glucocorticoids, 
cAMP and glucagon. There were no changes observed in the mRNA levels of LPIN-2 and 
LPIN-3 isoforms (Manmontri 2008).  
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Lipin-1 undergoes phosphorylation upon insulin stimulation and in sharp contrast, 
epinephrine leads to its dephosphorylation. The phosphorylation did not affect PAP-1 
activity but mediated cytoplasmic to microsomal localization of lipin-1 (Reue 2008). The 
PAP-1 activity levels increased in liver in fasting conditions and this correlated with 
increase in mRNA levels of Lpin-1.  Most of these studies have shown lipin-1 to be the 
regulated isoform and the contribution of lipin-2 and lipin-3 to triglyceride synthesis is 
not known.  
PAP2 activity is less selective for its substrate and dephosphorylates 
lysophosphatidic acid, diacylglycerol pyrophosphate and sphingosine1-phosphate in 
addition to phosphatidic acid. Therefore, this activity is referred to as lipid phosphate 
phosphatase (LPP). LPP1-3, DPPL1 and DPPL2 encode for PAP2 activity in mammals 
(Brindley 2004; Takeuchi 2007). The members of PAP2 (LPP) family are predicted to 
regulate cell signaling by lipid phosphates and their dephosphorylated forms such as 
diacylgycerol and sphingosine (Carman 2006).  
 
In Yeast  
In yeast, PAH1 encodes for PAP1 activity while DPP1, LPP1 contribute to PAP2 
activity (Carman 2006) (Figure 1.3). Pah1 shares sequence similarity with mammalian 
PAP1 enzyme, Lipin1. Pah1 is localized to the cytosolic and membrane fractions of cell. 
The pah1∆ deletion mutants when labeled with 32 Pi to steady state show an increase in 
cellular PA levels by 120-160% consistent with its role as PAP. The pah1Δ mutants 
showed a decrease in phosphatidylcholine (43%) and increase in 
phosphatidylethanolamine (50%) and phosphatidylinositol (80%).  
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The incorporation of [2-14C] acetate in triglyceride was reduced by 92% in pah1Δ 
mutant stationary phase and by 62% in exponential phase. All these results show that 
PAH1 is responsible for the generation of diglyceride required for the synthesis of 
phospholipids and triglyceride in S. cerevisiae (Han 2006). PAP activity  encoded by 
PAH1 is inhibited by phosphorylation and ATP  (O'Hara 2006).  
DPP1 and LPP1 encoded enzymes have broad substrate specificity and they are 
able to utilize lysophosphatidic acid and diacyglycerol pyrophosphate besides 
phosphatidic acid. The dpp1Δlpp1Δ mutants when labeled with [2-14C] acetate did not 
show any major effect on neutral lipid composition in either the exponential or stationary 
growth phase. DPP1 and LPP1 are responsible for regulation of phosphatidic acid levels 
in vacuoles and Golgi but they might not contribute to the de novo synthesis of  
triglyceride that occurs in endoplasmic reticulum (Carman 1997). A dpp1∆lpp1∆pah1∆ 
triple deletion yeast mutant still shows some PAP1 activity, suggesting the presence of an 
additional gene or genes that are yet to be identified (Han 2006).  
 
Step 4: Synthesis of triglyceride 
 In this terminal and unique step of triglyceride synthesis the diglyceride is esterified to 
triglyceride by an acyl CoA: diacylglycerol acyltransferase (DGAT) reaction (Figure 1.1, 
Appendix 1) 
 
In mammals  
DGAT1 and DGAT2 catalyze diglyceride esterification reaction in mammals (Figure 
1.2). DGAT1 was identified by sequence similarity to acyl-CoA: cholesterol 
acyltransferase (ACAT1). Mouse DGAT-1 protein is 20% identical to the mouse ACAT1. 
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DGAT1 cDNA when expressed in H5 insect cells, showed acyl CoA dependent activity 
capable of utilizing only diglyceride (Cases 1998). Normal triglyceride levels in plasma 
and adipose tissue of DGAT1-/- mice indicated the presence of another triglyceride 
synthetic mechanism. Subsequently DGAT2 was identified by sequence homology to a 
DGAT purified from the oleaginous fungus M. rammaniana using column 
chromatography.  DGAT2 does not share sequence similarity to DGAT1 that is a member 
of ACAT family.  DGAT2 when expressed in insect cells showed DGAT activity which 
was specific for diglyceride and sensitive to magnesium chloride concentrations higher 
than 20mM (Cases 2001). DGAT1 and DGAT2 have similar substrate specificities for 
acyl-CoAs and prefer oleoyl-CoA to palmitoyl-CoA, arachidonoyl CoA and linolenoyl 
CoA at a fixed concentration of 25μM (Cases 2001). 
Both DGATs are expressed in tissues that are active in triglyceride synthesis, such 
as white adipose tissue (WAT), small intestine, liver, and mammary gland. DGAT1  
mRNA levels are highest  in small intestine, while DGAT2 is expressed at high levels in 
liver and white adipose tissue (Cases 1998; Cases 2001; Stone 2004).  DGAT1-/- mice are 
viable, have 50% less body fat and are resistant to diet induced obesity. Disruption of 
DGAT2 gene in mice leads to perinatal lethality (~ 6 hours after birth), decrease in plasma 
triglyceride by 64% and undetectable triglyceride in liver (Stone 2004). The inability of 
DGAT1 to compensate for DGAT2 suggests that these two enzymes have different 
functions.  DGAT1 and DGAT2 overexpression in liver increased their mRNA levels by 
ninety fold and two fold and increased the hepatic triglyceride content by three fold and 
five fold respectively.  In comparison to DGAT1, small increase in DGAT2 mRNA 
resulted in greater increase in triglyceride content (Monetti 2007).  
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This study reinforced that DGAT2 might be more specific and effective than 
DGAT1 in promoting triglyceride synthesis. There are very few studies, which have 
examined the regulation of DGATs. In differentiating 3T3-L1 adipocytes, the DGAT1 
mRNA increases by seven fold whereas the protein level increases by 90 fold, suggesting 
posttranscriptional regulation of DGAT1 gene. Increase in DGAT1 protein level by 90 
fold correlated with 100 fold increase in DGAT activity in differentiated adipocytes. 
Overexpression of DGAT1 in 3T3-L1 adipocytes by an adenovirus construct increased 
mRNA levels by 20 fold but the protein levels by only two fold. The discordant DGAT1 
protein and mRNA expression were not due to changes in protein stability. The steady 
state DGAT1 protein levels in 3T3-L1 adipocytes were not altered in the presence of 
proteolytic inhibitor N- acetyl-Leu-Leu-norleucinal (ALLN). In addition, treatment of 
3T3-L1 adipocytes with cycloheximide did not show change in the protein turnover. 
DGAT1 when mutated at conserved tyrosine phosphorylation site to phenylalanine 
(T316F) did not affect DGAT activity in 3T3-L1 adipocytes. DGAT1 encoded enzyme 
activity does not seem to be regulated by phosphorylation. Thus it was speculated that 
regulation of DGAT1 expression occurs at the translational level (Yu 2002).  
Total DGAT specific activity was found to decrease by 86% upon 24 hours 
incubation of 3T3-L1 adipocytes in media not containing glucose. Addition of glucose to 
the media of glucose-starved adipocytes for additional 24 hours increased the DGAT 
activity by 2- fold.  DGAT1 mRNA were abolished in the adipocytes incubated in media 
not containing glucose and were replenished upon addition of glucose to the media. The 
DGAT2 mRNA levels were unaffected by similar treatment (Meegalla 2002). To further, 
study the effect of insulin on DGAT1 and DGAT2 mRNA levels the mature adipocytes 
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were serum starved for 16 hrs followed by addition of insulin for 24 hours. Insulin was 
shown to preferentially enhance DGAT2 mRNA levels (Meegalla 2002). CAAT/enhancer 
binding proteins (alpha and beta) play an important role in adipogenesis and these 
transcription factors have been shown to increase DGAT2 mRNA levels during adipocyte 
differentiation (Payne 2007) 
Studying DGAT2 regulation is complicated because DGAT2 gene family in 
humans has six members, identified by sequence similarity to DGAT2 the original 
member of the family. Three members are monoacylglycerol acyltransferases (MGAT1-
3), which synthesize diacylglycerol by esterification of monoacylglycerol. MGAT1-3 
when expressed in insect cells also show weak DGAT activity(Cao 2007). Two other 
members are wax-alcohol acyltransferases, that synthesize wax esters and the last 
member hDC3 remains to be biochemically characterized (Sturley 2007). 
 
In Yeast    
All the enzymes responsible for mediating diglyceride esterification in 
Saccharomyces cerevisiae have been identified. DGA1, LRO1 and ARE2 encoded 
enzymes mediate diglyceride esterification in yeast (Oelkers 2002) (Figure 1.3). These 
three genes belong to different gene families. DGA1 is the yeast homolog of human 
DGAT2, and is responsible for acyl CoA dependent DG esterification. LRO1 is a member 
of lecithin cholesterol acyltransferase (LCAT) family and mediates triglyceride synthesis 
by an acyl CoA independent mechanism that utilizes phospholipids to esterify 
diacylglycerol (phospholipid diacylglycerol acyltransferase or PDAT) (Oelkers 2002).  
Dga1 and Lro1 mediate most of triglyceride synthesis (98%) while ARE2, a homolog of 
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DGAT1, has a minor role. Depending on the growth conditions, Dga1 and Lro1 
contribute differently to the triglyceride synthesis (Oelkers 2000; Oelkers 2002). The 
dga1Δ yeast strain when grown to stationary phase and pulse labeled with [3H] oleate for 
30 minutes showed 50% reduction in incorporation of radioactive oleate into triglyceride. 
The lro1∆ deletion mutants grown to stationary phase in the similar experiment did not 
show significant change in triglyceride synthesis. However, during exponential growth 
phase lro1∆ deletion led to 75% loss of triglyceride synthesis while dga1∆ deletion 
caused 25% reduction. This suggests that Dga1 can mediate all of the triglyceride 
synthesis in stationary phase in the absence of Lro1, but not in exponential phase where 
Lro1 plays a major role in diglyceride esterification (Oelkers 2000; Oelkers 2002). A 
dga1∆lro1∆are2∆ strain lacks the ability to synthesize triglyceride (Oelkers 2002), and 
has been used a model system to study the role of DGAT2 family members in triglyceride 
synthesis (Turkish 2005). 
 
1.1.2 Regulation of triglyceride synthesis  
Since several enzymes in the triglyceride synthetic pathway have only been 
recently identified, their regulation has just begun to be studied.   The role of transcription 
factors, liver X receptors (LXR), sterol regulatory element binding protein (SREBP-1c), 
peroxisome proliferator-activated receptor-γ (PPARγ) and hormonal and nutritional 
regulators has been acknowledged (Coleman 2004).  However, few studies have focused 
on the enzymes involved in triglyceride synthesis and the intracellular regulation of the 
pathway. There can be multiple points of regulation of a biochemical pathway.  
 22
 
The first enzyme of the metabolic pathways is often the regulated step, and several 
studies have shown that the mitochondrial GPAT regulation occurs at the transcriptional 
level. Interestingly, animal models lacking each of the four reactions of the triglyceride 
synthesis show profound effect on triglyceride levels. The intermediates of the pathway 
lysophosphatidic acid, phosphatidic acid and diglyceride, are signaling molecules and is 
possible that these alter the gene expression of triglyceride synthetic enzymes. Regulation 
is also likely to occur at branch points of the pathway. Diacylglycerol esterification, 
mediated by DGAT is one such branch point. DGAT is the only reaction that exclusively 
mediates the terminal step of triglyceride synthesis. In cultured permeabilized rat 
hepatocytes, under the experimental conditions when the substrates for the triglyceride 
synthetic pathway are available, DGAT has been regarded as a rate-limiting step 
(Mayorek 1989).  
In comparison to mammals, yeast enzymes that mediate DG esterification have 
been completely identified. Yeast cells have fewer and conserved isoforms of triglyceride 
synthetic enzymes and the gene enzyme relationship has been established for almost all of 
them. This, coupled with the availability of powerful genetic tools, can allow studies on 
regulation of intracellular triglyceride synthesis. 
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1.2 Phospholipid Biosynthesis 
 Phospholipids are structural and functional components of biological membranes. 
They typically have a glycerol backbone with acyl chains linked by ester linkage to the 
first and second carbon of glycerol, and a polar group attached by a phosphodiester 
linkage to the third carbon. Phosphatidylcholine (PC), phosphatidylethanolamine (PE), 
phosphatidylinositol (PI) and phosphatidylserine (PS) are the major phospholipids. 
Phosphatidylglycerol (PG) and cardiolipin (CL) are also present in mitochondrial 
membranes (Appendix 1). Phospholipid biosynthesis initially described by Kennedy 
occurs mainly by CDP-diacylglycerol (CDP-DAG) and CDP-choline pathway (Figure 
1.5) (Kennedy 1961). The synthesis of phosphatidic acid, a major building block for 
phospholipids occurs by reactions common to triglyceride synthesis described earlier.  
 Phosphatidic acid is an important branch point intermediate as it can form either 
diacylglycerol or CDP-DAG (Figure 1.5). Phosphatidic acid is converted to 
diacylglycerol, a reaction catalyzed by phosphatidic acid phosphatase (PAP). This 
diacylglycerol can be utilized either to synthesize triglycerides or PC, PE and PS. The 
conversion of phosphatidic acid to CDP-DAG is mediated by CDP-DAG synthase 
(CDS). CDP-DAG is converted to PI, a reaction catalyzed by phosphatidylinsotiol 
synthase (PIS). Cardiolipin, an exclusive mitochondrial phospholipid is also synthesized 
from CDP-DAG.  
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Figure 1.5 Phospholipid synthetic pathway in mammals  The abbreviations used are: 
GPAT: Glycerol-3-phosphate acyltransferase, AGPAT: Acylglycerol-3-phosphate 
acyltransferase, PAP: Phosphatidic acid phosphatase, DGAT: Diacylglycerol 
acyltransferase, CDP-DAG: CDP-diacylglycerol, CDS: CDP-diacylglycerol synthase, 
CL: cardiolipin CLS: Cardiolipin synthase, PI: Phosphatidylinositol, PIS: PI synthase, 
PS: Phosphatidylserine, PC: Phosphatidylcholine, PSS1: PS synthase1, PSS2: 
Phosphatidylserine synthase 2, PSD: PS decarboxylase, PE:Phosphatidylethanolamine, 
PEMT: PE methyl transferase, EK: Ethanolamine kinase, ET: CTP:phosphoethanolamine 
cytidylyltransferase, EPT: Ethanolamine phosphotransferase, CK: Choline Kinase, CT: 
CTP:phosphocholine cytidylyltransferase, CPT: Choline phosphotransferase 
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Figure 1.6 Phospholipid synthetic pathway in Saccharomyces cerevisiae  The 
abbreviations used are: GPAT: Glycerol-3-phosphate acyltransferase, AGPAT: 
Acylglycerol-3-phosphate acyltransferase, PAP: Phosphatidic acid phosphatase, DGAT: 
Diacylglycerol acyltransferase, CDP-DAG: CDP-diacylglycerol, CDS: CDP-
diacylglycerol synthase, CL: cardiolipin CLS: Cardiolipin synthase, PI: 
Phosphatidylinositol, PIS: PI synthase, PS: Phosphatidylserine, PC: Phosphatidylcholine, 
PSS1: PS synthase1, PSD: PS decarboxylase, PE:Phosphatidylethanolamine, PEMT: PE 
methyl transferase, EK: Ethanolamine kinase, ET: CTP:phosphoethanolamine 
cytidylyltransferase, EPT: Ethanolamine phosphotransferase, CK: Choline Kinase, CT: 
CTP:phosphocholine cytidylyltransferase, CPT: Choline phosphotransferase 
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 PC and PE can be synthesized via the CDP-choline and CDP-ethanolamine 
pathway. Choline kinase (CK) mediates the formation of phosphocholine, the first 
reaction of the CDP-choline pathway. The phosphocholine is then converted into CDP-
choline by CTP: phosphocholine cytidylyltransferase (CT). This reaction requires 
activation by cytosine triphosphate (CTP). In the subsequent and last reaction, catalyzed 
by cholinephosphotransferase (CPT), a diacylglycerol molecule is utilized to form PC. A 
similar pathway converts ethanolamine to PE. This PE can get methylated to PC by 
phosphatidylethanolamine methytransferase (PEMT). PC synthesis by methylation in 
addition to CDP-Choline pathway occurs only in liver. In all other tissues CDP-choline 
pathway is the only pathway to synthesize PC.  PS is synthesized from PC and PE by a 
base dependent reaction. PS synthase-1 (PSS-1) mediates exchange of serine for choline 
while PS synthase-2 (PSS-2) uses PE.  PS is also converted to PE by PS decarboxylase 
(PSD). 
In Yeast 
 The basic pathways of phospholipid biosynthesis in S.cerevisiae are similar to those 
in higher eukaryotes with the exception of PS synthesis (Figure 1.6).  In yeast, PS is 
synthesized from CDP-DAG and serine whereas in mammalian cells, the only pathway to 
synthesize PS is a base-exchange reaction in which the head group of PC and PE is 
replaced by serine. PC synthesis in yeast occurs primarily by CDP-DAG pathway 
(Carman 1989), while in mammals with the exception of liver, CDP-choline pathway is 
the only pathway to synthesize PC. 
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1.2.1 Acyl chain asymmetry in phospholipids  
  Phospholipids exhibit a variety in their molecular species, because of different 
combinations of acyl chains present at the sn-1 and sn-2 positions. In general, there is an 
asymmetrical distribution of acyl group on phospholipids (Hanahan 1960). Saturated 
fatty acids are usually esterified at the sn-1 position whereas unsaturated fatty acids are 
esterified at the sn-2 position. This asymmetrical distribution of acyl chains in 
phospholipids might influence the degree of order and motion of phospholipid molecules 
in lipid bilayer, a property referred to as membrane fluidity. The temperature, at which 
the membrane changes from gel like to a fluid like physical state, is dependent on the 
acyl chain composition of phospholipids. This transition temperature (Tt) is higher for 
distearoyl phosphatidylcholine (58ºC), phospholipid with two saturated acyl chains 
compared to 1-stearoyl-oleoyl phosphatidylcholine (3ºC), phospholipid with one 
saturated and one unsaturated acyl chain (Cronan 1975).  
  Membrane properties like carrier mediated transport, phagocytosis and endocytosis 
are affected with changes in acyl chain composition of phospholipids (Spector 1985). It is 
acknowledged that membrane fluidity and properties are also influenced by other 
components of membrane such as cholesterol and proteins. This positional distribution of 
acyl groups in phospholipids is particularly important when arachidonic acid is present at 
the sn-2 position. This fatty acid is a precursor for biologically active eicosanoids (Funk 
2001). The distinct acyl chain composition of phospholipids has been observed in various 
cells and tissues. It is possible that acyl chain composition of phospholipids is required 
for a particular cellular function, an example being dipalmitoylphsopahtidylcholine, a 
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major component of the pulmonary surafactant (Yamashita 1997). Mostly the 
physiological relevance of individual molecular species of phospholipids is not known.  
 
1.2.1.1 Mechanisms to incorporate acyl chains in phospholipids 
  There can be two mechanisms to incorporate acyl chains in phospholipids: (1) de 
novo phospholipid synthesis and (2) acyl chain remodeling of existing phospholipids 
by deacylation/reacylation reaction. 
 
Incorporation of acyl chains by de novo phospholipid synthesis 
  De novo synthetic enzymes catalyzing the fatty acid esterification at sn-2 position 
might determine positional distribution of acyl groups in phospholipids. 1-acylglycerol3-
phosphate acyltransferases (AGPAT) introduce acyl chains at the sn-2 position of the 
glycerol backbone of lysophosphatidic acid to form phosphatidic acid (PA), an important 
intermediate in the de novo synthesis of membrane phospholipids and triglycerides 
(Figure 1.1) (Kennedy. 1961).  Among the AGPATs 1-9, only AGPAT-1 and AGPAT-2 
show robust enzyme activity. Cell lysates from insect cells expressing human AGPAT-1 
using 10μM of acyl-CoAs showed highest activity for palmitoyl-CoA (16:1) and then the 
rank order was C16:0=C14:0=C12:0=C18:2>C18:3=C18:0=C20:4>C18:1. In the same 
study using 45 μM of acyl-CoAs the preference was in the rank order 
C16:1=C16:0=C14:0>C18:3=C18:2>C20:4=C18:0=C18:1. At these two fixed 
concentrations AGPAT-1 seems to utilize wide range of acyl-CoAs from C12- C18   with 
no clear preference for acyl groups by degree of saturation (Aguado 1998).  The 
preference of the AGPAT-2 for different molecular species of acyl-CoA was studied 
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using membrane preparations of Sf9 cells expressing the human AGPAT2. At a single 
concentration of 8μM acyl-CoAs were preferred in the following order: 
C18:1>C18:2=C14:0=C16:0>C18:0>C20:4. The AGPAT2 activity displayed a Vmax of 
200 nmol/min/mg and an apparent Km of 2μM with varying concentrations of oleoyl-
CoA. In the same study competition experiments were performed with Sf9 membrane 
preparations containing AGPAT2, [3H] lysophosphatidic acid, 0.6μM [14C]18:1-CoA and  
1.2 μM unlabeled acyl-CoAs. AGPAT2 displayed equal preference for C18:0-CoA and 
C16:0-CoA in comparison to 18:1-CoA (Eberhardt 1997; Aguado 1998; Leung 2001 
Hollenback 2006). Due to single concentration of acyl-CoAs used in these studies to 
determine the acyl-CoA specificity of AGPAT1 and AGPAT2 it is difficult to compare 
substrate preferences of the enzyme in terms of catalytic efficiency. However, these 
results suggest that AGPAT1 and AGPAT2 might have a generic role in synthesizing 
precursors with a variety of acyl chain composition for phospholipids and triglyceride 
synthesis and might not contribute to asymmetric distribution of acyl chains in 
phospholipids.   
 
Acyl chain remodeling of existing phospholipids 
  Various studies have shown  that the distribution of fatty acids in phospholipids 
present in tissues and cells was different from its precursor molecule phosphatidic acid. 
This suggested that the phospholipid undergo fatty acid remodeling after de novo 
synthesis. Experiments using [14 C]acetate to label fatty acid residues and [14C] glycerol 
to label the glycerol backbone of phospholipids showed for the first time differences in 
turnover of acyl chains and glycerol in phospholipids (Lands 1958).  
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  These results introduced the concept that the phospholipid species synthesized by 
the de novo synthetic reaction undergo deacylation at the sn-2 position by phospholipase 
A2 and reacylation by lysophospholipid acyltransferases to form remodeled phospholipid 
species (Lands cycle) (Figure 1.7). The presence of acyl-CoA dependent 
lysophosphatidylcholine acyltransferase (LPCAT) activity in rat liver microsomes 
supported the idea of phospholipid remodeling (Lands 1960). The rat liver microsomal 
LPCAT activities selectively incorporated palmitoyl-CoA at the sn-1 position of 2- acyl 
lysophosphatidylcholine and oleoyl-CoA at the sn-2 position of 1-acyl 
lysophosphatidylcholine. These experiments were done with mixtures of 1-acyl lysoPC 
and 2-acyl lysoPC with a single concentration of 0.5mM [14C] fatty acid and 0.2mM Co-
A (Lands 1963). This demonstrated the role of acyl-CoA specificity of these activities in 
maintaining asymmetrical distribution of acyl chains in phospholipids. 
  There are very few in vivo studies on the deacylation-reacylation mechanism for 
acyl chain remodeling in phospholipids. Labeled lysophosphatidylcholine (lysoPC) and 
lysophosphatidylethanolamine (lysoPE) when injected intravenously disappeared from 
blood and labeled PC and PE were recovered in organs such as liver, small intestine, 
skeletal muscles, lungs, kidney and heart. To study the mechanism of formation of PC, 
lysoPC labeled in both phosphate (32P) and acyl chain (14C) was injected into rats. The 
labeled PC was found to have a similar 14C/32P ratio suggesting that majority of PC was 
synthesized from lysoPC by acylation reaction and not by transacylation reaction 
between two lysophospholipid molecules (Stein 1966). 
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Figure 1.7 Phospholipid remodeling (Lands Cycle) 
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  Another study showed that remodeling of PC occurred in tissues post synthesis. 
Hamster hearts were perfused with, [1-3H] glycerol and then the lipids were extracted at 
various time points (0, 30, 60, 120 and 240 minutes). Immediately after label was 
introduced, the acyl chain composition of diacylglycerol and newly synthesized PC was 
similar. The composition of newly synthesized PC was different from that of endogenous 
PC. During the chase period the medium chain and saturated species showed gradual 
decrease and dienoic species increased. At the end of chase (240 minutes post labeling) 
the acyl chain distribution in PC was found to be similar to that of the endogenous PC. 
Since the labeling in diacylglycerol decreased by 90% after 30 minutes the redistribution 
of label in molecular species of PC did not occur due to de novo synthesis of 
phospholipids but was a result of acyl chain remodeling of phospholipids by deacylation 
and reacylation (Arthur 1984).  
 
1.2.1.2 Acyl chain remodeling of phospholipids by acyl-CoA dependent 
lysophospholipid acyltransferases  
  Lysophospholipids are acylated by two types of reactions. The acyl-CoA dependent 
reactions involve transfer of acyl group from acyl-CoA to lysophospholipids to form 
phospholipids and these reactions are catalyzed by acyl-CoA: lysophospholipid 
acyltransferases (LPLAT). The acyl-CoA independent reactions also known as 
transacylation, involve the transfer of acyl group of a phospholipid directly to another 
lysophospholipid to synthesize phospholipids. The focus of this study is the acylation 
mediated by acyl-CoA dependent 1-acyl lysophospholipid acyltransferase. 
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  Since LPLAT activity is involved in manipulating the acyl chain composition of the 
phospholipids it is likely that this activity is present in most of the tissues. In rat brain in 
vitro LPCAT activity was demonstrated (Webster 1964). Acylation activity for 1-acyl 
lysophosphatidylinositol and 1-acyl lysophosphatidyserine and 2-acyl 
lysophosphatidylserine was reported in rat liver (Yamashita 1997). In rat liver 
microsomes 0.5mM linoleate in the presence of 0.1mM Co-A was incorporated 
preferentially in the sn-2 position of 1-acyl lysophosphatidylethanolamine in comparison 
to stearate (Lands 1963). Also in rat pancreas, enzyme activity in homogenate responsible 
for acylation of 2-acyl lysoPC, 2-acyl lysoPE, 2-acyl lysoPI and 2-acyl lysoPS showed 
preference for arachidonate over stearate at 17μM in the presence of 0.1 mM CoASH and 
6mM ATP (Rubin 1983). 
   In general, in these single concentration studies LPLAT activities seem to prefer 
saturated acy-CoA at the sn-1 position and unsaturated acyl-CoA for the sn-2 position, 
thus maintaining the acyl chain asymmetry in phospholipids. There are exceptions to this 
selectivity, in adult rat lung type II epithelial cells 1-acyl lysophosphatidylcholine 
acyltransferase (1-acyl-LPCAT) shows preference for palmitoyl-CoA at varying 
concentrations ranging from 0.5-22 μM. The Km and Vmax values were not reported in the 
study (Tansey 1975). However, in rabbit lung cells 1-acyl LPCAT showed only mild 
preference for palmitoyl-CoA (Km=15μM, Vmax=137nmol/min/mg) over oleoyl CoA 
(Km=16μM, Vmax= 100 nmol/min/mg). The reacylation system was suggested to 
catalyze the synthesis of dipalmitoyl phosphatidylcholine, a major constituent of 
pulmonary surfactant system (Yamashita 1997). It is possible that physiological 
concentrations of palmitoyl-CoA in lung cells favor its incorporation in the sn-2 position.  
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  Almost 50 years after the lysophospholipid acyltransferase activity was reported, 
there are very few studies on molecular nature of these enzymes.  The genes encoding 
mouse lysophsophatidylcholineacyltransferase-1(LPCAT1) and lysoplatelet activating 
factor acetyltransferase (LysoPAFAT)/ LPCAT2 were recently identified (Nakanishi 
2006; Shindou 2007). LPCAT1 has been suggested to catalyze synthesis of dipalmitoyl 
PC in alveolar type II cells of lung. Platelet activating factor has an ether linked alkyl 
chain at the first carbon of glycerol, acetyl group in the second carbon and choline head 
group linked to the third carbon similar to phosphatidylcholine (Appendix 1). 
LysoPAFAT/LPCAT2 exhibited acetyltransferase activity also capable of incorporating 
arachidonoyl-CoA into sn-2 position of lysoPAF to  synthesize PAF (Nakanishi 2006; 
Shindou 2007). The gene or genes encoding the lysophospholipid acyltransferase activity 
in other tissues reported in literature, responsible for asymmetrical distribution of fatty 
acids in phospholipids are yet to be identified. 
 
1.2.1.3 Phospholipid remodeling in Saccharomyces cerevisiae 
  Similar to mammals, yeast phospholipids have saturated acyl groups (mostly 
palmitate) localized to sn-1 position and unsaturated acyl group (predominantly oleate) to 
the sn-2 position in phospholipids (Yamada 1977). As reviewed earlier, yeast can 
synthesize PC by either methylation of PE or via CDP-choline pathway (Figure 1.6). 
However, in wild type yeast the steady state acyl chain composition of PC is different 
from that of PC newly synthesized by either of these pathways (Boumann 2003). Yeast 
cells when incubated with [3H]oleic acid, just after 2 minutes, show rapid and exclusive 
incorporation of oleate preferentially in sn-2 position of PC, PE , PI and PS.   
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 The deacylation mediated by phospholipase and reacylation was suggested to explain 
these findings (Wagner 1994). Later, an acyl-CoA dependent 2-acyl 
lysophosphatidylcholine activity localized to endoplasmic reticulum was reported in 
yeast (Richard 1998). Acyl-CoA independent mitochondrial 1-acyl lysoPC 
acyltransferase activity encoded by TAZ1 has been described in yeast (Testet 2005). 
However, for the acyl CoA dependent lysophospholipid acyltransferase activity the gene 
enzyme relationship was not established until the present study was undertaken (Jain  
2007). Identification of yeast gene would enable the identification of the human 
homologs responsible for the reacylation arm of phospholipid remodeling in higher 
eukaryotes. 
 
1.2.1.4 Physiological role of lysophospholipid acyltransferases 
  Lysophospholipid acyltransferases (LPLAT) play an important physiological role in 
selective placement of acyl chains in the sn-1 and sn-2 position of phospholipids. 
Remodeling of phospholipids helps to maintain acyl chain composition of membrane 
lipids and allows for the incorporation of arachidonic acid in the sn-2 position of 
phosphatidylcholine which when released by cytosolic PLA2 is a substrate for 
eicosanoids (Funk 2001). The acyl chain composition of the peritoneal macrophage 
membrane phospholipids when enriched for saturated fatty acids, showed a reduction in 
endocytosis and bilayer fluidity (Mahoney 1980). Although it is agreed that 
lysophospholipid acyltransferases are involved in remodeling of acyl chains in 
phospholipids but this might not be the only function of acyltransferases in all tissues. 
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 In intestinal mucosa, 1-acyl-lysophosphatidylcholine acyltransferase activity is enriched 
in the brush border free microsomal fraction. At a fixed concentration of 125μM, when 
equimolar amounts of labeled oleoyl-CoA and unlabeled palmitoyl-CoA were used, the 
enzyme incorporated 60% less palmitoyl-CoA in the sn-2 position of lysoPC to 
synthesize PC.  This enzyme synthesizes PC from lysoPC formed after digestion of 
phospholipids. This PC can then be packaged into chylomicrons and secreted into lymph. 
Thus this enzyme has an important physiological role in absorption of phospholipids 
(Subbaiah 1969).  
  Few studies have suggested that lysophospholipid acyltransferases might play an 
important role in vesicular trafficking. Lysophospholipids produced by the action of 
cytoplasmic phospholipase A2 on membrane phospholipids, have been shown to induce 
the formation of Golgi membrane tubules. These tubules most likely play an important 
role in intracellular trafficking pathways, that include transport between Golgi to 
endoplasmic reticulum (ER) and maintenance of Golgi structure. It has been proposed 
that lysophospholipid acyltransferases tightly associated with Golgi membranes reduces 
the lysophospholipid levels and promotes fission of tubules leading to vesicle formation. 
This hypothesis is supported by the in vitro studies in which Golgi membrane incubated 
with [14C] palmitoyl-CoA incorporated majority of labeled acyl chain into PC and PE.  
However, in the presence of CI-976, an ACAT inhibitor, the lysophospholipid 
acyltransferase activity associated with Golgi membrane was inhibited. In vitro and in 
vivo studies on the same inhibitor have shown that it induces tubule formation in Golgi 
and increase lysophospholipid content in Clone 9 cells (Drecktrah 2003).  
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High levels of lysophosphatidylcholine lead to apoptosis (Takahashi 2002; Han 2008), 
cell lysis (Weltzien 1979) and inflammation (Kougias 2006). Thus in addition to the 
above mentioned functions lysophospholipid acyltransferases might play an important 
role in regulation of lysophospholipid levels, thus mitigating their harmful effects. 
Characterization of molecular nature of lysophospholipid acyltransferases will provide us 
with tools (RNAi or knock out animals) to understand the physiological role of these 
enzymes. 
 
1.3. Specific Aims  
1. Examine the intracellular regulation of triglyceride synthesis at the step of 
diglyceride esterification in Saccharomyces cerevisiae. 
2. Identify novel yeast acylglycerol-3-phosphate acyltransferase(s) (AGPAT) in 
Saccharomyces cerevisiae. 
3. Identify uncharacterized human genes with sequence similarity to the novel yeast 
AGPAT. 
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CHAPTER 2: REGULATION OF TRIGLYCERIDE SYNTHESIS IN 
SACCHAROMYCES CEREVISIAE 
 
2.1 Abstract 
Dga1, Lro1 and Are2 are the only enzymes that mediate the terminal step of 
diglyceride esterification to synthesize triglyceride in Saccharomyces cerevisiae. 
Identification of all the enzymes responsible for diglyceride esterification allows yeast to 
be used as a model system to study the intracellular regulation of triglyceride synthesis. 
Initially, various genetic and growth conditions were studied where triglyceride synthesis 
varies. Using metabolic labeling with [3H] oleate, we found that the deletion of POX1, 
the enzyme that mediates the initial step of fatty acid oxidation, significantly increased 
triglyceride synthesis by 75%. However, deletion of two glycogen synthase enzymes 
(GSY1 and GSY2) did not alter triglyceride synthesis. To identify additional growth 
conditions in which triglyceride synthesis is regulated the effect of water soluble 
phospholipid precursors, inositol (75 μM) and choline (1 mM) on triglyceride synthesis 
was studied. Addition of inositol and choline or both to growth medium did not alter 
triglyceride synthesis. 
Additionally, deletion of the two enzymes that mediate the vast majority of 
triglyceride synthesis, LRO1 and DGA1, did not result in an increase in glycogen 
synthesis. Therefore, an inability to hydrolyze fatty acids seems to promote their storage 
while an inability to store energy as carbohydrate does not result in a compensatory 
increase in energy storage in lipid form.  
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       We further hypothesized that Dga1 mediated diglyceride esterifying activity will 
be regulated by the level of certain cellular metabolites. Specifically, those metabolites 
that indicate a relatively energy poor environment (AMP, ADP and NAD+) would likely 
inhibit the enzyme and the metabolites that indicate a relatively energy rich environment 
(ATP, NADH, Acetyl CoA) would activate it. A lro1Δare1Δare2Δ triple deletion yeast 
strain was created in which Dga1 was the only diglyceride esterifying enzyme. In vitro 
diacylglycerol acyltransferase (DGAT) activity in microsomes from this strain was 
measured in the presence of physiological concentration of the metabolites of interest. 
DGAT activity was not regulated in response to the metabolites. 
 
2.2 Introduction 
Triglycerides are important energy storage molecules in all eukaryotes. The 
intracellular triglyceride synthetic pathway was largely identified by Kennedy (Kennedy 
1961) and shares initial steps with phospholipid synthesis. This de novo synthetic 
pathway requires glycerol 3-phosphate and acyl-CoA as substrates (Figure 1.1). Glycerol 
3- phosphate is acylated at the sn-1 position to form 1-acylglycerol-3-phosphate 
(lysophosphatidic acid), and then at sn-2 position yielding phosphatidic acid. 
Phosphatidic acid is then dephosphorylated to form diglyceride. The terminal and unique 
step in triglyceride synthesis is the esterification of diglyceride catalyzed by 
diacylglycerol acyltransferase (DGAT). In mammals, two independent enzymes DGAT1 
and DGAT2 catalyze this reaction (Cases 1998; Cases 2001).  DGAT1 is a member of the 
acyl CoA: cholesterol acyltransferase (ACAT) gene family.  
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DGAT2, the founding member of the DGAT2 gene family, was identified by its 
sequence similarity to two proteins DGAT enzymes purified from the fungus, Mortierella 
ramanniana (Cases 2001). Members of the DGAT2 family share no sequence homology 
to the ACAT family which includes DGAT1. In humans, the DGAT2 family is complex 
and has seven members: DGAT2, three monoacylglycerol acyltransferases (MGAT1-3), 
two wax alcohol acyltransferases (AWAT1-2) and hDC3 which remains to be 
characterized. MGAT catalyzes the esterification of monoacylglycerol (MG) to 
synthesize diglyceride, an important reaction for the absorption of dietary fat in small 
intestine (Lehner 1996).  MGAT1-3 when expressed in insect cells also show weak 
DGAT activity (Cao 2007), hence the physiological role of the members of DGAT2 
family is not well defined. 
       In yeast, enzymes mediating diglyceride esterification have been completely 
identified. Three different enzymes mediate diglyceride esterification. Dga1, the yeast 
ortholog of human DGAT2 enzyme mediates diglyceride esterification by a DGAT 
reaction (Oelkers 2002). Lro1, a homolog of mammalian lecithin cholesterol 
acyltransferase (LCAT) mediates triglyceride synthesis by phospholipid diacylglycerol 
acyltransferase (PDAT) reaction (Oelkers 2000).  This reaction utilizes phospholipids in 
an acyl-CoA independent esterification of diglyceride. PDAT activity has also been 
identified in plant species (Stahl 2004). However, in mammals LCAT specifically 
catalyzes the cholesterol esterification.  Dga1 and Lro1 contribute to 98% of triglyceride 
synthesis in yeast cells grown in media containing low nitrogen or 0.1% oleate and in 
logarithmic and stationary growth phase.  
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Are2, one of the sterol esterifying enzymes in yeast and homolog of DGAT1 
contributes to the residual (2%) triglyceride synthesis (Oelkers 2002).  Deletion of DGA1, 
LRO1, and ARE2 leads to complete loss of triglyceride synthesis in yeast (Oelkers 2002). 
Thus, Saccharomyces cerevisiae is a good model system to study the intracellular 
regulation of triglyceride synthesis. In the current study we hypothesized that digyceride 
esterification, the only committed step in triglyceride synthetic pathway, is responsible 
for the regulation of triglyceride synthesis and the enzymes which mediate digyceride 
esterification are regulated. In addition to this central hypothesis we also pursued the idea 
that there is a coordinated regulation of triglyceride and glycogen (cellular energy 
reserves) synthesis in a cell. Inability to synthesize triglyceride by digyceride 
esterification might result in increased glycogen synthesis and vice versa.  To address the 
hypothesis the specific objectives of the study were: 1) identify genetic backgrounds and 
growth conditions where triglyceride synthesis is altered, 2) determine if the changes in 
the protein and activity levels of Dga1 and Lro1 are responsible for the alteration in 
triglyceride synthesis in conditions identified in aim1 and 3) examine whether glycogen 
synthesis is altered in the absence of triglyceride synthesis and vice versa. 
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2.3 Experimental Procedures 
Material 
 Yeast extract, peptone, and Bacto-agar were from Fisher Scientific. Dextrose, inositol 
and choline were from Sigma. Synthetic defined media, yeast nitrogen base were 
obtained from Qbiogene (MP Biomedicals). Yeast extract peptone, plus 2% dextrose 
(YPD), synthetic complete (SC), and sporulation media (1% Potassium acetate) were 
prepared as described (Sherman 2002). [1-14C] oleoyl CoA (20,000 dpm/nmol) and [3H] 
oleate (2.63 Ci/mmol) were from PerkinElmer Life Sciences. All other chemicals were 
obtained from either Sigma or Fisher. 
Yeast Strains 
Molecular biology and yeast genetic procedures were performed according to 
conventional protocols. Deletion mutant strains for GSY1 and GSY2  were generated by 
homologous recombination in a W303-1B haploid (MATa ade2–1, can1–1, trp1–1, ura3–
1, his3–11, 15, leu2–3, 112) (Thomas 1989) by transformation with PCR derived 
products containing 50 base pairs of GSY1 or GSY2-specific sequence flanking the 
Kluyveromyces lactis URA3 sequence generated (Ito 1983; Rothstein 1991). GSY1 
knockout oligos were as follows: GSY1F, 5’ 
ATGGCTCGTGACTTACAAAATCATCTACTGTTCGAAGTAGCAACAGAAGTAC
ATGGCAATTCCCGGGGATCG and GSY1 R, 5’ 
TTAATTATCCTCGTAGTATGCAGACGTATCGTTGTCATCATCGTCATTGTTCA
ACATGGTGGTCAGCTGGAATT. GSY2 knockout oligos were as follows GSY2F, 5’ 
ATGTCCCGTGACCTACAAAACCATTTGTTATTCGAGACTGCGACTGAGGTACA
TGGCAATTCCCGGGGATCG and GSY2 R, 5’ 
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TTAACTGTCATCAGCATATGGGCCATCGTCGTCATCGTCAGCTGCAGGATTCA
ACATGGTGGTCAGCTGGAATT.  Single deletion transformants were confirmed by 
PCR using gene specific primers.  Conventional inter strain crosses were used to generate 
double or triple deletion strains.  The generation of yeast strains with single or multiple 
deletions in the DGA1, LRO1, ARE1 and ARE2 genes have been described previously 
(Oelkers 2002). The pox1Δ strain was obtained from Dr. Peter Oelkers. Yeast strains 
were grown in YPD media , SC media (Adams 1997). 
Pulse labeling 
 A dilute inoculation (1/1000 of a saturated culture) of each strain into YPD was grown 
overnight at 30°C into logarithmic (log) phase (OD660 0.55–0.80). 4 ml of cells were 
labeled with 4μl of [3H] oleate (2.63 Ci/mmol) at 30°C for 30 minutes with shaking, 
washed twice with 0.5% tergitol and once with water, and frozen. Lipids were extracted 
from cell pellets by lyticase treatment and organic extraction. The extracted lipids were 
resolved by thin layer chromatography (TLC) in hexane: diethyl ether: acetic acid 
(70:30:1) as described (Oelkers 2000). For pulse labeling experiments two independent 
strains of each genotype were assayed on three different days. 
Isolation of Microsomes 
 Yeast cells were grown in YPD into early stationary phase (O.D.660 = 1.0). The cells 
were harvested, washed and lysed, and microsomes prepared from a 100,000 x g spin as 
described (Leber 1994). 
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In vitro Diacylglycerol Acyltransferase Assay 
 All DGAT assays were performed in a final volume of 200 µl for 5 minutes at 23°C. The 
final concentration of assay components was 175 mM Tris, pH 7.8, 10 mM sodium 
acetate, 2 mg/ml BSA (essentially fatty acid free), 8 mM MgCl2, 160 μM 
dioleoylglycerol (in ethanol), 7.5 - 60 µM [1-14C] oleoyl-CoA (20,000 dpm/nmol) and 40 
μg of microsomal protein. The reactions were stopped by adding chloroform: methanol 
(2:1) and lipids were extracted and resolved by TLC as described earlier. The background 
was determined as the activity observed when the radiolabel was added after the 
chloroform/methanol. Adenosine triphosphate (ATP), adenosine diphosphate (ADP), 
adenosine monophosphate (AMP), oxidized nicotinamide adenine dinucleotide (NAD+), 
reduced nicotinamide adenine dinucleotide (NADH), acetyl-CoA and malonyl-CoA were 
individually added to the reaction mixture to study their effect on in vitro DGAT activity. 
Parallel DGAT reactions were also conducted in the absence of these metabolites. Kinetic 
data was analyzed by using EZ -Fit and GraphPad Prism 5 software.  The Hill plot was 
used to estimate the Hill number and apparent Km for oleoyl-CoA.  
Glycogen estimation 
 Glycogen levels were assayed by alkaline digestion at 95ºC of yeast cells in 0.25 M 
Na2CO3 as described in literature (Parrou 1997). Briefly, yeast cells grown to different 
growth phases (O.D.660nm 1.2-3.6) were harvested by centrifugation (3000g for 5 minutes 
and at 0-4ºC), carefully drained to remove culture media and resuspended in 0.25 ml of 
0.25M Na2CO3 in screw top eppendorf tubes. The tubes containing the cell suspension 
was then incubated in water bath at 95ºC for 4 hours.  
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After 4 hours the pH of the cell suspension was brought down to 5.2 by addition of 0.15 
ml acetic acid and 0.6 ml of 0.2M sodium acetate, pH 5.2. The mixture was then 
incubated overnight with 2.5 μl amyloglucosidase (10 mg of enzyme/ml of acetate buffer) 
at 57 ºC with constant agitation in either a hybridization oven or in a water bath. After the 
overnight incubation the suspensions were centrifuged for 3 minutes at 5000g, and 
glucose was determined in 20μl of supernatant by addition of 200μl of glucose oxidase 
reagent (Parrou 1997). 
Statistical tests 
The statistical analyses involved comparing two means by t tests and greater than two 
means by employing ANOVA. F test for equality of variance among two samples was 
conducted before comparing means of two samples by t test. Levene’s test of 
homogeneity was used to establish equality of variances before analyzing the data by 
ANOVA. Post hoc tests were conducted after ANOVA analysis to find out which means 
significantly differed from each other. Tukey’s test was used for post hoc analysis if the 
variances were equal and Tamhane’s T2 or Dunnett’s T3 were used if the variances were 
not equal. The statistical analysis was done by using SPSS 16 and Excel software. All the 
experiments were done at least 3 times on 3 different days with at least two different 
strains with the same genotype to account for day to day and strain to strain variation. All 
the data was expressed as mean ± S.D. 
 
 
 
 
 46
 
 
2.4 Results 
Identification of genotypes and growth conditions that affect triglyceride synthesis 
       POX1 encodes for acyl-CoA oxidase, the first and rate-limiting enzyme in the β-
oxidation pathway in peroxisomes. The deletion of POX1 gene would disable the 
hydrolysis of fatty acids and might induce triglyceride synthesis to store excess fatty 
acids. The normal and pox1Δ deletion strains were pulse labeled with [3H] oleate for 30 
minutes. Indeed pox1Δ showed 75% more [3H] oleate incorporation into triglyceride in 
comparison to the normal yeast strain (Figure 2.1) (p<0.05). To further probe whether the 
removal of the ability of cell to store energy as glycogen would result in an increased 
storage of energy in the form of triglyceride, strains lacking glycogen synthetic enzymes 
gsy1Δ, gsy2Δ and gsy1Δgsy2Δ deletion mutants were created. The deletion strains when 
pulse labeled with [3H] oleate did not show significant alteration in triglyceride synthesis 
in comparison to the normal strain (Figure 2.2).  
       Previous studies have shown that triglyceride synthesis is up regulated when 
yeast enter stationary growth phase, undergo sporulation and when oleate is added to the 
growth media (Illingworth 1973; Taylor 1979). To identify additional growth conditions 
in which triglyceride synthesis is regulated the effect of inositol and choline, water 
soluble phospholipid precursors on triglyceride synthesis was studied. The reason for 
using these phospholipid precursors is that addition of 75µM inositol to the growth 
medium decreased phosphatidic acid (PA), an important intermediate in triglyceride and 
phospholipid synthesis, by 4.6 fold.  
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Figure 2.1 Inability to oxidize fatty acids significantly increases triglyceride 
levels in pox1∆ strain. Indicated yeast strains were grown in YPD media to (O.D. 
0.6-0.8, logarithmic phase), labeled with [3H] oleate for 30 minutes and harvested. 
Lipids were extracted from cell pellets, resolved by thin layer chromatography 
and quantified by scintillation counting of the cut TLC plates.( * indicates p< 
0.05). The data represent mean ± S.D of 3 independent experiments. 
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Figure 2.2 Triglyceride levels in glycogen deficient strains. Yeast cells were 
grown in YPD media to (O.D. 0.6-0.8, log phase), labeled with [3H] oleate for 30 
minutes and harvested. Lipids were extracted from cell pellets, resolved by thin 
layer chromatography and quantified by scintillation counting of the cut TLC 
plates. The data represent mean ± S.D of 3 independent experiments. 
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Also, phosphatidylinositol (PI) synthesis increased by 6 fold at the expense of decrease in 
phosphatidylserine (PS) and phosphatidylcholine (PC) synthesis by 1.2 and 3.8 fold 
respectively (Kelley 1988). Also, phosphatidylinositol (PI) synthesis increased by 6 fold 
at the expense of decrease in phosphatidylserine (PS) and phosphatidylcholine (PC) 
synthesis by 1.2 and 3.8 fold respectively (Kelley 1988). Thus inositol, by perturbing the 
synthesis of phospholipids and intermediates common to phospholipids and triglyceride, 
might alter the synthesis of triglyceride. The addition of choline (1mM) to the medium in 
addition to inositol enhances these effects (Homann 1985).  
Therefore, we decided to study the effect of addition of inositol, choline or both 
on triglyceride synthesis. In comparison to the YPD growth media all the components of 
synthetic complete (SC) media are defined and allow easy manipulation of growth media 
by systematic omission or inclusion of individual components. Normal yeast strains were 
grown in SC media (lacking inositol and choline) with 2% glucose or the same media 
supplemented with inositol (75 μM) or choline (1 mM) or both to logarithmic phase and 
pulse labeled with [3H] oleate (Figure 2.3). The addition of inositol resulted in a slight 
decrease in incorporation of [3H] oleate in triglyceride but it was not statistically 
significant.  Addition of both inositol and choline or just choline to growth medium did 
not alter triglyceride synthesis. 
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Figure 2.3 Effect of addition of water-soluble phospholipid precursors in 
media on triglyceride levels. Normal strain was grown to log phase (O.D. 0.6-
0.8) in synthetic complete media with 75µM inositol, 1 mM choline or both to log 
phase and labeled with [3H] oleate for 30 minutes and harvested. Lipids were 
extracted from cell pellets, resolved by thin layer chromatography and quantified 
by scintillation counting of the cut TLC plates. The data represent mean ± S.D of 
3 independent experiments.  
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The synthesis of energy reserves in yeast cell is not coordinately regulated. 
DGA1 and LRO1 contribute to 98% of triglyceride synthesis in yeast (Oelkers 
2002). Absence of the ability to esterify diglyceride to form triglyceride, which is a major 
energy store, might result in a compensatory increase in another energy reserve, 
glycogen. To test this hypothesis, the glycogen content of normal and dga1Δlro1Δ yeast 
strains grown in YPD to late exponential phase to stationary growth phase (O.D.660 1.2-
3.6)  was determined (Figure2.4). The cellular glycogen levels of normal and dga1Δlro1 
yeast strains increased by 15 and 17 fold respectively, as yeast cells progressed from late 
logarithmic to stationary growth phase. This increase in glycogen levels in normal and 
dga1Δlro1Δ yeast strains with growth phase is consistent with previous studies (Lillie 
1980; François 2001).  However, there was no significant difference in glycogen levels 
between yeast strains lacking triglyceride synthesis, dga1Δlro1Δ, and normal even at a 
high cell density (O.D660 = 3.6). 
 This shows that there is no coordinated regulation between triglyceride and 
glycogen synthesis in yeast in the culturing conditions used in the present study. It is 
possible that the loss of triglyceride synthesis has a pronounced effect on glycogen 
synthesis in a particular culturing condition. A quadruple deletion mutant 
dga1Δlro1Δgsy1Δgsy2Δ was created. This yeast strain lacks the ability to synthesize 
glycogen and triglyceride and is viable on YPD growth media at 30°C. This suggested 
that in laboratory conditions on energy rich media (YPD) energy reserves triglyceride and 
glycogen are non-essential for viability. Future studies on the ability of this strain to grow 
in energy poor media would be interesting. 
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Figure 2.4 Glycogen levels in triglyceride deficient yeast strain. Normal and 
dga1Δlro1Δ haploids were grow in YPD to an O.D. of 1.2 to 3.6. The cells were 
lysed, boiled, treated with amyloglucosidase and glucose oxidase in order to 
determine the amount of glycogen present.  Data are normalized to the number of 
cells. The data represent mean ± S.D of three independent experiments. Open 
bars-normal yeast strain, filled bars- dga1Δlro1Δ deletion mutant  
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Determination of protein and activity levels of diacylglycerol esterifying enzymes 
       The regulation of an enzyme can occur at the level of transcription, translation 
and / or changes in enzyme activity due to covalent modifications or modulator induced 
conformational changes. The next step involved the determination of protein and activity 
levels of diglyceride esterifying enzymes in the identified genetic and growth conditions 
in which triglyceride levels are altered. The results would test the hypothesis whether 
changes in expression and activity of diglyceride esterifying enzymes are associated with 
changes in triglyceride synthesis. This study was part of an ongoing larger study on the 
regulation of yeast triglyceride synthetic enzymes Dga1 and Lro1. Hence, the focus was 
on the in vitro microsomal DGAT activity mediated by Dga1, one of the diglyceride 
esterifying enzymes.   
       The experiments on mRNA abundance and protein expression by Western 
blotting were conducted by other members of the Oelkers lab. Real time PCR was 
conducted to quantify DGA1 and LRO1 mRNA levels in normal yeast cells grown in 
YPD to exponential and stationary phase.  The mRNA levels of DGA1 and LRO1 
(normalized to actin) increased by 3-fold in stationary phase which correlates with 
increased incorporation of [3H] oleate in triglyceride in a normal strain in stationary 
phase (Oelkers et al., unpublished data). The measurement of mRNA levels of DGA1 and 
LRO1 in other genetic and growth conditions yielded results with high variability and 
hence further studies were not carried. In order to study regulation at the 
posttranscriptional level, an attempt was made to measure the protein levels of Dga1 and 
Lro1 in conditions where triglyceride synthesis is altered.  
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Polyclonal antibodies were raised in rabbits against synthetic peptides derived 
from the protein sequences of DGA1 and LRO1. The experimental conditions were 
optimized to see if the specific antibodies could detect Dga1 and Lro1 immobilized on 
membrane. Western blot indicated non specific bands and failed to detect Dga1 and Lro1 
with reproducible results. Thus the changes in protein expression levels by Western 
blotting could not be pursued (Oelkers et al., unpublished data). Next we sought to study 
whether regulation of triglyceride synthesis occurred by change in enzymatic activity of 
diglyceride esterifying enzymes.  
In vitro microsomal diacylglycerol acyltransferase (DGAT) activity  
       To measure in vitro DGAT activity mediated specifically by Dga1 and to rule out 
any minor contribution from Are2, a lro1Δare1Δare2Δ yeast strain was created. Dga1 
was the only enzyme catalyzing acyl-CoA dependent diglyceride esterification in this 
yeast strain. To enrich Dga1 mediated activity microsomes were prepared from 
lro1Δare1Δare2Δ triple deletion strain. The assay conditions were optimized with regards 
to the protein mass and temperature. The enzyme activity was found to be linear for 5 
minutes with 40µg of microsomal protein at 23°C. The DGAT activity was recorded with 
a range (5µM-60μM) of [14C] oleoyl CoA concentrations (Figure 2.5). EZ-Fit and 
Graphpad Prism 5.0 software were used to analyze the kinetic data. Sigmoidal curve 
fitted better to the data in comparison to a Michaelis Menten curve (r2 = 0.99 versus 
0.87).  Therefore, the kinetic data were analyzed on a Hill plot which yielded a Hill 
number of 3.0.  This indicated positive cooperativity of enzyme for oleoyl-CoA (Figure 
2.5). The apparent K0.5 and Vmax for oleoyl-CoA were determined to be 16.1µM and 6.7 
nmol/min/mg respectively. 
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Figure 2.5 In vitro diacylglycerol acyltransferase (DGAT) activity with 
increasing concentrations of [14C] oleoyl-CoA. (A) Microsomes from 
lro1Δare1Δare2Δ deletion strain were incubated in the presence of diacylglycerol 
and varying concentration of [14C] oleoyl-CoA for 5 minutes at 23°C as described 
in “Experimental Procedures”.  The data represent mean ± S.D. n=3. (B) Hill plot 
of the data in panel A. 
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Effect of ATP, NADH, Malonyl-CoA and Acetyl-CoA on in vitro DGAT activity 
Acute regulation of triglyceride synthetic enzymes has been reported by two 
studies.  In vitro glycerol 3-phosphate acyltransferase (GPAT) and DGAT activity in post 
mitochondrial supernatant (PMS) from rat adipose tissue, upon incubation with 1mM  
adenosine 5’- triphosphate (ATP) for 15 minutes showed 25% and 35% reduced activity 
respectively.  DGAT activity has been shown to be predominantly (90%) associated with 
microsomal fraction. However, in the same study, the microsomal fraction obtained from 
the PMS did not show reduction in DGAT activity.  The addition of cytosolic fraction 
obtained from PMS when added to the in vitro DGAT assay with microsomal protein as 
enzyme source resulted in reduction of enzyme activity in the presence of 1mM ATP 
(Rodriguez 1992).  
The cytosolic activity responsible for reduction in in vitro DGAT activity was not 
inhibited by protein kinase C inhibitors. It was suggested that phosphorylation by 
tyrosine kinase was responsible for the reduction in DGAT activity (Walsh 1989; 
Rodriguez 1992).  Mouse and human DGAT1 contain a single conserved tyrosine residue 
while DGAT2 contains 6 potential protein kinase C phosphorylation sites (Cases 2001). 
However, no change in DGAT activity was observed when conserved tyrosine residue in 
human DGAT1 was mutated to phenylalanine (Oelkers 1998). 
 We hypothesized that the presence of metabolites which indicate energy status of 
the cell would affect in vitro microsomal DGAT activity. The metabolites that increase in 
concentration in energy replete cells, namely ATP, NADH, acetyl-CoA and malonyl-
CoA would activate DGAT activity so that energy can be stored in the form of 
triglyceride and vice versa. 
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It was suggested as early as 1960s that adenosine phosphates regulate reactions 
involved in energy storage or energy production. Two classic examples include  
phosphofructokinase-1 and muscle glycogen phosphorylase that have been shown to be 
allosterically regulated by ATP and adenosine monophosphate (AMP) in opposite 
directions (Ramaiah 1964). Previous studies have shown that ATP levels are 5 fold 
higher in yeast cells grown in the presence of 2% glucose in media in comparison to the 
starved cells (Wu 1994). The cellular concentration of ATP has been estimated to be 2.3 
– 5.2 mM in yeast cells grown to logarithmic phase in  regular YEP growth media 
containing 2% dextrose and in starved cells the ATP concentration is 0.57mM (Ozier-
Kalogeropoulos 1991; Ingram 2000).   
5mM ATP was added to DGAT assay components and DGAT activity was 
recorded for varying concentrations of oleoyl-CoA. Hill plot analysis of kinetic data was 
performed (Figure 2.6). The apparent K0.5 for oleoyl-CoA with ATP and without ATP 
was 14.3 ± 4.3 μM and 17 ± 5.6 μM respectively. The Vmax values with and without ATP 
were 6 ± 3 nmol/min/mg and 5.8 ± 2 nmol/min/mg respectively. The decrease in apparent 
K0.5 with the addition of ATP was statistically not significant in comparison to the control 
reactions. Two way ANOVA and post hoc analysis of kinetic data did not indicate 
statistically significant difference in enzyme activity with and without ATP.  
Nicotinamide adenine dinculetoides work in conjunction with adenosine 
phosphates as energy transfer system in the cell. The ratio between reduced and oxidized 
forms of nicotinamide adenine dinculetoides is indicative of the cellular metabolic state 
(Krebs 1967).  
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Yeast cells grown in 0.5% glucose show a 50% decrease in NADH levels in 
comparison to cells grown in 2% glucose. The cellular concentration of NADH in yeast 
cells has been reported to be around 0.8mM in cells grown in YPD (2%glucose) (Lin 
2004). 0.8 mM NADH was added to the mixture for DGAT assay and Hill plot analysis 
was done (Figure 2.7). The K0.5 values with NADH and without NADH were 24.7 ± 9.8 
μM and 17 ± 4.2 μM respectively. The Vmax values with NADH and without NADH were 
5.5 ± 1.4 nmol/min/mg and 4.8 ± 1.6 nmol/min/mg respectively. However due to the high 
variability in the kinetic data the t-test did not detect significant difference between K0.5 
values with and without NADH. No statistically significant changes in DGAT activity at 
varying concentrations of oleoyl-CoA were seen with the addition of NADH. 
 Acetyl-CoA is a primary substrate for citric acid cycle with a marked function in 
energy production. Acetyl-CoA has been shown to allosterically activate pyruvate 
carboxylase, an enzyme involved in gluconeogenesis (Cooper 1966). The reported 
cellular concentrations of acetyl-CoA range from 25 - 100 μM (McCormick 1983). 0.25 
mM acetyl-CoA has been shown to allosterically activate  yeast pyruvate carboxylase and 
increase the enzyme activity by 100 fold  (Rhode 1986) and the same concentration of 
acetyl-CoA was added to the DGAT assay mixture (Figure 2.8). In the presence of acetyl-
CoA the apparent K0.5 was 17.9 ± 3.2 μM which was not significantly different from K0.5 
of 17± 4.2 μM of reaction without acetyl-CoA. The apparent Vmax upon addition of 
acetyl-CoA was 4.5 ± 0.9 nmol/min/mg and was similar to that of control reaction (4.8 ± 
1.6 nmol/min/mg). 
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Figure 2.6 Effect of 5mM ATP on in vitro Diacylglycerol acyltransferase (DGAT) 
activity. (A) Microsomes from lro1Δare1Δare2Δ deletion strain were incubated in the 
presence of 5mM ATP, diacylglycerol and varying concentration of [14C] oleoyl-CoA for 
5 minutes at 23°C as described in “Experimental Procedures”; The data represent mean ± 
S.D. n=3. (B) Hill plot of the data in panel A. 
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Figure 2.7 Effect of 0.8mM NADH on in vitro Diacylglycerol acyltransferase 
(DGAT) activity. (A) Microsomes from lro1Δare1Δare2Δ deletion strain were incubated 
in the presence of 0.8mM NADH, diacylglycerol and varying concentration of [14C] 
oleoyl-CoA for 5 minutes at 23°C as described in “Experimental Procedures”; The data 
represent mean ± S.D. n=3. (B) Hill plot of the data in panel A. 
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Figure 2.8 Effect of 0.2mM acetyl-CoA on in vitro Diacylglycerol acyltransferase 
(DGAT) activity. (A) Microsomes from lro1Δare1Δare2Δ deletion strain were incubated 
in the presence of 0.2mM acetyl-CoA, diacylglycerol and varying concentration of [14C] 
oleoyl-CoA for 5 minutes at 23°C as described in “Experimental Procedures”; the data 
represent mean ± S.D. n=3. (B) Hill plot of the data in panel A. 
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Figure 2.9 Effect of 0.1 mM malonyl-CoA on in vitro Diacylglycerol acyltransferase 
(DGAT) activity. (A) Microsomes from lro1Δare1Δare2Δ deletion strain were incubated 
in the presence of 0.1mM malonyl-CoA, diacylglycerol and varying concentration of 
[14C] oleoyl-CoA for 5 minutes at 23°C as described in “Experimental Procedures”; the 
data represent mean ± S.D. n=3. (B) Hill plot of the data in panel A. 
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Malonyl-CoA is an intermediate in the de novo synthesis of fatty acids and is an 
allosteric inhibitor of carnitine palmitoyltransferase I (CPT I), an enzyme that regulates 
the rate at which long chain fatty acyl-CoAs are transported into mitochondria for β-
oxidation (Ruderman  1999). The effect of malonyl-CoA on in vitro DGAT activity was 
studied. 0.1 mM malonyl-CoA has been shown to inhibit 92-96% of rat liver CPT I 
activity upon ectopic expression in yeast (de Vries 1997). The apparent K0.5 in the 
presence of malonyl-CoA was 18.7 ± 1.6 μM compared to 17 ± 4.2 μM of control 
reaction (Figure 2.9). This slight increase in K0.5 in the presence of malonyl-CoA was not 
found to be statistically significant. Vmax of the enzyme was unaffected upon addition of 
malonyl-CoA. Overall the addition of metabolites which indicate energy rich status of 
cell did not affect the Vmax and Km of DGAT for oleoyl-CoA. Statistical analysis of 
kinetic data in the presence of modulators by two way ANOVA and post hoc tests did not 
detect any changes in DGAT activity at varying concentrations of oleoyl-CoA. 
       Next, we proceeded to determine kinetic parameters of DGAT in the presence of 
metabolites that indicate energy poor status of cell: AMP, ADP and NAD+. We 
hypothesized that these metabolites should lead to decrease in DGAT activity so that 
energy storage in form of triglyceride is not favored.  The cellular AMP levels in yeast 
range from 0.1mM to 1mM (Polakis 1966; Betz 1967). In the presence of 0.1mM AMP 
the apparent K0.5 was 15.4 ± 5.5 µM while in the presence of 1mM AMP it was 16.4 ± 
5.8 µM (Figure 2.10). The K0.5 values were not statistically significant in comparison to 
the K0.5 of 17.6 ± 8.7 µM in the absence of AMP. There was no change in Vmax of the 
enzyme with increase in concentration of AMP.  
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The Vmax in the presence of 0.1m M and 1 mM AMP was 5.5 ± 1 nmol/min/mg and it 
was not significantly different from Vmax in the absence of AMP. Statistical analysis by 
two way ANOVA followed by post hoc tests did not detect any effect of AMP on DGAT 
activity at varying concentrations of oleoyl-CoA. The cellular concentration of ADP in 
yeast has been reported to range from 0.3 mM to 1 mM (Wu 1994; Ingram 2000). At 
concentration as high as 6 mM, ADP has been shown to enhance glucose binding by 
yeast hexokinase (Woolfitt 1988). Microsomes of liver rat when incubated for 15 minutes 
with 5 mM ADP show 14% reduction in DGAT activity (Haagsman 1982). 5mM ADP 
was added to the DGAT assay components to investigate whether ADP modulates in 
vitro DGAT activity. In the presence of 5 mM ADP the DGAT activity was linear for 
7.5-20 μM of oleoyl-CoA (Figure 2.11). We did not study the effect of ADP on DGAT 
activity at concentrations higher than 20 μM of oleoyl-CoA. Therefore, it was not 
possible to determine a K0.5 or Vmax for oleoyl-CoA using Michaelis–Menten equation 
and Hill plot analysis. The change in DGAT activity upon addition of ADP to the DGAT 
assay components was not found to be statistically significant. Next we studied the effect 
of addition of 0.8 mM NAD on DGAT activity (Figure 2.11). Intracellular concentration 
of NAD+ of 1-1.2 mM  has been reported in yeast grown on YPD (Lin 2004). The kinetic 
data was analyzed by Hill plot (Figure 2.11). The Km of DGAT for oleoyl-CoA in the 
presence and absence of NAD+ was 16.7 ± 8 μM and 17.6 ± 8.7 μM respectively. The 
Vmax of the enzyme upon addition of NAD+ was 5.6 ± 0.3 nmol/min/mg in comparison to 
4.8 ± 1.6 nmol/min/mg for the control reaction. Addition of NAD+ did not have 
statistically significant effect on Vmax or Km of enzyme for oleoyl-CoA. 
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Figure 2.10 Effect of 0.1 mM and 1mM AMP on in vitro Diacylglycerol 
acyltransferase (DGAT) activity.(A) Microsomes from lro1Δare1Δare2Δ deletion 
strain were incubated in the presence of 0.1mM AMP and 1mM AMP, diacylglycerol and 
varying concentration of [14C] oleoyl-CoA for 5 minutes at 23°C as described in 
“Experimental Procedures”; the data represent mean ± S.D. n=3. (B) Hill plot of the data 
in panel A. 
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Figure 2.11 Effect of 0.1mM ADP and 0.8 mM NAD+ on in vitro Diacylglycerol 
acyltransferase (DGAT) activity. (A) Microsomes from lro1Δare1Δare2Δ deletion 
strain were incubated in the presence of 0.1mM ADP and 0.8 mM NAD+, diacylglycerol 
and varying concentration of [14C] oleoyl-CoA for 5 minutes at 23°C as described in 
“Experimental Procedures”; the data represent mean ± S.D. n=3. (B) Hill plot of the data 
in panel A. 
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2.5 Discussion 
Diglyceride esterification is the terminal and unique step in triglyceride synthesis. 
Diglyceride is common intermediate for triglyceride and phospholipid synthesis. Cells 
must maintain a balance between storage of energy in triglyceride and membrane 
phospholipid synthesis, therefore it is likely that this branch point is subject to regulation. 
The main hypothesis of the study was that the regulation of triglyceride synthesis occurs 
at the step of diglyceride esterification and the enzymes that mediate this step are 
regulated. Another hypothesis was that inability of cells to esterify diglyceride to form 
triglyceride will increase glycogen synthesis as an alternative to store energy. 
We used Saccharomyces cerevisiae as a model system to study the intracellular 
regulation of triglyceride synthesis. In yeast Lro1, Dga1 and Are2 are the only 
diglyceride esterifying enzymes and a yeast strain lacking all of these enzymes is devoid 
of triglycerides (Oelkers 2002). Identification of all the diglyceride esterifying enzymes 
allows genetic manipulation to study their role individually. In addition, yeast has 
conserved glycerolipid synthetic pathways homologous to those in mammalian cells. The 
amino acid sequence of Dga1 shares 35% identity with mammalian DGAT2 protein and 
like its mammalian counterpart catalyzes acyl CoA dependent diglyceride esterification 
(Oelkers 2002). Lro1 is the yeast ortholog of mammalian lecithin-cholesterol 
acyltransferase (LCAT) with which it shares 27% identity.However, Lro1 catalyzes 
triglyceride synthesis by a PDAT reaction which is acyl-CoA independent. Together 
Dga1 and Lro1 conribute to 98% of triglyceride synthesis and the residual diglyceride 
esterification is mediated by Are2, with a predominant role in sterol esterification 
(Oelkers 2000; Oelkers 2002). 
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 To address our hypothesis that triglyceride synthesis is regulated at the step of 
diglyceride esterification, it was necessary to first identify genetic backgrounds and 
growth conditions in which triglyceride synthesis is regulated.  Previous studies have 
described few conditions in which triglyceride synthesis is altered. Yeast cells grown in 
media containing 0.1% oleate as the only carbon source, show seven fold increase in total 
lipids, the majority of which is triglyceride (Dyer 2002). Triglyceride synthesis also 
increases in yeast cells in stationary growth phase and when they undergo sporulation in 
nitrogen poor media (Henry 1973; Taylor 1979). In lro1∆ yeast strains triglyceride 
synthesis is reduced by 75% in logarithmic growth phase while dga1∆ shows 50% 
reduction in stationary phase (Oelkers 2002). To identify additional conditions in which 
triglyceride synthesis might be altered, we examined yeast strains with gene deletions 
which disable fatty acid hydrolysis (pox1∆) or glycogen synthesis (gsy1∆, gsy2∆). We 
hypothesized that in these three genetic backgrounds, triglyceride synthesis will be 
increased to store the surplus energy. 
 Triglyceride synthesis was measured by pulse labeling pox1Δ and wild type yeast 
strain with [3H] oleate. Indeed, there was a 75% increase in incorporation of the labeled 
oleate in triglyceride in pox1Δ strain (p<0.05). Phospholipid and sterol ester synthesis 
were unaffected suggesting that the effect of pox1Δ was triglyceride specific. However, 
triglyceride and phospholipid synthetic pathways have common intermediates, substrates 
and initial steps; it is less likely that the availability of acyl-CoA will favor one process 
over another.  
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 There can be two possibilities: first being that the enzymes in glycerolipid 
synthetic pathway selectively channel substrates towards either phospholipid or 
triglyceride synthesis or the second possibility being that the enzymes utilizing 
phosphatidic acid and diglyceride as substrates for phospholipid and triglyceride 
synthesis are regulated. Glycerol 3-phosphate acyltransferase (GPAT) mediates the first 
step of triglyceride and phospholipid synthetic pathway. In yeast this reaction is mediated 
by Gat1 and Gat2.  The gat1∆ yeast cells show 50% increase in triglyceride synthesis 
while gat2∆ yeast show 50% decrease in triglyceride synthesis (Zaremberg 2002). This 
result raises the question whether lysophosphatidic acid species synthesized by Gat1 are 
utilized for phospholipid synthesis while that synthesized by Gat2 are utilized to 
synthesize triglyceride. So far no studies have been carried out to show that 
lysophosphatidic acid species synthesized by Gat1 and Gat2 are different. At least two 
isoforms exist for all the enzymes involved in synthesizing diglyceride, an important 
intermediate in triglyceride and phospholipid synthesis. It is also possible that these 
isoforms play an important role in directing intermediates of triglyceride and 
phospholipid synthesis to a particular pathway. However, there is lack of information 
about protein-protein interaction among different isoforms of the pathway that would 
facilitate substrate channeling towards particular pathway.  
Next we examined triglyceride synthesis in yeast strains with deletions in 
glycogen synthetic enzymes (gsy1∆, gsy2∆ and gsy1∆gsy2∆). GSY1 and GSY2, encode 
for yeast glycogen synthases with 50% similarity with mammalian muscle and liver 
glycogen synthases. Glycogen synthase catalyzes the rate-limiting step of glycogen 
synthesis.  
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Between the two yeast isoforms, Gsy2 mediates 90% of the enzyme activity in 
YPD in stationary phase.  Deletion of both the genes results in loss of glycogen synthesis 
(Francois, 2001). Loss of glycogen as an energy reserve was expected to stimulate 
storage of energy in form of triglyceride as a compensatory mechanism to maintain total 
cellular energy reserves. Yeast single and double deletion strains gsy1Δ, gsy2Δ, 
gsy1Δgsy2Δ, and wild type strains were pulse labeled with [3H]oleate to monitor 
triglyceride synthesis. There was no significant difference in triglyceride synthesis in 
glycogen synthesis deficient and wild type strains.  
Next, we addressed the question whether the loss of triglyceride synthesis 
increases glycogen accumulation in the cells. There is only one study which has 
examined whether there is coordination between synthesis of cellular energy stores. 
Glycogen synthesis in obese and lean rats was monitored by 3H2O after feeding them 
isocaloric meal. Obese rats showed 3-fold reduction in hepatic glycogen synthesis and 5-
fold increase in lipogenesis when compared to the lean rats. However, the plasma insulin 
levels were 4 times higher in obese animals in comparison to lean animals and it is 
possible that the changes in glycogen synthesis were due to insulin resistance rather than 
due to increase in lipogenesis (Obeid 2000).  
Since triglyceride and glycogen synthetic enzymes have been characterized in 
yeast it is possible to directly examine the effect of loss of intracellular triglyceride 
synthesis on glycogen synthesis The dga1Δlro1Δ double deletion strain is deficient in 
triglyceride synthesis yet viable and synthesizes only 2% of the normal amount of 
triglyceride (Oelkers 2002).  
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Glycogen levels in dga1Δlro1Δ yeast cells grown (in YPD) to late exponential 
phase and stationary phase were measured. Both the yeast strains showed an increase in 
glycogen levels as they progressed from exponential to stationary phase. This agreed with 
a previous study that found six-fold increase in glycogen levels (% of dry weight of cells) 
as yeast cells progress from exponential to stationary phase (Lillie 1980). The glycogen 
levels in dga1Δlro1Δ strain did not show significant increases in comparison to the wild 
type cells. This result suggested that cellular glycogen and triglyceride synthesis cannot 
compensate for the absence of each other and hence, there is no coordinated regulation in 
them in the present assay conditions. It is possible that culturing of the yeast strains in 
YPD, energy rich media might have masked any kind of coordinated regulation between 
triglyceride and glycogen synthesis. Further studies in different growth conditions will be 
required to establish how a cell adapts to loss in triglyceride synthesis. 
To identiy additional growth condition in which triglyceride synthesis is altered, 
we studied the effect of inositol and choline on triglyceride synthesis. Addition of water 
soluble phospholipid precursors, inositol and choline to the growth media has been 
shown to regulate a number of yeast phospholipid synthetic enzymes (Carman 1999).The 
levels of phosphatidic acid (PA), an important intermediate in triglyceride and 
phospholipid synthesis decreased by 2 fold in the yeast cells grown in presence of inositol 
(Kelley 1988). Phosphatidic acid can be either dephosphorylated to form diglyceride for 
triglyceride synthesis or can be converted to CDP-diacylglycerol (CDP-DG) for 
phospholipid synthesis. Triglyceride content of yeast cells has been shown to increase in 
stationary phase with simultaneous decrease in phospholipid synthesis (Taylor 1979).  
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This increase in triglyceride content is thought to occur by induction of 
phosphatidic acid phosphatase (PAP) activity (Hosaka 1984). In stationary phase, the 
activity of CDP-DG synthase is decreased by 2.5 fold, thus increasing the availability of 
phosphatidic acid for diglyceride synthesis mediated by PAP (Homann 1987).  
Loss of triglyceride synthesis in yeast cells lacking diglyceride esterifying 
enzymes increases the phospholipid synthesis significantly in logarithmic and stationary 
growth phases and when grown in the presence of oleate or nitrogen poor media (Oelkers 
2002). Thus according to these studies phospholipid synthetic pathway and triglyceride 
seem to be coupled to each other rather than former being regulatory. Interestingly, in the 
present study addition of 75 µM inositol or 1mM choline and both to the growth media, 
known to affect the activity of phospholipid synthetic enzymes showed no effect on 
triglyceride synthesis in wild type yeast grown to exponential phase. Similar result was 
obtained with wild type yeast grown to different growth phases (Appendix 3).  
A previous study reported that inositol requiring yeast mutant (ino1-13) 
incorporated twice the amount of [14C] acetate in triglyceride and phospholipids per cell 
six hours after being shifted to inositol starved culture and losing viability (McCammon 
1982). At earlier time points (2 and 4 hours) there was no difference in incorporation of 
acetate label in total phospholipids and triglyceride in cells starved for inositol and 
supplemented control containing 27.5µM of inositol (McCammon 1982). This results 
show that changes in phospholipid synthesis might not be tightly coupled to triglyceride 
synthesis required for storing excess fatty acids in a cell. 
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After identifying conditions which alter triglyceride synthesis, we studied whether 
in these conditions expression and activity of diglyceride esterifying enzymes are 
regulated. Regulation of diglyceride esterifying enzymes can occur at the level of mRNA 
abundance, protein abundance and enzymatic activity. Triglyceride synthesis is increased 
in yeast cells when they enter stationary phase from exponential growth phase (Taylor 
1979). Real time PCR was conducted to quantify DGA1 and LRO1 mRNA levels in wild 
type yeast cells grown in YPD to exponential and stationary phase (Oelkers et al., 
unpublished data).  The mRNA levels (normalized to actin) of DGA1 and LRO1 increase 
by 3-fold in stationary phase which correlates with increased incorporation of [3H]oleate 
in triglyceride in a wild type strain in stationary phase. The measurement of mRNA 
levels of DGA1 and LRO1 in other genetic and growth conditions yielded results with 
very high variability and hence further studies were not carried. 
In order to study regulation at the posttranscriptional level, we sought to measure 
the protein levels of Dga1 and Lro1 in conditions where triglyceride synthesis is altered.  
To do so polyclonal antibodies were raised in rats using synthetic peptides derived from 
the protein sequences of Dga1 and Lro1. The changes in protein expression levels by 
Western blotting could not be pursued due to inability to detect proteins by the antibodies 
(Oelkers et al., unpublished data). 
To address the possibility that Dga1 and Lro1 enzyme activity are regulated by 
post translational modification or by allosteric mechanism, the in vitro DGAT enzyme 
activity was measured in microsomes, an enriched source of the diglyceride esterifying 
enzymes. A yeast triple deletion strain lro1Δare1Δare2Δ was created, in which 
diglyceride esterification was only carried out by Dga1.  
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The microsomal DGAT activity with varying concentrations of oleoyl-CoA when 
plotted resulted in a sigmoidal shape plot. The enzyme activity when analyzed by Hill 
equation exhibited positive cooperativity (Hill number: 3). Cooperativity with respect to 
oleoyl-CoA might be important in regulating the rate of triglyceride synthesis. Studies 
done on permeabilized hepatocytes have suggested that at physiological levels of 
glycerol-3-phosphate (1mM) when DGAT is saturated with diglyceride the rate of 
triglyceride synthesis is determined by the affinity of DGAT for acyl-CoA (Stals 1994). 
 The apparent Vmax and K0.5 of DGAT for oleoyl-CoA were 6.7 nmol/min/mg and 
15.5 µM respectively. Previous study on microsomal DGAT activity in HepG2 cells has 
reported apparent Km of 8.3 µM for oleoyl-CoA (2.5-17 µM). The total DGAT activity 
was representative of 2 DGAT isoforms, DGAT1 and DGAT2 expressed in HepG2 cells 
(Ganji 2004). It is difficult to compare our data with that of this study because DGAT1 
and DGAT2 might have characteristic enzyme kinetic parameters and contribution to 
total DGAT activity in HepG2 cells. Nothing is known about the kinetic parameters of 
DGAT1. However, a study reported that human DGAT1 was a multimeric protein but the 
biochemical significance of tetramer formation was not examined (Cheng 2001).   
In our assays, the microsomal DGAT activity was only mediated by Dga1p, a 
member of DGAT2 family. Monoacylglycerol acyltransferase1 and 2 (MGAT1 and 
MGAT2) also belong to the DGAT2 family and it was suggested that they exhibit 
cooperative kinetics with varying concentrations of oleoyl-CoA ranging from 0-400 µM. 
No analysis was done in these studies to estimate kinetic parameters (Yen 2003). Thus 
this is the first study in our knowledge to describe the kinetic parameters of a member of 
DGAT2 family.  
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 To further characterize microsomal DGAT activity we studied the effect of 
metabolites which indicate cellular energy status: ATP,ADP,AMP,NAD,NADH, acetyl-
CoA, malonyl-CoA on Dga1. We hypothesized that during energy rich conditions in a 
cell, when the levels of ATP, NADH, acetyl-CoA and malonyl-CoA are high these 
metabolites may bind to Dga1 and allosterically activate the enzyme activity. This will 
result in increased triglyceride synthesis. On the other hand when ADP, AMP and NAD+ 
levels are high when cells are depleted of energy, the triglyceride synthesis will be 
inhibited. Enzymes involved in glycolysis and citric acid cycle such as pyruvate 
dehydrogenase, isocitrate dehydrogenase and phosphofructokinase-1 (PFK1) have been 
shown to be regulated in similar manner (Ramaiah 1964). Addition of ATP, ADP, AMP, 
NADH, NAD+, acetyl-CoA and malonyl-CoA individually to the assay components at 
cellular concentration did not alter the microsomal DGAT activity.  
In Brassica napus (oil seed rape)  in vitro microsomal DGAT activity was shown 
to increase by 2 fold when 1- 2 mM ATP was added to the assay mixture containing 
15µM of oleoyl-CoA and 330µM of diglyceride (Byers 1999). No changes in DGAT 
activity were observed upon addition of ATP to the DGAT assay components used in the 
present study.  It is acknowledged that our results are limited because of the single 
concentrations of most of the metabolites. However, the results are relevant because we 
tried to mimic the physiological conditions by adding metabolites at cellular 
concentration or at concentrations known to allosterically regulate activity of other 
enzymes.  
   . 
 
 
 76
 
 
 
CHAPTER 3: IDENTIFICATION OF A NOVEL LYSOPHOSPHOLIPID 
ACYLTRANSFERASE (LPT1) IN SACCHAROMYCES CEREVISIAE 
(Published as Jain et al. 2007) 
 
3.1 Abstract 
The incorporation of acyl chains in the sn-2 position of phospholipids during de 
novo synthesis is primarily mediated by the 1-acyl-glycerol-3-phosphate acyltransferase 
(AGPAT) reaction. In S. cerevisiae, Slc1 has been shown to mediate this reaction but 
AGPAT activity remains after SLC1 deletion.  To identify the enzyme that mediates the 
remaining activity, synthetic genetic array (SGA) analysis was performed using a slc1∆ 
strain. SGA analysis was performed in collaboration with Dr. Charles Boone and Michael 
Costanzo, University of Toronto, Toronto, Canada.  One of the genes identified by the 
screen, LPT1, was found to encode for an acyltransferase that uses a variety of 
lysophospholipid species, including 1-acyl-sn-glycerol-3-phosphate.  Deletion of LPT1 
had a minimal effect on 1-acyl-sn-glycerol-3-phosphate acyltransferase activity but over-
expression increased activity 7-fold.   Deletion of LPT1 abrogated the esterification of 
other lysophospholipids and over-expression increased lysophosphatidylcholine 
acyltransferase activity 7-fold.  The majority of this activity (65%) co-purified with 
microsomes.  To test the putative role for this enzyme in selectively incorporating 
unsaturated acyl chains into phospholipids, in vitro, substrate concentration series 
experiments were performed with the four acyl-CoA species commonly found in yeast.   
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While the saturated palmitoyl-CoA and stearoyl-CoA showed a lower apparent 
Km, the monounsaturated palmitoleoyl-CoA and oleoyl-CoA showed a higher apparent 
Vmax.  Arachidonyl-CoA, although not abundant in yeast, also had a high apparent Vmax.  
Pulse-labeling of lpt1∆ strains showed a 30% reduction in [3H] oleate incorporation into 
phosphatidylcholine only.  Therefore, Lpt1, a member of the membrane bound- O-
acyltransferase (MBOAT) gene family, seems to work in conjunction with Slc1 to 
mediate the incorporation of unsaturated acyl-chains into the sn-2 position of 
phospholipids.  
These findings identified LPT1, a novel lysophospholipid acyltransferase, as a 
component of the Lands cycle responsible for acyl chain remodeling at the sn-2 position 
of phospholipids. LPT1 belongs to the MBOAT family and shares sequence similarity 
with uncharacterized human MBOAT proteins. Identification of LPT1 provides a 
molecular tool to identify human homologs with similar function and study phospholipid 
remodeling and turnover in yeast. 
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3.2 Introduction 
According to the fluid mosaic model for the structure of biological membranes, 
phospholipids form a bilayer in which protein molecules are embedded. 
Phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidylserine (PS), 
phospatidylinositol (PI), cardiolipin, sphingolipids and sterols are major membrane lipids. 
Each subcellular fraction has a distinct lipid composition for instance mitochondrial 
membranes have high cardiolipin content while cholesterol is a major component of 
plasma membrane. 
 The acyl chains in phospholipids are thought to influence the degree of order and 
motion of phospholipid molecules in lipid bilayer, a property referred to as membrane 
fluidity. Saturated acyl chains in membrane phospholipids pack tightly in an array 
forming a gel like phase, while the unsaturated acyl chains cannot be packed as tightly 
leading to fluid bilayer. The temperature at which membrane transitions from a gel like 
state to a fluid like state is dependent on the acyl chain composition of the phospholipids 
(Cronan 1975).  In general, phospholipids have saturated acyl groups in the sn-1 position 
and unsaturated acyl groups in sn-2 position (Hanahan 1960) At temperatures in the 
physiological range the presence of saturated and unsaturated acyl chains in 
phospholipids allows the lipid bilayer to be more fluid and simultaneously avoid drastic 
phase changes with temperature. Changes in acyl chain composition of membrane 
phospholipids are also associated with changes in cellular functions. In mouse peritoneal 
macrophages an increase in unsaturation has been shown to result in an increase in 
phagocytic activity. A reduction in endocytosis was observed in peritoneal macrophages 
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which were enriched in saturated fatty acids (Mahoney 1980). In calf thymus 
lymphocytes, increase in linoleic acid and arachidonic acid content of the plasma 
membrane was associated with increase in activities of lecithin acyltransferase, Na+ / K+ 
ATPase and decrease in Mg2+- ATPase and γ-glutamyl transferase activities (Mavis 1972; 
Spector 1985).  
Thus the pathways that establish this positional distribution of acyl chains in 
phospholipids are of importance to the cell.  According to Kennedy pathway acyl chains 
are introduced at the sn-1 and sn-2 position by de novo synthetic enzymes glycerol 3-
phosphate acyltransferase (GPAT) and 1-acylglycerol-3-phosphate acyltransferase 
(AGPAT) to synthesize phosphatidic acid (PA), a precursor to phospholipids and 
triglycerides (Figure 3.1). One plausible hypothesis is that AGPAT selectively 
incorporates unsaturated acyl groups in the sn-2 position to establish asymmetry in acyl 
chain composition in phospholipids. However, human AGPAT1 and AGPAT2 when 
expressed in baculovirus utilize both saturated as well as monounsaturated acyl-CoAs of 
12-18 carbons at a single concentration of 8μM in the presence of 8 μM 33P labeled sn-1-
18:1 lysoposphatidic acid (lysoPA).  With varying concentrations of oleoyl-CoA (18:1-
CoA) and 8mM of 33P lysoPA the apparent Vmax and Km of the human AGPAT2 activity 
were 210 nmol/min/mg and 0.4 μM respectively. Since single concentration of acyl-CoAs 
was used to study acyl-CoA specificity, the catalytic efficiency for different acyl-CoAs 
could not be calculated. However competition experiments between 0.6 μM 14C-18:1-
CoA and 1.2 μM of other unlabeled acyl-CoAs with 6 μM 3H-labeled lysoPA and 
recombinant human AGPAT2 showed similar preference for 16:0-CoA, 18:0-CoA and 
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18:1-CoA. Other acyl-CoAs were utilized in the order of 18:2-CoA> 12:0-CoA>14:0-
CoA>20:0-CoA>20:4-CoA  ( Hollenback 2006).  
Acyl-CoA specificity of AGPAT1 and AGPAT2 suggests they might not be 
responsible for establishing acyl chain asymmetry in phospholipids. AGPAT family 
currently includes 3 other putative AGPATs that share sequence similarity with AGPAT1 
and AGPAT2 (Lu 2005; Agarwal 2007). AGPAT2 mutation is associated with congenital 
generalized lipodystrophy-1 (CGL-1) and is believed to have a regulatory role in 
adipocyte differentiation. AGPAT-1 and AGPAT-2 show robust AGPAT activity but the 
biochemical role of AGPAT 3-5 and their contribution to AGPAT activity is not clear 
(Agarwal 2002; Gale 2006). In yeast, SLC1 is the only member of AGPAT gene family 
(Nagiec 1993; Athenstaedt 1997) and encodes for a protein which shares 25% and 20% 
amino acid sequence identity with human AGPAT1 and AGPAT2.  The slc1Δ yeast 
mutants show no AGPAT activity in lipid particles but microsomes prepared from slc1∆ 
strain retain 46% of the total AGPAT activity. These results indicate the presence of 
another microsomal AGPAT in yeast, which contributes to the formation of phosphatidic 
acid in the absence of Slc1 (Athenstaedt 1997). Phosphatidic acid synthesized by AGPAT 
can then be used to synthesize glycerophospholipids, phosphatidylserine (PS), 
phosphatidylethanolamine (PE), phosphatidylcholine (PC), phosphatidylinositol (PI) and 
cardiolipin through cytidinediphosphodiacylglycerol (CDP-DAG) pathway (Figure 3.1). 
Alternatively, phosphatidic acid can be dephosphorylated to form diacylglycerol, a 
precursor for synthesis of PE and PC via the CDP-ethanolamine and CDP-choline, 
pathway (Kennedy 1961).  After de novo synthesis, the acyl chain composition of 
phospholipids can be modulated by phospholipid remodeling (Figure 3.1).  
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Figure 3.1 Pathways for phospholipid synthesis in Saccharomyces cerevisiae. A,  de novo 
synthesis. B. Remodeling/ salvage pathways.   
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This involves deacylation by phospholipase A2 at the sn-2 position and 
reacylation of resulting lysophospholipid by acyl-CoA dependent lysophospholipid 
acyltransferase (Lands 1960). The deacylation-reacylation referred to as Lands cycle, has 
many possible physiological functions. In addition to selectively incorporating 
unsaturated acyl chains for membrane fluidity, arachidonic acid (20:4), a precursor for 
eicosanoid synthesis is incorporated into sn-2 position by remodeling of phospholipids. 
This may prime signal cascades that involve phospholipase A2 and eicosanoids synthesis 
(Balsinde 2006). Besides maintaining acyl chain asymmetry in phospholipids, 
remodeling is also involved in preferential incorporation of saturated acyl groups in 
phosphatidylcholine to synthesize surfactant lipids in lungs (Yamashita 1997). In 
mammals, lysophospholipid acyltransferase might play an important role in keeping the 
levels of lysophospholipid low to prevent inflammation caused by lysophospholipids 
(Kougias 2006).  
So far only two lysophospholipid acyltransferases have been cloned and 
designated lysophosphatidylcholine acyltransferase1 (LPCAT1) and lysoplatelet 
activating factor acyltransferase (lysoPAFAT / LPCAT2) (Chen 2006; Nakanishi 2006; 
Shindou 2007). Both the LPCATs contain conserved motifs found in members of the 
AGPAT family and share ~ 50% similarities in their amino acid sequence. LPCAT1 is 
highly expressed in lungs and has a preference for short to medium chain saturated acyl-
CoAs (C10:0>C8:0>C12:0>C6:0=C14:0=C16:0) at a fixed concentration of 25μM 
(Nakanishi 2006). LPCAT1 is highly expressed in alveolar type II cells of the rat lung 
and a two fold LPCAT activity over endogenous activity was seen with 
lysophosphatidylcholine and palmitoyl-CoA.  
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Based on these observations it was suggested that LPCAT1 might be involved in 
the production of components of pulmonary surfactant lipids which include 40% 
dipalmitoylphosphatidylcholine (DPPC) (Nakanishi 2006). However no gene targeting 
studies were done to confirm the physiological role of LPCAT1 in the production of 
surfactant lipids. LPCAT2 is expressed in inflammatory cells and is involved in synthesis 
of platelet activating factor (PAF) from lyso-PAF (Shindou 2007).  
In yeast, acyl-CoA independent LPCAT activity is mediated by Taz1 (Testet 
2005). Acyl-CoA independent enzymes catalyze the transfer of acyl chain from 
phospholipids to lysophospholipids without requiring the presence of acyl-CoA. The acyl 
donor is a fatty acid present in the sn-2 position of phospholipids.  The coenzyme A 
independent transacylases are considered to play an important role in the incorporation of 
plyunsaturated fatty acids (C20-C22) in lysophospholipids with ether linkages 
(Yamashita 1997). Acyl-CoA dependent activity has been reported in yeast but no 
enzyme-gene relationship has been established (Richard 1998; Testet 2005).  
In this study, we established this relationship with LPT1 as the result of a 
synthetic genetic array analysis (SGA) analysis. SGA involves automated crossing of 
yeast strain containing a gene deletion of interest to ~4700 viable yeast gene deletion 
strains. Inviability of haploid double deletion mutants is inferred to be due to synthetic 
lethal interactions between two genes. Two mutations are considered synthetically lethal 
if in combination in a haploid cell, result in cell death, but each by itself leads to a viable 
cell (Tong 2001). Synthetic lethal interactions identify genes acting in the same essential 
pathway or in parallel redundant pathways, if product of one gene functionally 
compensates for defect due to another. 
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3.3. Experimental Procedures 
Material 
 Synthetic defined media and yeast nitrogen base were obtained from Q-biogene (MP 
Biomedicals). Myristoyl lysophosphatidylethanolamine and oleoyl 
lysophosphatidylserine were from Avanti Polar Lipids (Alabaster, AL).  [1-14C] 
Palmitoyl–lysoPC (55mCi/mmol) was from Perkin-Elmer Life Sciences.  All other 
chemicals were obtained from either Sigma or Fisher. 
Yeast strains 
 Molecular biology and yeast genetic procedures were performed according to 
conventional protocols (Ausubel 1998). Deletion mutant strains for SLC1 and LPT1 were 
generated by homologous recombination in a W303-1B haploid (MATa ade2–1, can1–1, 
trp1–1, ura3–1, his3–11, 15, leu2–3, 112) (Thomas 1989)  by transformation with PCR 
derived products containing 50 bp of gene-specific sequence flanking the Kluyveromyces 
lactis URA3 sequence (Ito 1983; Rothstein 1991): for LPT1, LPT1F, 5' 
ATGTACAATCCTGTGGACGCTGTTTTAACAAAGATAATTACCAACTATGGAC
ATGGCAATTCCCGGGGATCGL and LPT1R, 5’ 
CTACTCTTCCTTTTTTGAAATAGGCTTTGGTGAGTAACCACTAAAACTCATCA
ACATGGTGGTCAGCTGGAATT; for SLC1:  SLC1F, 5’ 
ATGAGTGTGATAGGTAGGTTCTTGTATTACTTGAGGTCCGTGTTGGTCGTACA
TGGCAATTCCCGGGGATCG and SLC1R, 5’ 
TTAATGCATCTTTTTTACAGATGAACCTTCGTTATGGGTATTGACATCGTTCA
ACATGGTGGTCAGCTGGAATT; for YBR042, YBR042F, 5’ 
GATATATCAGGTCCACTGGTATTGAGATTGCTAGCGAGGTCAATAAGCTGCT
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GTACTTCCTTGTTCATGTGTG and YBR042R, 5’ 
TCAAAAAATAAAACAATAAAGTTTATAAACTAACCAAATTATTGTTAGAGAC
CTGTATTCCTTTACATCCTCC and for YDR018 YDR018F, 5’ 
GAAATGAACAAACAACCCTACGTACGACTGTGTTTTGCAGTTTAAGAAGGCC
TGATTCTTGATCTCCTTTAGC and  YDR018R, 5’ 
TCAATGATTTTTTTTCATCACAAATACAAGAATAAGAAAAGCGAAGAACCGT
TCAGAATGACACGTATAGAATG.  Successful deletion was confirmed by PCR using 
gene specific primers.  Yeast were grown in YP media (1% yeast extract, 2% peptone) 
with 2% glucose (YPD) or in synthetic complete (SC) media .  
Synthetic lethality screen 
Synthetic genetic array (SGA) analysis was performed by Michael Costanzo and Dr. 
Charles Boone, University of Toronto, Toronto, Canada. A Mat α slc1∆:: NatMX4 
can1∆:: STE2 prSp his5 lyp1∆ strain was crossed to an array containing the set of ~ 
5,000 viable deletion mutant strains (Tong 2001). 
Yeast Expression Plasmid Construction 
 A PCR product including the LPT1 open reading frame, 90 bp of 5’- flanking sequence 
and 46 bp of 3’-flanking sequence was generated using the primers: 175-1, 
CAAAATACAGGCACAGGTCAAGC; 175-2, GACAACAAGACTGTGACTTCCAC, 
and W303-1B genomic DNA. The 2.0-kb PCR product was cloned into pCR 2.1 TOPO 
(Invitrogen). The LPT1 DNA fragment was digested by NotI / SacI and subsequently 
subcloned into similarly digested pRS423GP to create pRS423GP-LPT1. This was 
performed by Dr. Peter Oelkers. 
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Pulse-labeling  
 A dilute inoculation (1/1000 of a saturated culture) of each strain into YP + 2% dextrose 
was grown overnight at 30°C into logarithmic phase (OD660 = 0.55–0.80).  0.5 μCi of 
[3H] oleate (58,000 dpm / pmol) was added to 4 ml of cells and incubated at 30° C for 30 
min. with shaking (Oelkers 2002). Cells were washed and cellular lipids extracted as 
described previously. After resolving phospholipids by thin layer chromatography in 
chloroform: methanol: acetic acid: water (50:25:8:4), each lane was cut according to lipid 
standards and counted by liquid scintillation (Oelkers 2002). Assays were performed on a 
minimum of two independent strains of each genotype on two different days. 
Preparation of cell lysates, mitochondria and microsomes  
 Yeast cells were grown in YP containing either 2% glucose or 3% glycerol at 30°C into 
early stationary phase (O.D.660 = 1.0).  SC-His medium containing 2% galactose was used 
for yeast harboring a plasmid.  The cells were harvested, washed and cell lysates prepared 
as described earlier (Oelkers 2002). Mitochondria were prepared using a previously 
published protocol. Briefly, cells were grown in YP media containing 3% glycerol, 
harvested, lysed and crude mitochondria were precipitated by centrifugation at 12,000 x 
g.  Resuspension of the pellet, followed by sucrose step gradients allowed purified 
mitochondria to be collected (Meisinger 2000).  The microsomes were purified from the 
12,000 x g supernatant by precipitation by centrifugation at 100,000 x g for 1 hour 
(Oelkers 2002).  Lowry assays were used to measure protein concentration.  
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AGPAT and LPLAT assays, spectrophotometric method  
 AGPAT activity was measured by the reaction of thiol groups of the released  CoA with 
5,5’-dithiobis (2-nitrobenzoic acid) (DTNB) resulting in absorbance at 412nm 
(Yamashita 1981) The reaction mixture contained 100mM Tris-HCl, pH 7.4, 1.5 mM 
DTNB, 50 μM lysophosphatidic acid (lysoPA), 50μM acyl-CoA, cell lysate (210 - 840 
μg) in a total volume of 1 ml.  The reaction was monitored in real time for 3 minutes in a 
Spectronic Genesys 2 spectrophotometer at room temperature.  A molar absorbance of 
13,600 M-1 cm-1 was used to calculate relative specific activity.  Lysophospholipid 
acyltransferase (LPLAT) activity was measured by replacing lysoPA with lysoPC, 
lysoPE, or lysoPI. 
LPCAT assay, radioactive substrate  
 LPCAT activity was measured by the incorporation of [1- 14C] palmitoyl lysoPC into 
PC.  The reaction contained 100 mM Tris-HCl, pH 7.4, 50 μM [1- 14C] palmitoyl lysoPC 
(50,000 dpm/nmol), 1 - 110 μM of the respective acyl-CoA, and 3μg of cell lysate 
protein in a final volume of 100 μl.  Fixed time assays were performed for 5 minutes at 
28°C.  The reactions were stopped by adding chloroform: methanol (2:1) and lipids were 
extracted and resolved as described elsewhere (Nakanishi 2006) .  EZ – fit software was 
used for nonlinear regression, curve fit analysis to calculate apparent Km and Vmax 
(Perrella 1988).  To calculate Vmax / Km, Vmax was first change to nM / min / mg to 
remove volume from the units of the ratio.  
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Statistical analysis  
The statistical analyses involved comparing two means by t tests and greater than two 
means by employing ANOVA. F test for equality of variance among two samples was 
conducted before comparing means of two samples by t test. Levene’s test of 
homogeneity was used to establish equality of variances before analyzing the data by 
ANOVA. Post hoc tests were conducted after ANOVA analysis to find out which means 
significantly differed from each other. Tukey’s test was used for post hoc analysis if the 
variances were equal and Tamhane’s T2 or Dunnett’s T3 were used if the variances were 
not equal. The statistical analysis was done by using SPSS 16 and Excel software. All the 
experiments were done at least 3 times on 3 different days with at least two different 
strains with the same genotype to account for day to day and strain to strain variation.  
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3.4 Results 
Identification of LPT1 in yeast by SGA analysis 
To identify the novel AGPAT that mediates phosphatidic acid synthesis in yeast 
in the absence of SLC1, SGA was carried out using a slc1∆ query strain (Tong 2001). 
Synthetic-lethal genetic interactions were identified with 52 single-gene deletion strains. 
Of these 52 genes, 17 genes encode for proteins involved in DNA repair, transcription, 
translation, and protein transport. 13 of the deleted genes encode for proteins with known 
function of which only one gene, fatty acid elongase (ELO2) is involved in lipid 
metabolism (Oh 1997).  The remaining 22 uncharacterized genes included YOR175c 
(from here on referred to as LPT1).   
This gene, along with PMT5 which encodes for a protein O-mannosyltransferase, 
was previously shown to be required for the viability of slc1∆ mutants (Schuldiner 2005). 
To test this further, independent slc1Δ and lpt1Δ haploid strains were generated and 
crossed to form compound heterozygous diploids.  Following meiosis, eighty haploid 
spores were isolated by tetrad dissection.  Twenty spores failed to grow into colonies.  Of 
the sixty viable haploids, genotyping showed that all were normal, slc1Δ or lpt1Δ.  In line 
with Hardy Weinberg equilibrium, ¼ of the progeny were therefore inviable and 
slc1Δlpt1Δ, confirming the synthetic lethality.  
In addition to synthetic lethality, a candidate gene approach was used to identify 
the protein that mediates Slc1-independent AGPAT activity. Two unassigned open 
reading frames YBR042C and YDR018C were identified by amino acid sequence 
homology to known AGPATs in eukaryotes. The sequence databases Gene Bank and 
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alignment tool BLASTP was used. YBR042 and YDR018 encoded proteins are ~ 16% 
identical to characterized AGPATS: Slc1, AGPAT1 and AGPAT2. AGPAT3-5 have not 
been biochemically characterized and share 23% identity with YBRO42 and YDR018 
predicted proteins. YBR042 and YDR018 encoded proteins are 37% identical to each 
other. The ybr042∆, ydr018 single deletion and ybr042∆ydro18∆ double deletion yeast 
strains were generated.  We also generated ybr042∆, ydr018∆ and ybr042∆ydro18∆ 
strains in the slc1∆ background. Unlike lpt1∆, ybr042∆, ydr018∆ and ybr042∆ydro18∆ 
strains did not show any growth defects in slc1∆ background. To find out whether these 
two candidate genes had any effect on triglyceride and phospholipid synthesis, normal 
and above mentioned single and multiple deletion strains grown to exponential phase in 
YPD were pulse labeled with [3H] oleate for 30 minutes (Figure 3.2). Consistent with its 
role as an AGPAT in yeast, absence of Slc1 resulted in significant reduction in 
diglyceride and phospholipid levels in comparison to the normal and ybr042∆, ydr018∆ 
single and double deletions strains.  Interestingly the triglyceride levels were significantly 
increased in slc1∆ strain in comparison to normal and other ydr018∆, ybr042∆ single or 
double deletions strains. A previous study also reported two fold increase in cellular 
triglyceride levels in slc1∆ strain in comparison to the normal strain during logarithmic 
growth phase (Athenstaedt 1997). One would expect, however, that defect in 
phosphatidic synthesis an intermediate required for both phospholipids and triglyceride 
synthesis, would affect the phospholipid as well as triglyceride levels. This selective 
increase in triglyceride over phospholipid levels or vice versa has also been reported in 
yeast strains deficient in Gat1 and Gat2, the enzymes which catalyze first step in 
triglyceride and phospholipid synthesis (Zaremberg 2002). 
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Figure 3.2 Incorporation of [3H] oleate into diglyceride, triglyceride and 
phospholipids in slc1Δ, ydr018Δ, ybr042Δ. Normal, slc1Δ, ydr018Δ, ybr042Δ  yeast 
strains were grown in YPD to logarithmic phase and pulse-labeled with [3H] oleate for 30 
minutes. Diglyceride (DG), triglyceride (TG), phospholipids were measured as described 
in "Experimental Procedures". The data represent mean ± S.D. n = 3. Asterisk indicates 
statistically significant difference between normal and slc11Δ (p<0.05) 
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Figure 3.3 Incorporation of [3H] oleate into diglyceride, triglyceride and 
phospholipids in ybr042∆, ydr018∆ and ybr042∆ydr018∆ in slc1∆ background. 
Normal and indicated yeast strains were grown in YPD to logarithmic phase and pulse-
labeled with [3H] oleate for 30 minutes. Diglyceride (DG), triglyceride (TG), 
phospholipids were measured as described in "Experimental Procedures". The data 
represent mean ± S.D. n = 3. 
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However, YDR018 and YBR042 gene deletions in conjunction with SLC1 showed similar 
effects as SLC1 deletion by itself. There was no significant difference in triglyceride, 
diglyceride levels and phospholipid levels in the ybro42∆ and ydr018∆ single and double 
deletions in logarithmic phase. This coupled with the fact that no growth defect or 
lethality was seen in ydr018∆ and ybr042∆ single double and triple deletion strains in slc1 
background led us to focus on LPT1. The inviability of lpt1∆slc1∆ double deletion strain 
and the presence of acyltransferase motif in LPT1 further strengthened the possibility of it 
being a candidate AGPAT. Studies on the physiological role of YBR042 and YDR018 
genes are being conducted by other members of Oelkers lab. 
 
Lpt1 is a member of MBOAT family:  
LPT1 is predicted to encode for a 619 amino acid protein with seven 
transmembrane domains. The C terminus of Lpt1 has a dilysine motif which functions as 
an ER retention signal (KKXX) (Vincent 1998) . Analysis of yeast strains expressing 
green fluorescent protein tagged proteins have indicated that Lpt1 is localized to 
endoplasmic reticulum (Huh 2003). LPT1 belongs to membrane bound-O-acyltransferase 
(MBOAT) superfamily of proteins. Members of this superfamily are postulated to encode 
for enzymes that catalyze transfer of fatty acyl groups to hydroxyl groups (Hofmann 
2000).  Lpt1 shares 25% sequence similarity to three characterized members of the 
MBOAT family which utilize diacylglycerol and cholesterol as substrates (Figure 3.4). 
Lpt1 contains the conserved hydrophobic region with putative catalytic histidine residue 
typical of an acyltransferase (Hofmann 2000). 
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LPT1 (341) WNMNTNKWLKYSVYLRVT.KKGKKPGFRSTLFTFLTSAFWHGTRPGYYLTFA
ACAT1(418) WNVVVHDWLYYYAYKDFLWFFSKRFKSAAMLAVFAVSAVVHEYALAVCLSFF
ACAT2(382) WNVVVHDWLYSYVYQDGLRLLGARARGVAMLGVFLVSAVAHEYIFCFVLGFF
DGAT1(374) WNIPVHKWCIRHFYKPMLR..RGSSKWMARTGVFLASAFFHEYLVSVPLRMF
   
 
 
Figure 3.4 Alignment of LPT1 and 3 human members of the MBOAT gene family. 
The four amino acid sequences are aligned over the MBOAT motif (Pfam PFO3062).  
Positions where 3 out of 4 amino acids are conserved are boxed.  In parentheses is the 
position of the first amino acid. Acyl-CoA cholesterol acyltransferase (ACAT); acyl-CoA 
diacylglycerol acyltransferase (DGAT) 
 
 
 
 
Determining if AGPAT activity is decreased in lpt1∆ 
Initial experiments examined whether lpt1∆ deletion affected AGPAT activity. 
AGPAT activity in cell lysates was measured by a spectrophotometric assay. This assay 
estimated AGPAT activity by measuring the release of coenzyme from the acyl-CoA 
added to the reaction mixture containing lysophosphatidic acid. Cell lysates prepared 
from normal, slc1∆ and lpt1∆ strains were assayed in the presence and absence of 
lysophosphatidic acid (Figure 3.5). AGPAT activity was calculated by subtracting 
coenzyme A generation in the absence of lysophosphatidic acid from that in the presence 
of lysophosphatidic acid. 
There was no difference in AGPAT independent activity in slc1∆, lpt1∆ and 
normal yeast strain.  AGPAT assays were conducted with saturated and monounsaturated 
acyl-CoAs. In line with previous studies, slc1∆ cell lysates showed 63% reduction in 
AGPAT activity in comparison to normal yeast. However, in lpt1∆ cell lysates no 
statistically significant reduction in AGPAT activity was observed.  
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 Since the depletion of Lpt1 did not affect the AGPAT activity, we further studied 
whether the overexpression of Lpt1 would influence AGPAT activity. Overexpression of 
LPT1 led to 7-fold increase in AGPAT activity suggesting that Lpt1 can mediate this 
reaction (Figure 3.5).  These results indicate that Slc1 contributes to most of AGPAT 
activity in the yeast cells grown to early stationary growth phase.  
 
Lpt1 mediates esterification of other lysophospholipids 
LPCAT activity has been described in yeast (Yamada 1977; Richard 1998), and the 
enzyme mediating this reaction has not been identified. We examined whether Lpt1 can 
mediate LPCAT activity in yeast. Spectrophotometric assays were conducted with 
lysophosphatidylcholine (lysoPC) and three different acyl donors: palmitoyl-CoA, oleoyl-
CoA and arachidonoyl-CoA. LPCAT activity with monounsaturated and polyunsaturated 
acyl-CoAs was 4-7 fold higher than the saturated acyl-CoA at a fixed concentration of 
50μM (Figure 3.6). No LPCAT activity was observed in lpt1∆ strain with any of the acyl 
donors. Similar results were obtained when [14C] lysoPC and oleoyl-CoA were used. Cell 
lysates of lpt1∆ cell lysates showed no activity while wild type cell lysates showed robust 
activity (55.6 ± 4.7 nmol/min/mg). These results suggest that Lpt1 is a major LPCAT in 
yeast. The possibility exists that other yeast LPCATs might not be expressed or active in 
the growth or assay conditions used in present study or might require acyl-CoAs of 
particular chain length. 
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Figure 3.5 In vitro 1-acyl-sn-glycerol-3-phosphate acyltransferase (AGPAT) assays. 
(A) Cell lysates from wild-type, lpt1Δ and slc1Δ haploids, grown to late logarithmic 
phase, were assayed for AGPAT activity by the spectrophotometric method described in 
"Experimental Procedures". The assay contained 50μM 1-oleoyl lysophosphatidic acid, 
50μM acyl-CoA, 1.5 mM DTNB, 0.42-0.84 mg cell lysate and 100 mM Tris-HCl, pH 7.4.  
palmitoyl-CoA (black), oleoyl-CoA (grey). The data represent mean ± S.E. n = 3-5. 
Asterisk indicates statistically significant difference compared with wild-type strain (p< 
0.05). B. Similar assays were performed with cell lysates from wild-type cells 
transformed with pRS423GP or pRS423GP-LPT1. 
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Figure 3.6 Lysophosphatidylcholine acyltransferase (LPCAT) activity is absent in 
lpt1Δ. (A). Cell lysates from wild-type, lpt1Δ and slc1Δ haploids, grown to late logarithmic 
phase, were assayed for LPCAT activity by the spectrophotometric method described in 
"Experimental Procedures" except lysoPA was replaced with lysoPC. Palmitoyl-CoA 
(black), oleoyl-CoA (grey) and arachidonyl-CoA (striped). The data represent mean ± S.E. 
n = 3-4. Asterisks indicate statistically significant difference compared with wild-type 
strain (p< 0.01). (B) Similar assays were performed with cell lysates from wild-type cells 
transformed with pRS423GP or pRS423GP-LPT1 
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To verify that Lpt1 was not an accessory protein required for true LPCAT activity, 
LPT1 was over expressed in wild type yeast. LPCAT activity was increased by 7-fold in 
comparison to the wild type yeast transformed with empty vector (Figure 3.6). This 
correlated with the role of Lpt1 as LPCAT. We further examined substrate specificity of 
Lpt1 for other lysophospholipid acyl acceptors with palmitoyl-CoA and oleoyl-CoA as 
acyl-donors (Figure 3.7). Wild type cell lysates showed lysophosphatidylethanolamine 
(LysoPE), lysophosphatidylinositol (LysoPE) and lysophosphatidylserine (Lyso PS) 
acyltransferase activities. These activities were 6-12 fold higher with oleoyl-CoA in 
comparison to palmitoyl-CoA, each at 50μM.  In lpt1∆ strain very little to no lyso PI, 
lysoPS and lysoPE acyltransferase activity was left. Assays with oleoyl-CoA as acyl 
donor established that lysoPC, lysoPI and lysoPS were better substrates for Lpt1 in 
comparison to LysoPE. These results suggest that Lpt1 has broad substrate specificity for 
lysophospholipids and is a lysophospholipid acyltransferase (LPLAT).  
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Figure 3.7 Lysophospholipid substrate specificity of Lpt1p. 
Lysophosphatidylethanolamine (lysoPE),  lysophosphatidylinositol (lysoPI) and 
lysophosphatidylserine (lysoPS) were used as acyl acceptors and LPLAT activity was 
determined by the spectrophotometric method using cell lysates prepared from wild-type 
yeast. palmitoyl-CoA (black), oleoyl-CoA  (textured).  The data represents mean ± S.E. n 
= 3. Asterisk indicates statistically significant difference (p<0.01) between wild-type and 
lpt1Δ.  
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Acyl-CoA substrate specificity of Lpt1 
To determine whether Lpt1 was responsible for establishing acyl chain asymmetry 
in phospholipids by esterifying lysophospholipids, we determined acyl-CoA substrate 
specificity of Lpt1 with [14C] lysoPC as acyl acceptor. We predicted that Lpt1 consistent 
with its role in phospholipid remodeling would use unsaturated acyl-CoAs preferentially. 
Substrate concentration series experiments were performed with [14C] lysoPC and five 
acyl-CoA species: palmitoyl-CoA (16:0), palmitoleoyl-CoA (16:1), stearoyl-CoA (18:0), 
oleoyl-CoA (18:1) and arachidonyl-CoA (20:4) (Figure 3.8.1-3). Except arachidonoyl-
CoA, the other four acyl-CoA substrates are the most abundant acyl chains in yeast 
phospholipids. The kinetic data was analyzed by EZ – fit software to obtain apparent Km 
and Vmax by fitting Michaelis Menten curve or sigmoidal curve to data (Table 3.1). There 
was discordance in Km and Vmax values obtained by these two methods. Then the data was 
transformed and   Lineweaver-Burk and Eadie Hofstee plots were used to determine Vmax 
and Km. The data could not be analyzed for most of the acyl-CoAs due to the lack of 
linear relationship and when analyzed gave inflated Km and Vmax values.  
The kinetic data was then analyzed by Hill plot to obtain apparent K0.5 and Vmax 
for different acyl-CoAs (Table 3.1). The Hill number ranged from 1.5-2 for all the acyl-
CoAs suggesting that kinetics did not follow the Michaelis Menten equation and were, in 
fact, cooperative. LPCAT activity showed low apparent K0.5 and Vmax for palmitoyl-CoA 
(16:0) and stearoyl-CoA (18:0). Higher apparent K0.5 and Vmax for palmitoleoyl-CoA 
(16:1) and oleoyl-CoA (18:1) was seen for the monounsaturated acyl-CoA substrates 
while polyunsaturated arachidonoyl-CoA (20:4) showed intermediate values.  
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Figure 3.8.1 Acyl-CoA substrate specificity of Lpt1.  Cell lysates from lpt1Δ yeast 
transformed with pRS423GP / LPT1 were assayed for LPCAT activity by the radioactive 
substrate method described in "Experiemental Procedures". The reaction contained 50μM 
[1-14C] palmitoyl lysophosphaitdylcholine, 1 - 50 μM of acyl-CoA, 3μg of cell lysate ,  
and 100 mM Tris-HCl, pH 7.4 and incubated for 5 minutes at 28°C. A. palmitoyl-CoA B. 
palmitoleoyl-CoA. The data represent mean ± S.E. n = 3 - 5. 
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Figure 3.8.2 Acyl-CoA substrate specificity of Lpt1p.  Cell lysates from lpt1Δ yeast 
transformed with pRS423GP / LPT1 were assayed for LPCAT activity by the radioactive 
substrate method described in "Experiemental Procedures". The reaction contained 50μM 
[1-14C] palmitoyl lysophosphaitdylcholine, 1 - 140 μM of acyl-CoA, 3μg of cell lysate ,  
and 100 mM Tris-HCl, pH 7.4 and incubated for 5 minutes at 28°C. C. stearoyl-CoA D. 
oleoyl-CoA. The data represent mean ± S.E. n = 3 - 5. 
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Figure 3.8.3 Acyl-CoA substrate specificity of Lpt1p.  Cell lysates from lpt1Δ yeast 
transformed with pRS423GP / LPT1 were assayed for LPCAT activity by the radioactive 
substrate method described in "Experiemental Procedures". The reaction contained 50μM 
[1-14C] palmitoyl lysophosphaitdylcholine, 2.5 - 75 μM of arachidonoyl-CoA, 3μg of cell 
lysate ,  and 100 mM Tris-HCl, pH 7.4 and incubated for 5 minutes at 28°C. The data 
represent mean ± S.E. n = 3 - 5. 
 
 
 
 
 
 
 
 
 
 104
 
Table 3.1 Comparison of different methods used to calculate kinetic parameters of 
Lpt1. Kinetic data from Figure 3.8.1-3 was used to calculate apparent Vmax and Km of 
Lpt1 for different acyl-CoAs. 
 
Acyl-CoA Hill Plot Analysis Michaelis Menten  
(Curve to fit data) 
 Km 
(μM)
Vmax 
(nmol / min / mg) 
Km 
(μM) 
Vmax 
(nmol / min / mg) 
Palmitoyl-CoA 
(16:0) 
 
2.2 
 
6.8 
 
1.8 
 
7.8 
Palmitoleoyl-CoA 
(16:1) 
 
11 
 
105 
 
21 
 
142 
Stearloyl-CoA 
(18:0) 
 
4.7 
 
9.6 
 
5.9 
 
12 
Oleoyl-CoA  
(18:1) 
 
30.5 
 
95.4 
 
49 
 
125 
Arachidonyl-CoA 
(20:4) 
 
10.5 
 
34.4 
 
11 
 
58  
 
 
Table 3.2 Kinetic parameters of Lpt1: Endogenous acyl-CoA profile in wild type (S288C 
background) yeast strain was obtained from literature (Faergeman 2001). * The 
concentration in (μM) was calculated by assuming a yeast haploid cell volume of 75 μm3. 
 
Acyl-CoA K0.5 
(μM) 
In vitro acyl-
CoA conc.* 
(μM) 
Expected 
LPCAT 
Activity at in 
vitro acyl conc. 
(nmol/min/mg) 
Vmax 
(nmol / 
min / 
mg) 
Vmax / K0.5
(min-1 
mg-1) 
Palmitoyl-CoA (16:0) 2.2 5.4 7.2 6.8 44 
Palmitoleoyl-CoA (16:1) 11 7.9 30 105 95 
Stearloyl-CoA (18:0) 5.5 6.2 5 11.6 21 
Oleoyl-CoA (18:1) 30.4 2.9 5 95.4 31 
Arachidonyl-CoA (20:4) 10.5 -  34.4 33 
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The ratio of Vmax/Km or the efficiency of enzyme can be used to find out what the 
preferred substrate is (Table 3.2). The value for efficiency of the enzyme was highest for 
palmitoleoyl-CoA followed by palmitoyl-CoA.  The Vmax/Km ratio was in general higher 
for unsaturated acyl-CoAs in comparison to saturated acyl-CoA, although palmitoyl-CoA 
was an exception due to its low apparent K0.5. 
 
Subcellular distribution of LPLAT activity 
  Acyl-CoA dependent LPCAT activities have been identified in yeast microsomes 
and mitochondria. Yamada et al., have shown that yeast LPCAT activity was localized 
mainly in microsomes and that mitochondrial fraction had much lower activity (4%of the 
microsomal activity). Acyl-CoA dependent LPCAT activity in mitonchodria was reported 
in yeast, although the percentage recovery of protein and activity in this subcellular 
fraction was not examined (Yamada 1977; Testet 2005). 
 To verify the location of LPLAT activity we used sucrose gradients to purify 
mitochondria, microsomes, and cell lysates by differential centrifugation. LPCAT activity 
(representative of LPLAT activity) was measured in these subcellular fractions (Table 
3.3). The microsomal fraction was highly enriched for LPLAT activity and had 10- fold 
higher activity than cell lysates. The mitochondrial fraction did not show any enrichment 
in LPLAT activity. No LPLAT activity independent of Lpt1 was detected in lpt1∆ 
mitochondria. This suggested that there is no acyl-CoA dependent mitochondrial LPCAT. 
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Table 3.3 Subcellular localization of acyl-CoA dependent LPCAT activity. Wild-type 
yeast were grown in YP with 3% glycerol to O.D.660 = 1. Cell lysates, mitochondria and 
microsomes were isolated as described under "Experimental Procedures". LPCAT 
activity was measured using the spectrophotometric method as described in fig. 3. The 
data represent mean ± S.E. n = 3. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Subcellular 
fraction 
 
LPCAT activity 
(nmol / min / mg) 
 
Fold 
enrichment 
 
Percent 
recovery 
Cell lysate 10.2 ± 0.5   
Mitochondria 8.1 ± 1.9 0.8 ± 0.1 1.9 ± 0.9 
Microsomes 99.2 ± 2.7 9.7 ± 0.2 65.1 ± 14.5 
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Figure 3.9 Incorporation of [3H] oleate into phospholipids and neutral lipids. Wild-
type and lpt1Δ yeast were grown in YPD to logarithmic phase and pulse-labeled with 
[3H]oleate for 30 minutes. A. Incorporation into the major phospholipids (PC, black; PE, 
white; PS/PI, striped) B. neutral lipids (diglyceride, dark gray; triglyceride, light gray; 
ergosterol ester, hatched) was measured as described in "Experimental Procedures". The 
data in counts per minute represent mean ± S.E. n = 4. Asterisk indicates statistically 
significant difference between wild-type and lpt1∆ (p<0.05) 
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Role of Lpt1 in oleate incorporation into glycerolipids 
We further studied the physiological role of Lpt1 mediated LPLAT activity in 
yeast.  Wild type and lpt1∆ strains were pulse labeled with [3H]oleate for 30 minutes and 
the incorporation of radioactive label in different phospholipid species and neutral lipids 
was measured (Figure 3.9). The lpt1∆ strains incorporated 30% less label in PC than the 
wild type strain. PS, PE, PI and neutral lipids did not differ between lpt1∆ strain and wild 
type yeast.  
The effect on PC synthesis may be due to reduction in AGPAT activity or LPLAT 
activity mediated by Lpt1. AGPAT mediates the synthesis of phosphatidic acid (PA), an 
important intermediate in the de novo synthesis of phospholipids and triglycerides. 
Therefore, one would expect that changes in Lpt1 mediated AGPAT activity would 
decrease the incorporation of oleate in triglycerides and phospholipids. Thus it is more 
likely that selective reduction in oleate incorporation in PC in lpt1∆ strains is due to the 
contribution of LPLAT activity mediated by Lpt1 towards PC synthesis. Since Lpt1 has 
the ability to esterify other lysophospholipids it is difficult to say why the effect was 
limited to PC. 
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3.5 Discussion 
AGPAT mediates the acylation of lysophosphatidic acid to phosphatidic acid, an 
essential intermediate in the de novo triglyceride and phospholipid synthetic pathway. The 
basic synthetic pathways of triglyceride and phospholipids (with some exceptions) in S. 
cerevisiae are same as in higher eukaryotes. Human AGPAT-1 and AGPAT-2 were 
cloned by homology to Slc1, the yeast AGPAT.  The slc1∆ mutants are viable and 
microsomes prepared from slc1∆ strain retain the ability to synthesize phosphatidic acid 
(Athenstaedt 1997) indicating that alternative pathway or another AGPAT must exist in 
yeast. We initiated the present study to identify the novel AGPAT in yeast, and 
potentially identify novel AGPAT members of the existing human AGPAT family or a 
new family of enzymes with AGPAT activity.  
Yeast is a versatile model system with well-defined genetic system making it 
possible to conduct a systematic analysis of lethality and other phenotypes associated 
with deletion of a gene in yeast. Because of the essential requirement of phosphatidic acid 
for the synthesis of membrane phospholipids in yeast, and indeed all eukaryotes, absence 
of enzymes synthesizing PA should prove lethal to cell. Therefore the present study 
employed synthetic lethal screen to identify candidate AGPAT genes which when deleted 
in conjunction with SLC1 would lead to cell inviability.  SGA analysis utilizing slc1∆ 
mutant was undertaken and a total of 52 synthetic lethal interactions were identified.  
Among the 13 synthetic lethal genes with known functions, FEN1 (ELO2) encodes 
protein required for the synthesis of very long chain fatty acids (VLCFA).   
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ELO2 and ELO3 belong to elongase family of proteins and have been shown to 
catalyze elongation of C16 to C18 fatty acids to C24-C26 respectively. These VLCFA are 
required for sphingolipid synthesis. Simultaneous disruption of ELO2 and ELO3 in a 
haploid cell is synthetically lethal (Dickson 2008). Sphingolipids are made up of long 
chain base (LCB), very long chain fatty acids (usually C26) and a polar head group. LCBs 
are required for cell viability; however strains lacking LCBs have been isolated. These 
lcb1- defective cells can grow because of a suppressor mutation in SLC1. SLC1-1 mutant 
cells, with Q44L substitution in the Slc1 protein suppresses the defect in sphingolipid 
synthesis by incorporating long chain acyl groups (C26) in the sn-2 position of inositol 
containing glycerolipids (Nagiec 1993). This novel lipid is postulated to mimic ceramides 
required for sphingolipid synthesis. Overexpression studies on SLC1-1 and SLC1 have 
shown that Slc1 shows AGPAT activity in the presence of 22:1-CoA and 24:0-CoA (Zou 
1997). Although this activity is only 21%-33% of that of SLC1-1 encoded mutant protein 
it might be sufficient to compensate for loss of sphingolipid synthesis in yeast. It is 
possible that ELO3 in conjunction with SLC1 can compensate for the defect in 
sphingolipid synthesis caused by the absence of ELO2. A yeast strain with a disruption in 
SLC1, ELO3 and LCB1 (lcb1∆slc1∆elo3) has been shown to be inviable (Dickson 2008). 
 LPT1, a member of MBOAT superfamily, was also identified by the synthetic 
lethality screen and further characterized.  The MBOAT superfamily which consists of 
membrane bound acyltransferases is evolutionarily conserved. 5 members of this family 
that are found in Saccharomyces cerevisiae are sterol acyltransferases Are1, Are2; 
glycosylphosphatidylinositol anchor remodeling enzyme Gup1, Gup2 and Lpt1.  
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In humans the MBOAT family consists of 16 members of which ACAT1, 
ACAT2, and DGAT1 are the only members whose biochemical role has been established. 
Lpt1 does not share sequence homology with Slc1 or any other AGPAT family members 
including lysophosphatidylcholine acyltransferases, LPCAT1 and LPCAT2. Lpt1 shares 
24%, 21% and 22% amino acid sequence identity with human MBOAT1, 2 and 5 
respectively. Further studies on the human counterparts of Lpt1 have been described later. 
To investigate whether Lpt1 was responsible for AGPAT activity in slc1∆ strain, 
we compared the AGPAT activity in lpt1∆ and slc1∆ cell lysates. AGPAT activity was 
reduced by 60% in the absence of SLC1, the known AGPAT in yeast. This is consistent 
with the results of a previous study that showed 54% reduction in microsomal 
phosphatidic acid synthesis in slc1∆ in comparison to the wild type yeast strain. However, 
AGPAT activity in lpt1∆ yeast strain was not statistically different from that in wild type 
strain. It is possible that in the absence of Lpt1, Slc1 is up regulated and hence AGPAT 
activity is unaffected. However, overexpression of LPT1 in a wild type yeast strain 
increased AGPAT activity by 7-fold. Also, simultaneous deletion of SLC1 and LPT1 in 
haploid cell lead to inviability suggesting that LPT1 is the novel AGPAT in yeast 
responsible for phosphatidic acid synthesis in the absence of SLC1.  
Additional experiments in the present study demonstrated that LPT1 is the major 
lysophospholipid acyltransferase in yeast. There is a complete loss of the ability to 
esterify sn-2 lysophosphatidylcholine upon LPT1 deletion in the assay conditions here 
employed. This LPCAT activity was mostly associated with microsomes (65%), which 
was in agreement with previous studies which showed that Lpt1 localizes to ER (Huh 
2003).  
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Loss of 1/3 of LPCAT activity might have been due to degradation of enzyme or 
inefficiency in the process of preparation of subcellular fractions. Acyl-CoA dependent 
LPCAT activity has been described in mitochondria (Testet 2005) but we found very little 
LPCAT activity (2%) to be associated with mitochondrial fraction in wild type strain and 
no activity in mitochondrial fractions prepared from an lpt1∆ strain. 
 The wild type strain showed the ability to esterify other lysophospholipids 
(lysoPE, lysoPI and lysoPS) by an acyl-CoA dependent reaction. The acylation rate of 
different lysophospholipids was in the order lysoPC=lysoPI=lysoPS>lysoPE when each 
was included at 50 μM. The lpt1∆ yeast strain showed very little to no ability to esterify 
lysoPC, lysoPE and lysoPI. In lpt1∆ yeast strain, around 15% of lysoPS acyltransferase 
activities with unsaturated aycl doors and 50% activity with saturated acyl-CoAs 
remained. It is possible that there are yet to be identified lysoPS acyltransferases in yeast. 
Lysates of slc1∆ yeast strain transformed with yeast expression vector containing coding 
region of SLC1 (pYEUra3-SLC1) showed no lysophospholipid acyltransferase activity 
with 45μM lysoPC, lysoPE and lysoPI and 18 μM [14C] 18:1-CoA (Zou 1997).  Since in 
these assays lysoPS was not included as acyl acceptor it is possible that Slc1 is 
responsible for residual lysoPS acyltransferase activity in the absence of Lpt1. 
In yeast, the role of lysoPE esterification was proposed in uptake and synthesis of 
PE from exogenous lysoPE (Riekhof 2006), however the enzyme mediating this 
esterification was not identified.  Microsomal lysoPI acyltransferase activity has been 
described in rat brain (Baker 1973),  pancreas (Rubin 1983) and bovine brain (Sanjanwala 
1989). Acyl-CoA dependent conversion of lysoPS to phosphatidylserine is also known to 
occur in rat liver (Holub 1980). 
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 The ability of Lpt1 to transfer acyl groups to sn-2 position of wide variety of 
lysophospholipids and the absence of activity upon its deletion shows that Lpt1 is the 
major LPLAT in yeast and may be the first characterized member of a LPLAT branch of 
the MBOAT gene family.  
Since Lpt1 esterifies lysophospholipids at the sn-2 position, we examined whether 
acyl-CoA selectivity of Lpt1 contributes to asymmetrical distribution of acyl groups in 
phospholipids. Using lysoPC as the acyl acceptor, low Km and Vmax values were obtained 
with saturated acyl-CoAs while unsaturated acyl-CoA showed higher Km and Vmax values. 
In comparison to previously described LPCAT activity in yeast (Km-152 μM; Vmax- 10.9 
nmol/min/mg), the Km for oleoyl-CoA was lower and the Vmax was higher. Vmax/Km ratio 
was used to compare the utilization of acyl-CoAs by the enzyme. In general the efficiency 
was higher for the unsaturated acyl-CoAs compared to the saturated acyl-CoAs.  
Comparison of LPLAT activity at physiological concentration of each acyl-CoAs would 
give better idea about the acyl-CoA specificity of Lpt1. There are very few studies which 
have measured the intracellular acyl-CoA pool in yeast.  
Endogenous levels of acyl-CoA species in wild type yeast cells grown to 
exponential phase (O.D 660 0.8) in YEPD media have been measured in nmol/ 2 * 109 
cells (Faergemann 2001). The average volume of haploid yeast is about 70 μm3 and this 
information allows us to calculate the concentration of each acyl-CoA in the cell 
(Sherman 2002). At these concentrations the Lpt1 will utilize the acyl-CoAs in the 
following order: 16:1-CoA> 16:0-CoA> 18:1-CoA = 18:0 CoA (Table 3.2).  As can be 
derived from our data, small changes in acyl-CoA species concentration may change the 
substrate used the most by Lpt1.  
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The physiological role of Lpt1 mediated LPLAT activity on glycerolipid synthesis 
was studied by pulse labeling wild type and lpt1∆ strain with [3H] oleate. 30% reduction 
in incorporation of label in PC was seen in lpt1∆ strain. This decrease is less likely to be 
due to decrease in AGPAT activity that mediates the synthesis of phosphatidic acid, a 
precursor for all phospholipid species and triglyceride.  Since no changes were seen in 
incorporation of label in any other phospholipids and triglyceride in lpt1∆ strain, it is 
more likely that the absence of LPLAT activity affects the PC synthesis via a remodeling 
pathway. Lpt1 can mediate esterification of lysoPE, lysoPI and lysoPS and a lack of 
effect on these phospholipids might be due to their low abundance or low turn over in 
cell. Mitochondrial phospholipase A2 activity in yeast has been reported but the 
preference for phospholipid species is not known (de Kroon 2007). Yeast phospholipase 
B, Nte1 selectively degrades PC synthesized by CDP-choline pathway, producing 
glycerolphosphocholine (Zaccheo 2004). Recently, glycerophosphocholine 
acyltransferase (GPCAT) activity was reported in yeast however, no gene–enzyme 
relationship was established. It was suggested that glycerophosphocholine is sequentially 
acylated by GPCAT and Lpt1 to synthesize phosphatidylcholine (Stalberg 2008). 
Another reaction which produces lyso-PC in yeast is the transfer of an acyl group 
from PC to diglyceride to synthesize triglycerides (Oelkers 2000). This acyl-CoA 
independent reaction catalyzed by Lro1, may contribute to substrates for Lpt1. In addition 
to membrane remodeling Lpt1 might be required to regulate intracellular levels of 
lysophospholipids in the event of increased rate of phospholipid turnover. The 
esterification of lysophospholipids to synthesize phospholipids might be energetically 
favorable for cell in comparison to de novo synthesis of phospholipids. 
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Phospholipids in general have saturated acyl chains in the sn-1 position and 
unsaturated acyl chains in sn-2 position. This asymmetrical distribution of acyl chains in 
phospholipids is thought to occur by phospholipid remodeling requiring lysophospholipid 
acyltransferase activity (Lands 1960). In Saccharomyces cerevisiae, Lpt1 mediates most 
of the lysophospholipid acyltransferase activity with a preference for unsaturated acyl-
CoAs suggesting its role in phospholipid remodeling. Absence of SLC1 in conjunction 
with LPT1 leads to cell lethality, suggesting a minor but important role of LPT1 as an 
AGPAT.  
After the publication of the present study, Ict1 a novel soluble yeast AGPAT was 
identified (Ghosh 2008). This AGPAT is expressed in yeast cells upon exposure to 
organic solvents and perhaps contributes to the phospholipid synthesis in conditions in 
which requirement of phospholipids for repair is increased.  Further studies will be 
required to examine the contribution of Slc1, Lpt1 and Ict1 in synthesis of PA, an 
important intermediate for triglyceride and phospholipid synthesis. Parallel studies by 
other investigators also identified LPT1 by using different genetic approaches (Benghezal 
2007; Chen 2007; Riekhof 2007). Identification of LPT1, a member of MBOAT 
superfamily will allow us to understand the functional role of the mammalian orthologues 
in establishing phospholipid acyl chain composition.  
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CHAPTER 4: IDENTIFICATION AND BIOCHEMICAL CHARACTERIZATION 
OF HUMAN LYSOPHOSPHATIDYLCHOLINE ACYLTRANSFERASE-3 
(LPCAT3) 
 
 
 
4.1. Abstract 
Phospholipids are important constituents of membranes. They are synthesized by 
a de novo synthetic pathway and are remodeled by the Lands cycle to achieve the 
asymmetric distribution of acyl chains commonly found in the phospholipids. The Lands 
cycle has two components, deacylation by phospholipase to form lysophospholipids and 
reacylation by lysophospholipid acyltransferases to form phospholipids. Recently, we 
characterized Lpt1, a lysophospholipid acyltransferase with broad substrate specificity in 
Saccharomyces cerevisiae.  
In this study we describe the characterization of lysophosphatidylcholine 
acyltransferase 3 (LPCAT3), a human homolog of Lpt1 which specifically esterifies 
lysophosphatidylcholine. LPCAT3, when expressed in insect cells, resulted in 10 fold 
higher LPCAT activity in cell lysates over endogenous activity. No other acyltransferase 
activity was detected with a variety of other acyl acceptors including lysophosphatidic 
acid. The LPCAT3 activity did not display specificity towards acyl chains present in the 
sn-1 position of lysophosphatidylcholine. Concentration series experiments with 
saturated, monounsaturated and polyunsaturated acyl-CoAs, showed that LPCAT3 has a 
low apparent K0.5 (5μM) and Vmax (50 nmol/min/mg) for saturated acyl-CoA and higher 
K0.5 (46.5 μM) and Vmax (759 nmol/min/mg) with monounsaturated aycl-CoA. 
Polyunsaturated acyl-CoA showed intermediate values.  
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Electrospray ionization-mass spectrometric analysis of phospholipids in Sf9 cells 
expressing LPCAT3 showed a relative increase in phosphatidylcholine containing 
saturated acyl chains and a decrease in phosphatidylcholine containing unsaturated acyl 
chains. This shift in acyl chain composition of phospholipids agrees with the in vitro 
preference of LPCAT3 for saturated acyl-CoA when physiological acyl-CoA 
concentrations are less than or equal to 5 μM. Characterization of molecular nature of 
human LPCAT3 will enable us to investigate whether other human MBOAT protein 
acylate lysophospholipids and help us understand the role of this family in phospholipid 
remodeling. 
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4.2 Introduction 
Lysophosphatidylcholine (LysoPC) is a major lysophospholipid in plasma with 
concentrations around 200µM (Murph 2007). It is mainly produced by phospholipase A2 
and lecithin:cholesterolacyltransferase (LCAT) (Albers 1976). High levels of 
lysophosphatidylcholine lead to apoptosis (Takahashi 2002; Han 2008), cell lysis 
(Weltzien 1979) and inflammation (Kougias 2006). The enzyme systems that utilize this 
lysophospholipid and might clear it from plasma include lysophospholipases and 
lysophosphatidylcholine acyltransferases (LPCAT) (Wang 1999).  LPCATs are also part 
of the acylation arm of Lands Cycle to synthesize remodeled phosphatidylcholine (PC) in 
rat liver (Lands 1960).  
Remodeling of phospholipids helps to maintain acyl chain composition of 
membrane lipids and allows for the incorporation of arachidonic acid in the sn-2 position 
of phosphatidylcholine which when released by cytosolic PLA2 is a substrate for 
eicosanoids (Funk 2001). The acyl chain composition of the peritoneal macrophage 
membrane phospholipids, when enriched for saturated fatty acids, showed a reduction in 
endocytosis and bilayer fluidity (Mahoney 1980). Thus, the acylation of 
lysophospholipids might regulate their plasma levels and maintain membrane function. 
The lysophospholipid acyltransferases esterify lysophospholipids by utilizing acyl groups 
of varying chain length and saturation (Lands 1960). These enzyme systems might 
catalyze the formation of remodeled phospholipids with specific biological function in a 
particular tissue.  
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Mouse LPCAT1 is highly expressed in lung and is suggested to catalyze the 
formation of dipalmitoyl lysophosphatidylcholine, a pulmonary surfactant (Nakanishi 
2006).  
LPCAT2 primarily synthesizes platelet activating factor in inflammatory cells (Shindou 
2007). Previous studies have shown that lysoPC in rat liver microsomes is acylated in 
vitro preferentially by oleoyl-CoA and arachidonoyl Co-A (Yamashita 1997). Similarly, 
LPCAT activity in guinea pig gall bladder utilizes oleoyl CoA as a preferred acyl donor 
(Niederhiser 1978). This suggests that there are other yet to be identified LPCATs, which 
are tissue specific and maintain acyl chain composition of membranes or quench excess 
lysophospholipids in their environment.  
We previously cloned LPT1, a novel lysophospholipid acyltransferase (LPLAT) 
in Saccharomyces cerevisiae with broad substrate specificity for lysophospholipids (Jain 
2007). LPT1 is a member of membrane bound O-acyltransferase (MBOAT) super family. 
Members of this family are membrane proteins and have a conserved histidine in their 
active site (Hofmann 2000). The human homologues of LPT1 shared no sequence 
similarity to the LPCAT1 and LPCAT2 family and most of them have not been 
biochemically characterized. MBOAT1 gene disruption due to translocation was 
associated with a novel brachydactyly-syndactyly syndrome (Dauwerse 2007). Recently, 
one of the members of the MBOAT family LENG4, encoded protein was characterized as 
lysophosphatidylinositol acyltransferase (Lee 2007). In this study, we report the 
identification and biochemical characterization of human LPCAT3, a LPT1 homolog and 
a member of MBOAT family.  
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4.3 Experimental Procedures 
 
 
Materials  
 
Lysophosphatidylethanolamine (lysoPE), lysophosphatidylserine (lysoPS), 
lysophosphatidylinositol (lysoPI), 1-O-alkyl lysoPC, and lysoPG were from Avanti Polar 
Lipids (Alabaster, AL). [1-14C] palmitoyl- lysoPC (55mCi/mmol) was from Perkin-Elmer 
Life. All other chemicals were obtained from Sigma or Fisher.  
Protein sequence analysis  
 Full-length sequences were aligned using clustalW2 (Labarga 2007). For percent 
identity, the conserved amino acids were counted and divided by the length of the shorter 
of the two proteins compared. Transmembrane domains were predicted by the  
transmembrane helix prediction hidden Markov model (TMHMM) 2.0 program (Krogh 
2001).  
Insect cell expression  
A 4.4 kb human LPCAT3 cDNA clone (GenBank Acc. # BC065194) was obtained from 
the American Type Culture Collection in pCMVsport6.  Restriction digest with SmaI, 
PvuII released the open reading frame with 45 bp of 5'UTR and 121 bp of 3'UTR.  This 
fragment was ligated into StuI digested pFastbac and sequenced.  Subsequent baculovirus 
expression in Sf9 insect cells was performed by Dr. David Schultz, Wistar Institute 
Protein Expression Core Facility.  The pFastbac / LPCAT3 plasmid and a pFastbac / 
Glutathione S-transferase (GST) control were transposed into DH10Bac cells.   
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Recovered bacmid DNAs were screened by PCR for proper transposition of the transfer 
vector into the baculovirus genome. Positive bacmid DNAs were transfected into Sf9 
cells and passage 1 (P1) virus stocks were recovered 96 hours post-transfection. A high-
titer P2 virus stock was generated by infecting Sf9 at a multiplicty of infection (MOI) of 
~0.1, followed by incubation for 96-120 hours.  For productions, 1 x 106 Sf9 cells/ml in 
Sf900-II medium (Invitrogen) were infected with viruses at an MOI of 1.  Cells were 
harvested 48 hours post-infection. 
Generating cell lysates for enzymatic assays  
 Sf9 cells were homogenized in 1 mM EDTA / 200 mM sucrose / 100 mM Tris-HCl, pH 
7.4 by 10-15 passages through a 26.5 gauge needle (Yen 2002).  Unlysed cells were 
removed by centrifugation at 1,000 x g for 5 min. at 4° C and the supernatant was stored 
frozen (-70° C) prior to assays. 
LPCAT assay, radioactive substrate  
 Lysophosphatidylcholine acyltransferase (LPCAT) activity was measured by the 
incorporation of [1-14C] palmitoyl lysoPC into phosphatidylcholine (PC). The reaction 
contained 100 mM Tris-HCl, pH 7.4, 50 μM [1-14C]palmitoyl lysoPC (50,000 dpm / 
nmol), 1 - 150 μM of the respective acyl-CoA, and 1 μg of cell lysate protein in a total 
volume of 100μl. Fixed time assays were performed for 7.5 minutes at 28° C.  Reactions 
were stopped by adding chloroform: methanol (2:1) and lipids were extracted, resolved 
by thin layer chromatography (TLC), and quantified as described elsewhere (Nakanishi 
2006). EZ-Fit software was used for non-linear regression, curve fit analysis to calculate 
apparent K0. and Vmax. To calculate Vmax / Km, Vmax was first changed to nM / min / mg to 
 122
 
remove volume from the units of the ratio. Hill plot analysis was done to obtain Hill 
number. 
LPLAT assays, spectrophotometric  
These assays were essentially performed as described in the previous chapter. The 
reaction mixture contained 100 mM Tris-HCl, pH 7.4, 50 μM of the respective lysoPL, 
50 μM oleoyl CoA, 1 mM DTNB, and 2 - 5μg cell lysate protein in a total volume of 1 
ml.  Real time assays were performed for 5 minutes at room temperature. 
Bligh-Dyer lipid extraction  
Cellular phospholipids were extracted using chloroform and methanol according to the 
method of Bligh and Dyer (Bligh 1959). Following transfection, Sf9 cells were 
homogenized in 3 mL of methanol: water (2:0.8), transferred to a glass test tube and 1.25 
mL chloroform was added.  Tubes were vortexed for 30 seconds and allowed to sit for 10 
minutes on ice.  After centrifugation at 213 x g for 1 minute the chloroform layer was 
collected.  The extraction was repeated and the lipid extracts were combined, dried under 
argon, reconstituted with 50μL of methanol: chloroform (2:1), and stored at -20°C. 
Lipid phosphorus assay  
This was performed by Dr. Brian Cummings, Department of Pharmaceutical and 
Biomedical Sciences, The University of Georgia, Athens, GA. 10 μL of lipid extract was 
dried under argon. 200 μL of perchloric acid was added and heated at 130° C for 2-3 
hours.  To this was added 1 mL of dH2O, 1.5 mL of reagent C (4.2 g ammonium 
molybdate tetrahydrate in 100 mL 5 N HCl and 0.15 g malachite green (Zhou 1992) 
oxalate in 300 mL dH20) and 200 μL of 1.5% (v/v) Tween 20.  After 25 minutes at room 
temperature, the A590 was measured. 
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Electrospray ionization-mass spectrometry (ESI-MS)  
This was performed in collaboration with Dr. Brian Cummings, Department of 
Pharmaceutical and Biomedical Sciences, The University of Georgia; Athens, GA. Lipid 
extracts (500 pmol/μl) were prepared by reconstituting in chloroform: methanol (2:1).  
Mass spectrometry was performed as described previously (Taguchi 2000). Samples were 
analyzed using a Trap XCT ion-trap mass spectrometer (Agilent Technologies, Santa 
Clara, CA) equipped with an ESI source.  5 μL of sample was introduced by means of a 
flow injector into the ESI source at a rate of 0.2 ml/min.  The elution solvent was 
acetonitrile: methanol: water (2:3:1, v/v/v) containing 0.1% (w/v) ammonium formate 
(pH 6.4).  The mass spectrometer was operated in the positive and negative ionization 
modes.  The nitrogen drying gas flow-rate was 8.0 L/min at 350°C, nebulizer pressure 
was 30 psi, and capillary voltage was 3 kV.  As previously described (Taguchi 2000) 
qualitative identification of individual PL molecular species was based on their calculated 
theoretical monoisotopic mass values and subsequent MSn fragmentation to identify the 
polar head groups.  Relative quantification was done by comparison to the most abundant 
phospholipid in each sample, which corresponded to m/z 760 or, 34:1 (16:0-18:1) PC.  
MassLynx 4.0 software was used for data analysis.  MSn fragmentation was performed on 
the same instrument under similar conditions except that the ion source and ion optic 
parameters were optimized with respect to the positive molecular ion of interest.   
Statistical Analysis 
Data from four separate Sf9 infections underwent analysis of variance using SAS 
software.  Individual means were compared by post hoc tests. 
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4.4 Results 
Identification of MBOAT5/ C3F as a LPT1 homolog 
To characterize functional homologs of Lpt1, we performed homology search of   amino 
acid sequence data bases using Lpt1 amino acid sequence as the query.  Three human 
proteins, MBOAT1, MBOAT2 and MBOAT5 (C3F) with approximately 25% identity to 
Lpt1 were identified. MBOAT5 (also called C3F) was chosen for initial analysis because 
of the conservation of the KKME motif at the C-terminal as an endoplasmic retention 
signal (Figure 4.1). Immunofluorescence studies using antibody against a peptide 
sequence of C3F have shown that C3F has endoplasmic reticulum localization in both 
HeLa and HEK293 cells (Hodges 2005). MBOAT5/C3F is predicted to encode for 487 
amino acid protein. Analysis of the predicted protein sequence by TMHMM 2.0 program 
identified seven transmembrane domains (Figure 4.2).  
 
Biochemical characterization of MBOAT5/C3F encoded Lysophosphatidylcholine 
acyltransferase activity 
To determine whether MBOAT5/C3F encoded protein was a functional homolog of Lpt1, 
a lysophospholipid acyltransferase in Saccharomyces cerevisiae, a putative full length 
cDNA clone for MBOAT5 was found in the mammalian gene collection  and inserted 
into baculovirus. Insect cells were infected with the recombinant hMBOAT5 baculovirus 
to express MBOAT5 protein. To account for the endogenous acyltransferase activity, 
parallel infections with a GST-encoding virus were done. 
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Figure 4.1 Alignment of Lpt1p and MBOAT5 / C3F.  ClustalW2 was used to align the 
yeast Lpt1p (610 amino acids) and human MBOAT5 / C3F (487 amino acids) peptide 
sequences. Numbers at the ends of lines refer to the location of the last residue.  Not 
shown are the C-terminal 107 amino acids of Lpt1p which terminate in KKEE.     
 
 
 
 
 
Figure 4.2 Predicted transmembrane domains of LPCAT3. Seven transmembrane 
domains (boxes in dark grey) were predicted by TMHMM 2.0 for LPCAT3  
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Cell lysates prepared from insect cells expressing human MBOAT5 showed 10-fold 
higher [14C] lysoPC incorporation in PC with oleoyl-CoA over the GST-expressing 
controls (Figure 4.3). We therefore renamed MBOAT5/C3F as LPCAT3. The yeast 
ortholog, Lpt1 can utilize a variety of lysophospholipid species therefore we examined 
the ability of LPCAT3 to esterify other lysophospholipids. Lysophosphatidylserine 
(lysoPS) and lysophosphatidylethanolamine (lysoPE) were used as substrates but showed 
8 fold less activity in comparison to lysoPC at 50μM. Lysophosphatidic acid (lysoPA), 
lysophosphatidylglycerol (lysoPG), lysophosphatidylinositol (lysoPI) and lyso-platelet 
activating factor (lysoPAF) were not used as acyl acceptors. LPCAT3 activity was not 
affected by variation of chain length or by the presence of double bond in the sn-1 acyl 
groups in lysoPC (Figure 4.4). 
 Kinetic analysis was carried out by examining the LPCAT activity with 
increasing substrate concentrations of 1-palmitoyl-lysoPC and 50μM oleoyl-CoA (Figure 
4.5). The kinetic data was analyzed by EZ – fit software to obtain apparent Km and Vmax 
of LPCAT3 for different acyl-CoAs by fitting Michaelis Menten curve or sigmoidal 
curve to data. There was discordance in apparent Km and Vmax values obtained by these 
two methods (Table 4.1). Then the data was transformed and Lineweaver-Burk and Eadie 
Hofstee plots were used to determine Vmax and Km.  Using Lineweaver-Burk plot the Km 
and Vmax for lysoPC were 85μM and 1666 nmol/min/mg respectively.  By Eadie Hofstee 
transformation the Km and Vmax for lysoPC were 64.5 μM and 1320 nmol/min/mg 
respectively.  
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Figure 4.3 Lysophosphatidylcholine acyltransferase (LPCAT) activity in infected 
Sf9 insect cells.  Cell lysates from Sf9 cells with baculovirus-mediated expression of 
MBOAT5 or GST were assayed for LPCAT activity by the radioactive substrate method.  
50 μM [1-14C] palmitoyl-lysoPC, 50 μM oleoyl-CoA, 1 μg cell lysate, and 100 mM Tris-
HCl, pH 7.4 were incubated for 7.5 minutes at 28°C.  Radioactive product (PC) was 
resolved from substrate (lysoPC) by TLC. The data represent mean ± S.E. n = 4. Asterisk 
indicates statistically significant difference (p< 0.001). 
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Figure 4.4 Lysophospholipid substrate specificity of LPCAT3.  LPLAT activity was 
measured using 50 μM oleoyl-CoA and 50 μM of lysoPC:  1-myristoyl (C14:0), 1-
palmitoyl (C16:0), 1-stearoyl (C18:0), 1-oleoyl (C18:1) and lysoPE 1-myristoyl (14:0), 
lysoPS 1-oleoyl (18:1).  The spectrophotometric method was used, as described in 
Experimental procedures, with cell lysates prepared from LPCAT3 or GST infected Sf9 
cells. The data represents mean ± S.E. n = 4. 
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Figure 4.5 Kinetics of lysoPC utilization by LPCAT3. (A) LPCAT assays were 
performed as described in Figure 4.2 except a range (5- 75 μM) of [1-14C] palmitoyl 
lysoPC was used. The data represent the mean of the net LPCAT activity S.E. n = 4 (B) 
Hill plot for the data in panel A. 
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Analysis of the velocity at varying concentrations of oleoyl-CoA by Hill plot 
yielded a Hill number of 1.8 and apparent K0.5 of 12.5 μM for lysoPC. The enzyme 
exhibited positive cooperative kinetics with respect to concentration of lysoPC. Therefore 
sigmoidal curve was fitted to the data to obtain the apparent Vmax.  
Next, we analyzed the acyl-CoA selectivity of LPCAT3 using [1-14C] palmitoyl-
lysoPC as an acyl acceptor. Increasing concentrations of saturated (stearoyl-CoA), 
monounsaturated (oleoyl-CoA), polyunsaturated, omega-6 (arachidonic acid), and 
polyunsaturated, omega-3 (linolenoyl-CoA) acyl-CoAs were used (Figures 4.6, 4.7, 4.8 
4.9).  The sigmoidal curve was fitted to the data to obtain the apparent Vmax for each of 
the acyl-CoAs (Table 4.1). The Michaelis Menten analysis of kinetic data gave higher 
Vmax and Km values for acyl-CoAs. The data could not be analyzed for all the acyl-CoAs 
by Lineweaver-Burk and Eadie Hofstee plots due to the lack of linear 
relationship.Subsequent analysis of the kinetic data by Hill equation yielded a Hill 
number and Km values. The Hill number for all the acyl-CoAs except linolenoyl-CoA 
were greater than 1 therefore LPCAT3 shows positive cooperative kinetics with respect 
to the varying concentration of acyl-CoAs (Table 4.1). Linolenoyl-CoA was the only 
substrate for which concentrations higher than 110 μM did not inhibit activity and hence 
a correct estimate of apparent Vmax and Km could not be obtained. According to the 
apparent Km values of LPCAT3 for acyl-CoAs, stearoyl-CoA was the preferred acyl 
donor (Table 4.1). Oleoyl-CoA was the most preferred substrate based on the capacity of 
enzyme (Vmax).  
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Figure 4.6 Kinetics of Stearoyl-CoA (18:0-CoA) utilization by LPCAT3. (A) LPCAT 
assays were performed as described except a range (2- 20 μM) of Stearoyl-CoA was 
used. For each data point, net LPCAT activity was obtained by subtracting LPCAT 
activity in Sf9-GST lysates from Sf9-LPCAT3 lysates. The data represent mean ± S.E. n 
= 4. (B) Hill plot for the data in panel A 
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Figure 4.7 Kinetics of Oleoyl-CoA (18:1-CoA) utilization by LPCAT3. (A) LPCAT assays 
were performed as described except a range (5- 110 μM) of oleoyl-CoA was used. For 
each data point, net LPCAT activity was obtained by subtracting LPCAT activity in Sf9-
GST lysates from Sf9-LPCAT3 lysates. The data represent mean ± S.E. n = 4. (B) Hill 
plot for the data in panel A 
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Figure 4.8 Kinetics of Arachidonoyl-CoA (20:4-CoA) utilization by LPCAT3. (A) LPCAT 
assays were performed as described except a range (10-130 μM) of arachidonoyl-CoA 
was used. For each data point, net LPCAT activity was obtained by subtracting LPCAT 
activity in Sf9-GST lysates from Sf9-LPCAT3 lysates. The data represent mean ± S.E. n 
= 4. (B) Hill plot for the data in panel A 
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Figure 4.9 Kinetics of Linolenoyl-CoA (18:3-CoA) utilization by LPCAT3. (A) LPCAT 
assays were performed as described except a range (20-150 μM) of arachidonoyl-CoA 
was used. For each data point, net LPCAT activity was obtained by subtracting LPCAT 
activity in Sf9-GST lysates from Sf9-LPCAT3 lysates. The data represent mean ± S.E. n 
= 4. (B) Hill plot for the data in panel A 
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Table 4.1 Kinetic parameters of human LPCAT3. Kinetic data from figures 4.6-4.9 
were used to calculate apparent Km and Vmax using Michaelis Menten analysis and Hill 
equation. 
 
 
 Hill Plot Analysis  Michaelis Menten Analysis 
 Km 
(μM) 
Vmax 
(nmol/min/m
g) 
Vmax / Km 
(min-1 mg-1)
Km 
(μM) 
Vmax 
(nmol/min/mg) 
Lyso-PC 13 486  44 1010 
Stearoyl-CoA 
(18:0) 
5.1 50 9.8 19 117 
Oleoyl-CoA 
(18:1) 
46.5 759 16.3 419 3600 
Arachidonyl-
CoA (20:4) 
55.8 529 9.5 334 1794 
α-linolenyl- CoA 
(18:3) 
214.1 268 1.3 338 354 
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The ratio of Vmax/Km or the efficiency of enzyme (assuming enzyme concentration is 
constant for all reactions) can be used to find out which substrate an enzyme is likely to 
turn into product faster. This value was the highest for oleoyl-CoA.  
Effect of expressing LPCAT3 on phospholipid species in Sf9 cells 
This was performed in collaboration with Dr. Brian Cummings, Department of 
Pharmaceutical and Biomedical Sciences, University of Georgia, Athens, GA. To begin 
to examine the physiological role of LPCAT3 in phospholipid metabolism, the effect of 
expressing LPCAT3 on the phospholipid profile in Sf9 cells was measured. We 
hypothesized that if LPCAT3 preferentially incorporates unsaturated acyl-chains into 
phospholipids then the cells expressing LPCAT3 will show abundance of unsaturated 
aycl chains in phsopholipids in comparison to the cells expressing GST. ESI-MS was 
performed on four independent cell lysates expressing LPCAT3 and GST (Figure 4.10). 
To account for alteration in ionization efficiency, the relative abundance of each PL 
species was expressed relative to the most abundant species (34:1 PC; m/z 760) within 
the sample. Normalizing to an added standard (28:0 PC, m/z 678) was also performed and 
showed similar trends (data not shown).   
After analyzing the abundance of 73 different m/z ratios in the positive mode, 10 
showed a significant difference between the LPCAT3 and GST expressing cells.  
Assigning specific PL species to m/z values was based on their calculated theoretical 
monoisotopic masses and verified by MS-MS. 
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Figure 4.10 Effect of LPCAT3 expression on Sf9 phospholipid species.  Lipids were isolated 
from Sf9 cells expressing GST or LPCAT3.  After lipid phosphorous content 
determination, 250 nmol was analyzed by ESI-MS as described in Experimental 
Procedures.  The results from 4 independent Sf9 infections were averaged.  The 
abundance of each PL species is expressed relative to that of the most abundant within 
the sample (34:1 PC in each case).  Of the 73 m/z values analyzed, all the ones that 
significantly differed (p<0.05) are shown. ePC = ether PC.  
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The five species that increased with LPCAT3 expression were 32:0 PE, 32:0 PC, 
36:0 PC, 32:0 (1-alkyl) PC, and 34:1 (1-alkyl) PC.  The five species that decreased were 
30:0 PC, 34:2 PC, 36:1 PC, 36:2 PC, and 34:2 (1-alkyl) PC (Fig. 4.10) became less 
abundant.  One thing to note is that when normalized to the added standard, 34:1 PC was 
about 30% more abundant in the LPCAT3 expressing cells. The overall trend was that the 
abundance of PC with more saturated chains increased with LPCAT3 expression while 
PC with more unsaturated chains. No differences between LPCAT3 and GST expressing 
cells were detected in the negative mode, suggesting that PI and PS species were 
unaffected. 
Tissue distribution of human LPCAT3 
 The expression pattern of LPCAT3 in human tissues was obtained from GNF 
SymAtlas and GeneNote, databases of human genes and their expression profiles in 
healthy human tissues. According to the GNF SymAtlas, LPCAT3 was expressed in all 
the 79 tissues and cell types. LPCAT3 was expression was 7-10 folds higher in 
adipocytes and bone marrow endothelial cells (CD34+, CD71+, or CD105+) when 
compared to most other tissues.  Modest expression of LPCAT3 (3 fold over the basal) 
was seen in placenta and prostrate. The GeneNote microarray data found no differences 
in LPCAT3 expression in 12 tissues including bone marrow but not adipose tissue.  
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4.5. Discussion 
In this study, we identified and characterized a human LPCAT3. hLPCAT3 was 
identified by its sequence similarity to previously characterized Lpt1, a lysophospholipid 
acyltransferase in S.cerevisiae (Benghezal 2007; Jain 2007; Riekhof 2007; Tamaki 2007). 
Our findings suggest that the LPCAT3 encodes for a protein that catalyzes the LPCAT 
reaction. Firstly, the cDNA of human LPCAT3 when overexpressed in insect cells confers 
a 10-fold increase in incorporation of radioactive [1-14C] lysoPC in PC over the 
endogenous activity. Secondly, the activity was specific for lysophosphatidylcholine. 
Other acyl acceptors lysoPA, lysoPI, lysoPG, lysoPAF were not used as substrates. The 
enzyme could use lysoPE and lysoPS as acyl acceptors, but the activity was eight fold 
less than that for lysoPC suggesting its specificity for lysoPC. However, this preference 
for acyl acceptors is limited to only one fixed concentration (50μM) of lysophospholipids 
used in the assay. These findings reaffirm that the hLPCAT3 cDNA encodes for a protein 
with LPCAT activity. We realize LPCAT3 has been designated in literature as 
MBOAT5/C3F and changes in enzyme nomenclature make the integration with previous 
reports troublesome. However, the consistent approach of incorporating the reaction 
catalyzed in any protein’s name provides clarity.  
LPCAT3 does not share sequence homology to previously identified LPCAT1 and 
LPCAT2 genes (Nakanishi 2006; Shindou 2007). It is a member of the MBOAT super 
family, which includes enzymes responsible for transfer of fatty acids to their substrates 
(Hofmann 2000). There are 16 proteins that belong to this super family (MBOAT1 and 
MBOAT2, each has 2 isoforms and Porcupine gives rise to 4 isoforms by alternative 
splicing) and a conserved histidine residue is thought to be the catalytic site (Figure 4.11). 
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Figure 4.11 Dendogram showing members of human MBOAT family 
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Acyl-CoA cholesterol acyltransferases (ACAT1 and ACAT2) that esterify 
cholesterol and diacylglycerol acyltransferase-1 (DGAT1) which utilizes diacylglycerol 
are the only members whose biochemical role has been established (Cases 1998).  
LPCAT3 encoded protein is 20% identical to MBOAT1 and MBOAT2 proteins. 
MBOAT1 and MBOAT2 are overall 52% identical. The disruption of MBOAT1 is 
associated with brachydactyly-syndactyly syndrome (Dauwerse 2007). The protein 
encoded by Drosophila homolog of LPCAT3 known as nessy, is 32% identical to the 
human counterpart and is regulated by homeotic (HOX) proteins during embryogenesis. 
HOX proteins are found in wide variety of organisms including Drosophila, mouse, and 
humans and are known to regulate morphognetic processes (Zaffran 1999). It is possible 
that LPCAT3 is a target of human HOX proteins and thus has a regulatory role in 
developmental processes. 
 MBOAT3, MBOAT4, Porcupine and Leng4 share 15% amino acid sequence 
similarity with LPCAT3. MBOAT3, shares sequence similarity to mammalian hedgehog 
acyltransferase (HHAT) but does not show in vitro HHAT activity (Abe 2007). 
Porcupine has been associated with processing and secretion of Wnt signaling proteins 
(Tanaka 2000; Caricasole 2002). Besides these studies very little information exists about 
the biochemical role of by these orthologs.  
LPT1, the yeast homolog of LPCAT3, encodes for LPLAT activity and utilizes all 
major lysophospholipids. It is possible that each human homolog utilizes specific 
lysophospholipid species as substrate and is tissue specific in expression. Recently 
LENG4 encoded protein was shown to have lysophophotidylinositol acyltransferase 
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(LPIAT) activity (Lee 2007). In the assay conditions used in this study, LPCAT3 showed 
robust activity with lysoPC. A comparison of LPCAT3 affinities for lysoPC and acyl-
CoAs with that of identified LPCAT1 and LPCAT2 will give us an idea about the likely 
contribution of each LPCAT at varying substrate concentrations. 
LPCAT1 has lower apparent Km for lysoPC in comparison to LPCAT3 (2.3 μM 
vs. 13.1 μM).  Inspite of LPCAT3 having a higher Vmax than LPCAT1, both the 
enzymes seem to saturate with lysoPC at concentrations between 25-35 μM. The kinetic 
paramters of LPCAT2 are not known. Regarding acyl chain specificity it is expected that 
LPCATs would preferentially introduce unsaturated acyl groups in the sn-2 position of 
phospholipids to maintain asymmetrical distribution of acyl chains in phsopholipids. 
However, LPCAT1 utilizes wide variety of acyl donors at a single concentration of 25 
μM (Nakanishi 2006). LPCAT2 has lower apparent Km for arachidonoyl-CoA in 
comparison to acetyl-CoA (21.1 Μm vs 50.4 μM) (Shindou 2007). Whether or not 
LPCAT2 utilizes acyl-CoAs other than arachidonoyl-CoA and acetyl-CoA is not known. 
LPCAT3 showed lower apparent Km for stearoyl-CoA but higher capacity for 
oleoyl-CoA.  At concentrations ≤ 5 μM stearoyl-CoA was a better substrate for LPCAT3 
than oleoyl-CoA. However, LPCAT3 showed highest catalytic efficiency for oleoyl-CoA 
among all acyl-CoAs.  The enzyme showed similar affinity for arachidonoyl-CoA and 
oleoyl-CoA but lesser capacity. LPCAT3 showed higher apparent Km for arachidonoyl-
CoA compared to LPCAT2 (55.8 μM vs. 21.1 μM). Depending on physiological 
concentrations of arachidonoyl-CoA, LPCAT3 might be responsible for enrichment of 
this acyl group in the sn-2 position of phosphatidylcholine. Previous studies have shown 
that lysoPC in rat liver microsomes is acylated in vitro preferentially by oleoyl CoA (4-
 143
 
fold higher) in comparison to the stearoyl-CoA at 15μM (Lands 1963).  It is not known 
whether LPCAT3 is responsible for the LPCAT activity reported in liver. The enzyme 
activity seems to be not only affected by the presence of a double bond but also by the 
position of the double bond. Linolenoyl CoA, a n-3 fatty acyl CoA was utilized at higher 
concentrations compared to other acyl donors and showed activity even at concentrations 
beyond 150 µM at which the LPCAT activity declined for oleoyl and arachidonoyl CoA. 
Thus the kinetic parameters for linolenoyl CoA could not be accurately measured. The 
enzyme did not seem to show robust activity with linolenoyl CoA in comparison to n-9 or 
n-6 fatty acyl CoA.  Perhaps, the position of the double bond hinders in the effective 
formation of enzyme substrate complex. The ability of the enzyme to discern between the 
substrates with different position of double bonds might spare linolenic acid as precursor 
to docosahexaenoic acid and eicosapentaenoic acid. Interestingly, endogenous LPCAT 
activity in Sf-9 cells had low Km for all the acyl donors. Calcium independent PLA2 has 
been reported in the Sf-9 cells (Yeh 1997) however, lysophospholipid acyltransferase 
activity has not been characterized. Identification of this LPCAT activity in insect cells 
will be the subject of future studies. 
The physiological role of LPCAT3 mediated activity in the maintenance of acyl 
chain composition of phospholipids can only be speculated by its expression pattern in 
various tissues. LPCAT3 is highly expressed in adipose tissue and endothelial cells of 
bone marrow (CD34+, CD71+, or CD105+).  In adipocytes, LPCAT3 might be involved in 
regulation of the acyl chain composition of the adipocyte membrane phospholipids which 
in turn might regulate the properties of adipocyte membranes.  
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The binding property of insulin receptor has been shown to be affected by the acyl 
group composition of surrounding phospholipids in membrane (Gould 1982). Adipocytes 
from rats fed on diet rich in polyunsaturated fats bound more insulin than the cells from 
animals fed diets rich in saturated fats (Field 1988). It is possible that LPCAT3 mediated 
changes in acyl chain composition of membrane phospholipids in adipocytes has a role in 
modulating the insulin sensitivity. In addition, LPCAT3 introduced arachidonic acid in 
lysoPC when released by PLA2 might prime the formation of eicosanoids in adipocytes. 
Arachidonic acid derived eicosanoids PGF2α and PGJ2 have been shown to act as 
ligands for peroxisome proliferator-activated receptor gamma, a nuclear receptor that 
plays an important role in adipocyte differentiation (Reginato 1998). Recently, mouse 
lysocardiolipin acyltransferase (LyCAT) a member of AGPAT gene family, part of 
cardiolipin remodeling pathway, was shown to be required for hematopoietic and 
endothelial cell development in mouse embryonic stem cells. High LyCAT mRNA levels 
were detected in CD31+ and CD45- endothelial cells in adult mouse bone marrow. 
Overexpression of LyCAT in mouse stem cells increased hematopoietic and endothelial 
gene expression while siRNA mediated knock down of the gene showed an opposite 
effect (Wang 2007). The substrates modified by LyCAT that might have mediated this 
effect were not described. Whether LPCAT3 has similar role in bone marrow endothelial 
cells is not known. Lysophosphatidylcholine has been shown to be proinflammatory in 
nature and has been shown to be a ligand for G-protein- coupled receptors expressed in 
endothelial cells. The lysophospholipid G-protein-coupled receptors regulate a variety of 
cellular functions: cell proliferation and survival, migration and chemotaxis, cytoskeletal 
architecture, cell-cell-contacts and adhesion, Ca2+ homoeostasis and Ca2+-dependent 
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functions (Meyer 2007). It would be interesting to study whether LPCAT3 has any role in 
regulating the levels of ligands for GPCRs. To understand the physiological function of 
LPCAT3, the abundance of phospholipid species was analyzed in Sf-9 cells expressing 
LPCAT3.  Increased levels of disaturated PC (32:0 and 34:0) and decreased levels of 
unsaturated acyl chains in PC (34:2, 36:1, 36:2) was seen. To account for this change in 
acyl chain composition of phospholipids, the endogenous saturated acyl-CoA 
concentrations in Sf-9 cells proposed to be ≤ 5 μM for preferential incorporation of 
saturated acyl groups in phosphatidylcholine by LPCAT3. It needs to be established 
whether similar effect are seen by in vitro or in vivo studies in mammalian system. 
Finally, the identification of human LPCAT3 will enable us to investigate whether other 
human MBOAT protein acylate lysophospholipids and help us understand the role of this 
family in phospholipid remodeling. 
 
 
 
 
 
 
 
 
 
 
 
 146
 
 
 
CHAPTER 5: SUMMARY 
 
 
Triglyceride (TG) molecules allow storage of surplus energy in form of fatty acyl 
chains that are esterified to glycerol molecule. The TG synthetic pathway shares 
substrates (acyl-CoA and glycerol 3-phosphate) and initial steps with phospholipid 
synthesis (Kennedy 1961). The de novo glycerolipid synthetic pathway begins with 
acylation of glycerol-3-phosphate at the sn-1 and sn-2 position in the first two steps to 
form first lysophosphatidic acid (1-acyl glycerol 3-phosphate) and then phosphatidic acid 
(PA) (Figure 1.1).Glycerol 3-phosphate acyltransferase (GPAT) and 1-acyl glycerol-3-
phosphate (AGPAT) catalyze the first and second reaction respectively. Phosphatidic 
acid can be either dephosphorylated by phosphatidic acid phosphatase (PAP) to form 
diacylglycerol (DG) or used as precursor for phospholipid synthesis. The DG formed 
from this reaction is esterified with a third acyl-CoA at the sn-3 position to form TG. This 
terminal reaction is unique to TG synthesis and is mediated by diacylglycerol 
acyltransferase (DGAT). Alternatively, DG can be used by CDP-choline pathway to 
synthesize phosphatidylethanolamine (PE) and phosphatidylcholine (PC) (Kennedy 
1961).  
Cells must maintain a balance between TG and phospholipid synthesis to allow 
for energy storage as well as cell growth. Regulation at the branch point of TG and 
phospholipid synthesis seems likely. Hence we hypothesized that that the rate of TG 
synthesis is regulated at the step of DG esterification and that the DG esterifying enzymes 
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are regulated. Another hypothesis was that cells unable to esterify DG to TG will increase 
glycogen synthesis as an alternative to store energy.  
To understand the intracellular regulation of TG synthesis at the step of 
diacylglycerol esterification we used Saccharomyces cerevisiae as our model system. 
Yeast cells synthesize TG and phospholipids by pathways largely homologous to those in 
mammalian cells (Rajakumari 2008). In yeast the DG esterifying enzymes have been 
completely characterized. Dga1 (a homologue of mammalian DGAT2), and Lro1 (a 
homologue of mammalian lecithin cholesterol acyltransferase) contribute to 98% of TG 
synthesis, and the residual activity is contributed by Are2 (a homologue of mammalian 
DGAT1) (Oelkers 2002). To address our hypothesis we first identified genetic 
backgrounds and growth conditions where TG synthesis was altered. Next step was to 
determine whether in these conditions, changes in the mRNA, protein or activity levels of 
Dga1 and Lro1 were responsible for altering TG synthesis. We also measured glycogen 
levels in TG deficient yeast cells to examine any evidence of coordinated regulation of 
energy stores. 
Among the genetic backgrounds which were examined, disabling fatty acid 
hydrolysis was found to increase TG synthesis by 75%. Addition of inositol and choline, 
water soluble phospholipid precursors to growth media is known to affect the activity of 
phospholipid synthetic enzymes (McCammon 1982) mainly though the presence of 
upstream activating sequence known as inositol and choline responsive element (ICRE) 
or UASINO (Carman 1999).  Although ICRE motifs are not found upstream of DGA1 and 
LRO1, genes encoding for DG esterifying enzymes in yeast (Saccharomyces Genome 
Database) we hypothesized that perturbations in phospholipid synthetic pathway would 
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affect TG synthesis as these pathways share initial steps and have common intermdiates 
of glycerolipid synthesis.  However addition of inositol and choline did not affect TG 
synthesis. Absence of glycogen synthesis did not stimulate storage of energy in TG and 
vice versa. This result established TG and glycogen synthesis are not coordinately 
regulated in the growth conditions utilized. Glycogen levels in wild type yeast have been 
shown to increase 8 fold in response to poor nitrogen media (Francois 2001). It would be 
interesting to see whether yeast cells unable to store glycogen in nitrogen poor media 
upregulate their TG synthesis.   
Variability in the measurement of mRNA and protein levels of the DG esterifying 
enzymes did not allow us to examine the changes at transcriptional or translational level. 
In vitro microsomal DGAT assays were performed and Dga1 mediated DGAT activity 
showed cooperative kinetics with varying concentrations of oleoyl-CoA. Results from 
studies on permeabilized rat hepatocytes in the presence of saturating amounts of glycerol 
3-phosphate and DG suggest that the rate of TG synthesis might be determined by acyl-
CoA supply and the affinity of DGAT for acyl-CoA (Stals 1994). Perhaps positive 
cooperativity with oleoyl-CoA can amplify the response of the enzyme to the substrate. 
At a fixed concentration of 50μM oleoyl-CoA and palmitoyl-CoA are preferred substrates 
for Dga1 (Oelkers 2002). 
To address the possibility of allosteric regulation of DG esterifying enzymes in 
vitro microsomal DGAT activity assays were performed in the presence of metabolites 
indicative of cellular energy status, ATP, ADP, AMP, NAD, NADH, acetyl-CoA and 
malonyl-CoA. No changes in the kinetic parameters of Dga1 were seen by addition of 
these metabolites. We further addressed the question whether the regulation of TG 
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synthesis occurs at the level of phosphatidic acid (PA), another branch point in the TG 
and phospholipid synthetic pathway. Another possibility at the time was whether AGPAT 
which catalyzes the synthesis of PA by introducing acyl chain at sn-2 position might 
determine asymmetrical distribution of acyl groups (saturated at sn-1 and unsaturated at 
sn-2 position) in phospholipids.  
Slc1 was the only known AGPAT in yeast when we began our study. The fact that 
slc1∆ deletion mutants retained ~ 50% of the total microsomal AGPAT activity indicated 
the presence of another AGPAT (Athenstaedt 1997). Since synthesis of phosphatidic acid 
is an essential requirement for de novo synthesis of phospholipids we hypothesized that 
absence of SLC1 in conjunction with the novel AGPAT gene in a haploid cell would be 
lethal.  A synthetic lethality screen was performed by crossing a slc1∆ strain with each of 
~ 5000 viable single deletion haploids in collaboration with Charlie Boone, University of 
Toronto. Synthetic lethality screen identified LPT1 (YOR175c), a member of membrane-
bound-O-acyltransferase (MBOAT) super family. LPT1 does not share sequence 
similarity with SLC1. The lpt1∆ cell lysates did not show significant decrease in vitro 
AGPAT activity, possibly due to up regulation of SLC1 activity. 
 Since the depletion of Lpt1 did not affect the AGPAT activity, we further studied 
whether the overexpression of Lpt1 would influence AGPAT activity. Overexpression of 
LPT1 led to 7-fold increase in AGPAT activity suggesting that Lpt1 can mediate this 
reaction.  Subsequent experiments showed that Lpt1 can mediate lysophospholipid 
acyltransferase (LPLAT) reaction by the introduction of acyl chains in the sn-2 position 
of lysophospholipids. In lpt1∆ yeast cells there was a complete loss of LPLAT activity 
suggesting that Lpt1 is the major LPLAT in yeast (Jain 2007). The acyl chain selectivity 
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studies on Lpt1 showed high capacity for unsaturated species but low affinity for 
saturated species. LPLAT is the reacylation arm of Lands cycle, which involves acyl 
chain remodeling of de novo synthesized phospholipids at the sn-2 position by 
phospholipase A2 mediated deacylation followed by reacylation. This phospholipid 
remodeling is believed to result in positional distribution of saturated acyl groups in sn-1 
and unsaturated acyl groups in sn-2 position (Lands 1960). In yeast, LysoPC 
acyltransferase activity was reported but the enzyme-gene relationship was not 
established (Yamada 1977; Richard 1998). In lpt1∆ yeast cells there is 30% reduction in 
incorporation of [3H] oleate in phosphatidylcholine (PC) presumably due to lack of 
LPLAT activity in yeast. We established that Lpt1 is the novel LPLAT/AGPAT in yeast 
which might be responsible for selective incorporation of acyl chains in sn-2 position of 
lysophospholipids (Jain 2007). LPT1 does not share sequence similarity with lysoPC 
acyltransferase-1 (LPCAT1) and lysoPC acyltransferase-2 (LPCAT2) the only LPCATs 
which have been characterized so far and is a member of MBOAT family which is 
conserved across species (Figure 5.1).The amino acid sequence of LPT1 encoded protein 
is 25% identical to human MBOAT1, MBOAT2 and MBOAT5 proteins (Figure 5.2).To 
determine whether MBOAT5 possessed LPLAT activity similar to Lpt1 we expressed 
human MBOAT5 in Sf-9 cells. Cell lysates prepared from insect cells expressing human 
MBOAT5 showed 10-fold higher [14C] lysoPC incorporation in PC with oleoyl-CoA over 
the GST-expressing controls. Further experiments showed that MBOAT5 preferentially 
utilized lysoPC compared to other lysophospholipid species suggesting that it is a 
LPCAT. We therefore renamed MBOAT5 as LPCAT3. MBOAT5 similar to Lpt1 shows 
more activity with unsaturated acyl-CoAs but has low affinity for saturated acyl-CoA.  
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Figure 5.1 Evolutionary dendogram showing homologs of Lpt1 in other eukaryotes 
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Figure 5.2 Dendogram showing Lpt1 homologs in human MBOAT family 
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There are 16 human MBOAT proteins of which only 3 have been characterized. 
These characterized proteins include cholesterol acyltransferases (ACAT1 and ACAT2) 
and DGAT1. While our study was in progress, MBOAT7 was characterized as a 
lysophosphatidylinositol acyltransferase (Lee 2007). Perhaps each human MBOAT 
protein specifically esterifies a lysophospholipid species unlike Lpt1 in yeast which has 
broad substrate specificity. To elucidate the physiological role of LPCAT3, the 
abundance of phospholipid species was analyzed in Sf-9 cells expressing LPCAT3. There 
was an increase in PC species with saturated acyl chains and decrease in unsaturated PC 
species in cells expressing LPCAT3.  Although it needs to be established whether similar 
effect are seen by in vitro or in vivo studies in mammalian system this finding does 
suggest that LPCAT3 might be responsible for asymmetric distribution of acyl groups  in 
phosphatidylcholine in tissues where it is highly expressed (adipose and endothelial 
cells). 
Significance of the findings:  
1. A new genetic background (pox1∆) in which TG synthesis is altered was 
identified.The kinetic paramters (Km and Vmax) of Dga1, the DG esterifying 
enzyme in S.cerevisiae were determined and it was shown that the enzyme 
displays cooperative kinetics for oleoyl-CoA. The enzyme activity was not 
regulated by AMP, ADP, ATP, NAD+, NADH, acetyl-CoA and malonyl-CoA, the 
levels of which are sensitive to energy status of cell. No coordinated regulation in 
triglyceride synthesis and glycogen synthesis was seen in energy rich conditions. 
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2. A novel AGPAT/ LPLAT, distinct from the known AGPAT or LPCAT families 
was identified in Saccharomyces cerevisiae. Molecular characterization of the 
novel AGPAT has completed the characterization of almost all of the enzymes in 
the triglyceride synthetic pathway. 
3. Human LPCAT3, a member of MBOAT family was identified by its sequence 
similarity to LPT1. Other members of MBOAT family (MBOAT1 and MBOAT2) 
that share sequence similarity to MBOAT5 will be the subject of future studies. 
4. Identification of novel lysophospholipid acyltransferases will enable us to 
understand the role of these acyltransferases in remodeling of acyl chains in 
phospholipids and their physiologicsl role in the tissues where they are highly 
expressed. 
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APPENDIX 1:  GENERAL STRUCTURE OF GLYCEROLIPIDS 
 
 
1. Glycerol 
 
 
 
 
 
 
2. Fatty acids   
    
 
 
 
 
 
 
 
 
 
 
 
 
 
3. Monoacylglycerol 
 
 
4. Diacylglycerol  
 
 
 
 
 
 
 
5. Triacylglycerol or Triglyceride 
 
 
 
 
 
Palmitate (16:0) 
CH3 CH2CH2CH2CH2 CH2 CH2CH2CH2CH2CH2 CH2 CH2 CH2 CH2 C 
O
O -1 
CH3 CH2CH2CH2CH2 CH2 CH2 CHCHCH2CH2 CH2CH2CH2 CH2 
O -C
O
Oleate (18:1) 
CH2 CH2
10 9 1 
Linoleate (18:2) 
CH3 CHCH2CH2CH2 CH2 CH2 CHCHCH2CH CH2CH2CH2 CH2 
O -C
O
CH2 CH2
10 9 12 1 
O
CH3 CHCH2CH2CH2 CH2 CH2 CHCHCH2CH CH2CH2CH2 CH2 
O -
CCH2 CH2
11 5 14 
Arachidonate (20:4)
CH2CH2
8 1 
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6. Phosphatidylcholine 
 
 
 
 
 
 
7. Phosphatidylethanolamine 
 
 
 
 
 
 
8. Phosphatidylserine   
 
 
 
 
 
 
 
 
9. Phosphatidylinositol  
 
 
 
 
 
 
 
 
 
 
 
10. Phosphatidylglycerol 
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11. Cardiolipin   
 
 
 
 
 
 
 
 
 
 
 
12. Platelet Activating Factor  
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APPENDIX 2: MISCELLANEOUS EXPERIMENTS 
 
1. Effect of pox1∆, tgl3∆tgl4∆tgl5∆ on glycogen levels 
Rationale: The pox1∆ shows 75% more incorporation of [3H] oleate in triglyceride 
(TG) compared to the normal strain. The tgl3∆tgl4∆tgl5∆ was also chosen because 
Tgl3, Tgl4 and Tgl5 are TG lipases hence absence of the lipases leads to 
accumulation of TG in yeast cell.  Cells store energy in form of TG and glycogen and 
if there is coordinated regulation between these two energy reserves the glycogen 
synthesis will be down regulated when TG accumulates in yeast cell. 
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Figure A1. Glycogen levels in pox1, tgl3∆tgl4∆tgl5∆ yeast strains. 
Yeast strains were grown in YPD to an O.D.660 of 1.4 to 3.6. The cells 
were lysed, boiled, treated with amyloglucosidase and glucose oxidase in 
order to determine the amount of glycogen present. n=1 
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Result: Although the expected trend was seen in pox1∆ strain at O.D. 2.6-3.6 but 
glycogen levels remain unchanged in tgl3∆tgl4∆tgl5∆ yeast strain for most part of the 
growth curve. At O.D. 3.6 20% increase in triple deletion was seen which was contrary to 
what we hypothesized. The experiment was not pursued due to ade2 mutation in pox1∆ 
strain which caused the strain to grow faster in comparison to other yeast strains. 
2. Effect of cerulenin, fatty acid synthase inhibitor on glycogen levels 
Rationale: Cerulenin specifically inhibits fatty acid synthesis in yeast. This would 
decrease TG synthesis and would increase glycogen synthesis in case these energy 
reserves are coordinately regulated.  
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Figure A2. Effect of cerulenin on glycogen levels in wild type yeast strain Yeast 
strains were grown in YPD to log phase. The cells were lysed, boiled, treated with 
amyloglucosidase and glucose oxidase in order to determine the amount of glycogen 
present. n=1 
 
    
 
 178
 
Experimental Set up: Wild type strain was grown to O.D. 3.6. 40 ml of the culture was 
split into 8 tubes with 5 ml in each tube. 5μl of cerulenin was added to 4 tubes. The cells 
were harvested at 0 hour, 0.5 hour, 1 hour and 3 hours after the addition of cerulenin. In 
parallel cells were harvested from culture without cerulenin. 
Result: No difference in glycogen levels were seen in wild type yeast strain treated with 
cerulenin in comparison to untreated yeast strain. 
3. Effect of inositol and choline on TG synthesis at different growth phases 
Rationale: Addition of water soluble phospholipid precursors (inositol and choline or 
both) would affect phospholipid synthetic enzymes (reviewed in chapter 1) and hence 
TG synthesis. 
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Figure A3. Effect of inositol and choline on TG synthesis in wild type yeast 
strain at different growth phases, n=1 
 
Experimental Set up:  Wild type yeast strain was grown to different growth 
phases (O.D. 0.6 to 3) in synthetic complete media with 50µM inositol, 1 mM 
choline or both to log phase and labeled with [3H] oleate.  
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Result:  At O.D. 0.6 we have seen earlier that inositol alone or with choline shows 
decrease in TG synthesis. However this result is not reproducible. At O.D. 1.6 the 
addition of inositol or choline or both does not have a pronounced effect. At O.D. 
3 the addition of inositol does not show any effect on TG synthesis while addition 
of inositol and choline decreases TG synthesis. According to literature addition of 
choline to inositol enhances its effects. 
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